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ABSTRACT
This thesis investigates the effects of modification of crystals, resulting from
alternative crystallization techniques, on the compaction properties of paracetamol.
Paracetamol was subjected to different crystallization procedures in the absence or
presence of polyvinylpyrrolidone (PVP) as an additive. The drug crystals were
characterized using scanning electron microscopy, differential scanning calorimetry
(DSC), infrared spectroscopy (IR) and X-ray powder diffraction (XPD) to assess their
habit and solid state characteristics. Sieved fractions of untreated and the modified
forms of paracetamol were compressed at different compaction forces and speeds
using a high speed compaction simulator. The elastic recoveries and the crushing
strengths of tablets, and the Heckel constants and energies involved during
compaction were used to investigate their compaction properties.
Compression of two different particle sizes of untreated paracetamol produced
extremely weak tablets with a high tendency to cap. The results of Heckel analyses,
including low correlation coefficient of initial part of Heckel plot, low degree of strain
rate sensitivity (SRS), and increase in mean yield pressure (MYP) with decrease in
particle size, indicated that the main mechanism of compaction of paracetamol was
fragmentation. The phase III of Heckel plots, elastic recoveries and elastic energies
of tablets indicated that paracetamol underwent a high elastic deformation during
compaction. The elastic energy/plastic energy (EE/PE) ratio indicated that the
majority of energy involved during compaction was utilized as elastic energy which
increased with increasing compaction force or speed.
Prismatic polyhedral crystals of paracetamol were prepared by cooling an aqueous
saturated solution of paracetamol at 65°C to 25°C. Thin plate-like crystals were
prepared by adding a concentrated solution of paracetamol in hot ethanol to water
at 3°C. This was termed the watering-out method. IR, XPD and DSC studies
confirmed that these two forms of crystals were structurally similar, therefore
polymorphic modifications were ruled out. Compression of both polyhedral and plate-
like crystals, similar to untreated paracetamol, produced very weak tablets with a
high tendency to cap. The crystal habit had influenced the compression properties
of paracetamol, the Heckel plots and their associated constants being dependent on
the habits. The correlation coefficient of the initial part of Heckel plots, and also the
values of SRS, were lower for thin plate-like crystals, indicative of greater
fragmentation for the plate crystals as compared to polyhedral crystals. The tablets
made from plate-like crystals exhibited higher elastic recoveries and elastic energies.
These indicated that thin plate-like crystals underwent more elastic deformation
during compaction than the polyhedral crystals.
Crystallization of paracetamol by a combination of watering-out and in the presence
of 0.5% w/v of PVP 10000 or PVP 50000 produced near spherical, agglomerated
particles, consisting of numerous rod-shaped microcrystals. Particles crystallized in
the presence of PVP 2000 consisted of fewer microcrystals. IR, XPD and DSC proved
that paracetamol crystallized in the presence of PVP had not undergone polymorphic
modification. The tablets made from particles crystallized in the presence of PVP
10000 or 50000 exhibited excellent hardness and lack of tendency to cap, even at
high compression speeds. The very low values of SRS for these particles was
indicative of a high degree of fragmentation during compaction. Low deviations from
the horizontal of the phase III of the Heckel plots and low elastic recoveries and
elastic energies of tablets were indicative of less elastic behaviour than untreated
paracetamol. The low EE/PE ratio for paracetamol crystallized in the presence of
PVP, indicated that contrary to untreated paracetamol, a minor portion of
compaction energy was utilised as elastic energy.
H.A. GAREKANI
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CHAPTER 1 INTRODUCTION
1.1 GENERAL INTRODUCTION
Crystal morphology plays an important role in the physico-mechanical
behaviour of drug substances. The performance of a drug in a pharmaceutical
formulation may depend on its polymorphism and crystal habit. Certain
habits of a particular drug may be disliked because they produce difficulties
during or after production. For example, one crystal habit of a drug may
tablet well while another may not. One polymorph may sh<c' better €thiity
and bioavaiability than another polymorph of the same drug (Haleblian,
1975). York (1992), in his review article, referred to the work of Hallas-Moler
et a! (1952) which revealed that the solubility of insulin was determined by
its solid states (amorphous, crystalline or size of crystal) and also by other
parameters such as the zinc content. Therefore, it is necessary to modify the
type of drug crystals produced by control over the crystallization process.
Crystallization is widely employed for purification of the majority of drugs.
However, as a result of changes in the crystallization conditions, alterations
in the properties of the resultant crystals can occur. In recent years, a
number of examples have been reported whereby improved control over the
crystallization or particle preparation stage has produced material with the
desired properties.
York (1992) referred to two major questions about this research area:
1
1-Is it possible to prepare "designer material" crystals with preferred
processing properties giving optimised product characteristics?
2-How can such materials be efficiently manufactured?
The concept of engineering materials with improved properties is widely
applied in many industries. Examples include the use of metallic alloys,
semiconductors and polymer composites. However until recently, its
application in the pharmaceutical industry has been minimal. There are a
limited number of examples in the pharmaceutical literature of attempts to
deliberately alter the properties of crystals by alternative crystallization
procedures. This technique has been termed "crystal engineering".
Crystal and particle engineering of drugs can play a significant role in the
design of materials for compaction. Therefore, the driving force for controlled
modification must be to provide the required properties for direct compression
or good compressional behaviour and to overcome the deficiencies in the
unmodified material which lead to problems in tabletting and compaction
(York, 1992). For example, different mechanical properties exhibited by
various forms of lactose can be related to the crystallization and pretreatment
procedures (Bolhuis, 1988). Slow crystallization of lactose produces single
crystals with plane faces for a-lactose monohydrate, whilst rapid
crystallization or dehydration of the crystals result in aggregates of
microcrystals of anhydrous a-lactose and anhydrous n-lactose. These
aggregates undergo an intensive fragmentation under compaction, leading to
2
higher tablet crushing strength compared with a-lactose monohydrate. The
superior bonding ability of spray-dried lactose monohydrate can be attributed
to the presence of an amorphous phase of lactose which exhibits plastic flow
during compaction (Boihuis, 1988).
Since, a study of the effect of alternative crystallization processes on the
properties of a drug crystals and ultimately on their compaction behaviour
will be presented in this thesis, it is now appropriate to examine the theory
and relevant literature pertaining to the two major areas of this project, i.e.
1- Crystallization and crystalline states and 2- Compaction.
1.2 THE CRYSTALLIZATION PROCESS
Crystallization process is usually used to obtain drug substances with a high
chemical purity (by leaving impurities in the mother solvent) or to achieve
better or different crystal shapes and sizes. The crystallization process ranks
high in the list of industrial processes devoted to the production of pure
crystals (Mullin, 1993). Apart from the fact that its final product has an
attractive appearance, crystallization frequently proves to be the
cheapest and sometimes the easiest way in which a pure substance can be
produced.
Crystals may be grown from the vapour of the substance (sublimation), from
the melt or from a solution in a suitable solvent. However, crystallization
from solution is of most interest because, firstly, most solids are purified by
3
recrystallization from solution and secondly, interesting changes of habit may
be brought about either by changing from one solvent to another or by adding
a second solute (additive) to the solution (Wells, 1946).
1.2.1 CRYSTALLIZATION STAGES
The process of crystallization consists of three main stages:
1.2.1.1 Production of a supersaturated solution
A solution that consists of solute and solvent in equilibrium is said to be
saturated. However, if the concentration of solute is raised above that in the
saturated state, the solution is considered to be supersaturated.
Supersaturation can be achieved by both cooling a solution or removing the
solvent by evaporation.
1.2.1.2 Formation of crystal nuclei
The condition of supersaturation alone is not sufficient cause for a system to
begin to crystallize. Before crystals can develop there must exist in the
solution a number of minute solid bodies, nuclei or seeds, that can act as
centre of crystallization. Nucleation is the production of the smallest possible
particles (or nuclei) in a supersaturated solution of a substance which is
being crystallized. These nuclei then act as centres for further agglomeration
of solute molecules or ions. This process may occur spontaneously or it may
be induced by the addition of foreign particles, termed homogeneous and
heterogeneous nucleation, respectively (Mullin, 1993).
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The formation of crystal nuclei is a difficult process to envisage. The solute
molecules (building units) have to become oriented into a fixed lattice. Before
formation of nuclei, critical clusters are produced. Further addition of
molecules to the critical cluster results in nucleation. The number of
molecules in a stable nucleus can vary from about ten to several thousands
and they are too small to observe directly.
1.2.1.3 Growth of the crystals
As soon as the stable nuclei have been formed in a supersaturated system,
they begin to grow in crystals of visible size. There are three proposed
mechanisms to explain crystal growth: 1- the diffusion mechanism, 2- the
adsorption layer mechanism and 3- the surface energy mechanism (Mullin,
1993).
1.2.1.3.1 Diffusion mechanism
This mechanism is thought to consist of two steps:
1- diffusion of the solute molecules through the bulk of the supersaturated
solution to the solid surface.
2- incorporation of these adsorbed molecules inth the crystal lattice.
1.2.1.3.2 Adsorption layer mechanism
This mechanism proposes that growth occurs via adsorption onto a crystal
surface, layer-by-layer and is controlled by the formation of two-dimensional
surface nuclei.
5
1.2.1.3.3 Surface energy mechanism
According to this mechanism the equilibrium shape of a crystal is related to
the free energies of the faces, suggesting that the crystal faces would grow at
rates proportional to their respective surface free energies.
1.2.2 INDUCTION PERIOD
A period of time usually elapses between the achievement of supersaturation
and the appearance of crystals. This time lag is known as the "induction
period". This period is considerably influenced by the Ieve
and presence of impurities. The induction period may therefore be considered
as being made up of several parts. For example a certain relaxation time (tr)
is required for the system to achieve a quasi-steady-state distribution of
molecular clusters. Time is also required for formation of a stable nucleus (ta)
and then time is required for the nucleus to grow to a detectable size (t,). The
induction period (tjd) may be written therefore as: tj fld=tI.+tfl+tg (Mullin, 1993).
Factors that can influence the induction time are: temperature, agitation,
degree of supersaturation, seeding and the presence of impurity. The
presence of seeds generally reduces the induction period. At very high
supersaturation, the induction period can be extremely short. Induction times
are often measured visually. However, when tind is less than about 5 s, a
sensitive and fast method such as laser light scattering must be used for
detection of changes in the system.
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1.2.3 INFLUENCE OF IMPURITIES ON NUCLEATION, INDUCTION TIME
AND CRYSTAL GROWTH
The presence of impurities in a crystallization system can have a profound
effect on nucleation, induction time and crystal growth. It has long been
known that the presence of small amounts of high molecular weight
substances such as gelatin, sodium carboxyrnethylcellulose or polyacrylamide
can suppress or inhibit the nucleation and subsequently increase the
induction time during crystallization from an aqueous solution (Davey, 1982).
Traces of foreign ions, especially Cr3 and Fe3 , can have a similar action on
inorganic salts. The modes of action of high molecular weight substances and
cations are probably quite different. The former renders the nuclei inactive
by adsorbing on their surfaces, whereas the latter may act as structure-
breakers of nuclei (Mullin, 1993).
Although some impurities can suppress growth, others may exert a highly
selective effect on certain crystal faces and thus modifSr the crystal habit in
specific directions which will be discussed later. Impurities can influence
crystal growth rates. They can change the equilibrium solubility and hence
the degree of supersaturation. They can alter the characteristics of the
adsorption layer at the crystal-solution interface and influence the integration
of growth units (Mullin, 1993).
1.2.4 HABIT MODIFICATION
Without altering the internal structure, crystals can change their habit
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(external appearance) due to variations in face dimensions or the appearance
or disappearance of some faces (Khamskii, 1976). An important parameter
liable to be affected by the crystallization process is crystal habit. Under
certain conditions of crystallization one set of crystal faces may be induced
to grow faster than others, or the growth of another set of faces may be
retarded. For example, one method of crystallization may favour an acicular
(needle) habit, while another may give a tabular habit (plates or flakes). This
variation is termed modification of habit. Figure 1.1 shows three different
habits of a crystal belonging to the hexagonal system. The centre diagram (b)
shows the predominant crystal with prismatic habit, whereas stunted growth
in the vertical direction results in tabular crystals (a). An elongated growth
in the vertical direction yields needle or acicular crystals (c).
(a) Tabular	 (b) Prismatic
	 Cc) Acicular
Figure 1.1 Different crystal habit of a hexagonal crystal.
1.2.4.1 Industrial importance of habit modification
Certain crystal habits are disliked in commercial industry because they may
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give the crystalline mass a poor appearance, induce poor flow characteristics
or give rise to difficulties in the handling or packaging of materials
(Haleblian, 1975). Properties such as dissolution rate, powder flow and
compressibility which are of pharmaceutical interest, can also differ for
various habits of the same material (York, 1983; Marshall & York, 1991).
Therefore, the reproducible modification of crystal habit using alternative
crystallization techniques may facilitate the production of powders with
desirable properties.
The different crystal forms of a particular drug possess different planes and
thus differ not only in their specific surface, but also in their free surface
energy. Therefore they may exhibit different physico-mechanical properties
(Huttenrauch, 1983). Crystal habit can be an important parameter which
may affect the compressibility of a particular drug. Poor compressibility of a
specific habit of a particular drug can be attributed to the presence of crystal
faces that give poor adhesion to each other and the absence of faces that are
required for optimal adhesion (Miosovich, 1963).
1.2.5 FACTORS AFFECTING THE CRYSTAL HABIT
The morphology of a crystal depends on the growth rates of the different
crystallographic faces. The growth of a given face is governed by the crystal
structure on the one hand and by the local environmental conditions on the
other. A number of factors which may affect the morphology of a crystal
during crystallization process include; the presence of impurities, type of
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solvent, degree of supersaturation and rate of crystallization, i.e. the rate of
cooling or evaporation.
1.2.5.1 Influence of impurities on habit modification
One of the most common causes of habit modification is the presence of
impurities in the crystallizing solution. Sometimes the impurities are added
deliberately to produce desirable crystal habits (York, 1983). The case where
a new chemical compound is formed as a result of chemical reaction between
the impurity and the substance being crystallized, is not considered as a
habit modification (Khamskii, 1976).
The presence of a small amount of an effective additive in the crystallization
medium can dramatically reduce the nucleation and crystal growth and also
change the crystal size and shape. These effects were attributed to the
adsorption of the additive at the growth sites (Davey, 1982). The degree of
interaction (adsorption) between the additive and the crystal surface depends
on their chemical and structural properties such as anionic or cationic groups
or to the possibility of the formation of hydrogen bonds (Khamskii, 1976;
Davey, 1982).
The additives used in crystallization procedures may be classified into several
groups (Davey, 1982; Mullin, 1993):
1- Surface active agents (surfactants), e.g. alkyl suiphates,
2- Low molecular weight organic substances e.g. citric or succinic acids,
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3- Low molecular weight inorganic substances e.g. sodium triphosphate,
4- Polymeric materials e.g. polyvinylalcohol and alginates, and
5- Long chain proteinaceous materials e.g. gelatin.
A modification of habit will result if the impurity exerts a selectivity towards
certain faces of the crystal. It has been suggested that the impurity molecules
bind stereospecifically to growth sites in a similar manner to the substrate
molecules. However, due to the modified side chain of the impurity, the
regular deposition of substrate molecules in certain directions is disturbed.
Thus, the growth rates in these directions are reduced, producing a change
in crystal morphology (Mullin, 1993; Berkovitch-Yellin et al, 1982; 1985). A
simple example in this case is the modification of benzamide crystals in the
presence of three different impurities; benzoic acid, o-toluamide or p-
toluamide. All these three substances, which have similar structure to
benzamide but contain substituent groups, were capable of retarding the
growth rates along specific directions (Berkovitch-Yellin et al, 1982).
One of the initial investigations into the effect of impurities on the crystal
habits of pharmaceuticals was performed by Michaels and Colville (1960)
using the excipient adipic acid. The facial growth rates of the adipic acid
crystals were reduced by the presence of both anionic and cationic
surfactants. An anionic agent (sodium tetrapropyl benzene sulphonate)
caused the production of needle-like particles whereas a cationic surfactant
(trimethyl dodecyl ammonium chloride) led to the formation of thin plates or
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flakes. Fairbrother and Grant (1978, 1979) in similar studies, reported that
the crystallization of adipic acid from solutions containing alkanols produced
elongated rods and in the presence of alkanoic acids produced plate-form
crystals. These studies were expanded by Chow et al (1984, 1985), who
investigated the effect of these processes on the crystal properties, such as
density, specific surface area, melting point, enthalpy of fusion and
dissolution rate.
Chow et al (1985) and, Chow and Grant (1988a,b) crystallized paracetamol
from water containing various concentrations of para-acetoxy-acetanilide as
an additive. Negligible amounts of the additive were incorporated into the
crystals. Its presence changed the crystal habit (shape), surface properties,
melting point and dissolution rate of the crystals.
Sometimes the impurities are added to the crystallization medium to enhance
the dissolution rates of poorly soluble drugs. Dissolution rates of
chioramphenicol, suiphathiazole, and prednisolone were markedly increased
by crystallization from aqueous solutions containing small amounts of a
surfactant, polysorbate 80 (Chiou et al, 1976). Naggar et al (1980), Ismail et
a! (1987), El-Bary et al (1990), El-Gindy et a! (1982), Shawky and Mesiha
(1988) reported the enhancement of the dissolution rates of the poorly soluble
drugs phenylbutazone, phenacetin, chlorpropamide, nalidixic acid, and
lorazepam following different crystallization techniques from solutions
containing small amounts of polymers or surfactants such as
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polyvinylpyrrolidone or polysorbate. These additives adsorbed onto the
crystals. Chiou et a! (1976) suggested that the presence of small amounts of
surfactant in treated crystals would increase the wettability of the powder
and thereby increase its dissolution rate.
Mackellar et a! (1994 a,b) investigated the effect of the surfactant, poloxamer
188, on the crystallization of ethyl-p-hydroxybenzene. The surfactant resulted
in a decreased particle size and changed the habit from plate to prismatic.
1.2.5.1.1 Assessment of additive activity
Davey (1982) introduced a number of methods to assess the activity
(effectiveness) of additives in influencing the crystallization processes. One
frequent manifestation of an effective additive is that it produces crystals of
a different shape to those formed from a solution in the absence of additive.
The simplest quantitative assessment of the activity of an additive is
obtained by measurement of the time required for the appearance of the solid
phase in the presence or absence of additive. Active additives invariably
extend induction times. Davey (1982) referred to the work of Smith and
Alexander (1970) who showed that during crystallization of CaSO4.2H2O the
induction times greatly increased as the amount of the impurity, polyacrylic
acid, increased.
Effective additives normally decrease the crystal growth rate resulting in a
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decrease in the mass of crystals deposited. Therefore, measuring the
crystallization yield is useful index of the ability of an additive to influence
the crystallization process.
It was explained that the observed effects of additives on crystal habit,
nucleation and crystal growth are due to their adsorption on to the crystal
surfaces. Therefore, measuring the amount of adsorbed additive in the
harvested crystals may also be used to assess the activity of an additive
(Davey, 1982). Chow and Hsia (1991), Gordon and Chow (1992), and Chow
et al (1995) reported that the crystallization of phenytoin in the presence of
three different esters homologue of diphenyihydantoin changed the crystal
habit from needles to elongated plates. They observed a drastic reduction in
crystal yield and also an increase in the amount of adsorbed additive as the
concentration of additives in the crystallization medium increased. The
authors suggested that the most active additive was that one which changed
the crystal habit at the lowest concentration and caused greatest reduction
in crystal yield.
1.2.5.2 Influence of solvent on habit modification
A change of solvent will often result in a change of crystal habit. In general,
the interaction (adsorption) between the solvent molecules and the different
crystal faces is believed to play a major role in determining the crystal
morphology. If adsorption is selective, i.e. only on to specific faces of crystals,
or to different extents on the different faces, different growth rate of faces
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and hence habit modification will be produced (Mullin, 1993).
Berkovitch-Yellin (1985) proposed a method for predicting the habits of
crystals grown from various solvents. He suggested that polar solvents are
preferentially adsorbed by poiar faces and non-polar solvents by non-polar
faces. The polarities of the faces, which are governed by the atoms exposed
normal to the face, were calculated by analyzing their structures. Davey et
a! (1982) demonstrated that crystallization of succinic acid from water or
isopropanol produced plate and needle habits, respectively. They suggested
that the carboxylic acid groups of succinic acid interact presumably through
hydrogen bonding, more strongly with isopropanol than with water. The
stronger adsorption would reduce the growth rate of faces containing
carboxylic acid groups, leading to modifications in the crystal habit.
Garti and Tibika (1980), and Marshall and York (1989) demonstrated that
when nitrofurantoin was crystallized from formic acid and formic acid/water,
its crystal habit was modified. The crystals from formic acid had a tabular
habit whilst those from formic acid/water (a more polar solvent) were needle-
like. These two forms of crystals exhibited different compaction properties
(Marshall & York, 1991).
Gordon and Amin (1984) reported that when ibuprofen was crystallized from
hexane or heptane (the less polar solvent) the crystals were rod or needle
shape, while when it was crystallized from C1-C3 alkanols (polar solvents),
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the crystals were essentially grain-like or hexagonal shape. It was claimed
that the latter crystals exhibited better flow, less static charge, improved
dissolution rate and compaction and binding ability.
Gonda et al (1985) reported that crystallization of hexamethylmelamine from
polar solvents (e.g water, methanol and dichloromethane) yielded
predominantly acicular crystals, but crystallization under similar conditions
from solvents with zero dipole moments (e.g. cyclohexane or benzene)
produced hexagonal crystals. These were habit modifications.
Watanabe et al (1982) reported that crystallization of aspirin from different
types of solvents gave various habits. Aspirin crystals obtained from water
were thin-plate; from methanol, ethanol or acetone were plates or prisms,and
from dioxane or n-heptane were thin needles or elongated prisms. These
different habits, exhibited different dissolution rates.
1.2.5.3 Influence of the degree of supersaturation
The degree of supersaturation of a system, S, can be expressed as shown in
equation 1.1.
S = c/ct	 Equation 1.1
c is the solution concentration and c* is the equilibrium saturation (solubility)
at the crystallization temperature (Mullin, 1993). The degree of
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supersaturation may have a major effect on crystal growth and crystal habit.
By raising or lowering the degree of supersaturation, it is sometimes possible
to cause the preferential growth of crystals in one particular direction and
therefore to produce a considerable control over the crystal habit.
1.2.5.4 Influence of cooling rate
When naphthalene was crystallized by rapid cooling from ethanol or
methanol, it gave thin plates and when it was slowly crystallized, it yielded
compact crystals (Wells, 1946). Garti and Tibika (1980) demonstrated that by
increasing the cooling rate during the crystallization of nitrofurantoin from
a mixture of formic acid/ethanol, more elongated crystals were collected.
These two examples reveal that the rate of cooling is effective in altering the
crystal habit. The cooling rate influences the degree of supersaturation and
consequently the crystal growth and crystal habit. Decreasing the
crystallization temperature will cause the value of c in equation 1.1 to
decrease. Consequently the degree of supersaturation, S, will increase.
1.2.6 CRYSTALLIZATION PROCEDURES
The methods available for crystallization are many and varied but in all cases
a state of supersaturation has first to be achieved. The way in which
supersaturation is produced depends on the characteristics of the crystallizing
system. In this section an account of the most common ways in which
crystallization can be performed, is given.
17
1.2.6.1 Cooling and evaporation
The most common method by which the supersaturation can be achieved is
by means of the cooling process. If the solubiity of the solute in the solvent
decreases with a decrease in temperature, some of the solute will be
deposited on cooling. If the solubility characteristics of the solute in the
solvent are such that there is little change with a reduction in temperature,
some of the solvent may have to be deliberately evaporated from the system
in order to affect the necessary supersaturation and crystal deposition.
1.2.6.2 Crystaffization by solubifity reduction
Another method by which a supersaturated solution can be formed, is by the
addition of a substance that reduces the solubility of the solute. Such a
process is known as salting-out. The added substances may be liquid, solid
or gas. This method is commonly used during crystallization of organic
substances from water-miscible organic solvents, by the controlled addition
of water to the solution. The term "watering-out" is used in this case.
Salting-out has many advantages. For example, very concentrated initial
solutions can be prepared by dissolving the crystals in a small amount of
suitable solvent and a high solute recovery can be made by cooling the
solution in addition to salting it out. However, salting-out can have the
disadvantage of needing a separation device if the solvents and precipitant
have to be recovered (Mullin, 1993).
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1.2.6.3 Spray crystaffization
The term spray crystallization is really a misnomer, because crystals are not
grown by this method. The solid is simply deposited from a very concentrated
solution similar to spray drying. The size and shape of the solid particles
depend to a large extent on those of the spray droplets. The spray method is
often employed when a product with better handling properties can be
produced.
1.2.6.4 Spherical crystaffization
One interesting technique for transforming fine crystals into dense spherical
agglomerates during the crystallization process is spherical crystallization.
The method is based on the addition of a small amount of an immiscible
liquid to a crystallizing system which preferentially wets the developing fine
crystals during agitation. In fact the immiscible solvent acts as a "bridging
agent", encourages the particles to aggregate into spherical agglomerates.
Chloroform, toluene, hexane, hexanol or octanol appear to be the preferred
organic bridging agents in most studies. The original idea was introduced by
Farnand et al (1961) and Sutherland (1962) and the method was developed
by Kawashima et al (1982a, 1984) and kawashima (1984) using salicylic acid
as a model drug. Agitation of a mixture of ethanol-water-chloroform
containing salicylic acid yielded spherically agglomerated particles
(Kawashima et al, 1982a).
Several pharmaceutical substances have been successfully processed by this
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technique in order to improve their flowabiity, compressibility and
dissolution rate. Examples include; aminophylline (Kawashima et al, 1982b),
phenytoin (Kawashima et al, 1986), tolbutamide (Sano et al, 1987), naproxen
(Gordon & Chowhan, 1990), meprobamate (Guillaume et al, 1993) and
bucillamine (Morishima et al, 1993; Morishima et al, 1994).
1.2.6.5 Sublimation
So far, only the crystallization of a solid phase from a liquid phase containing
a suitable solvent has been considered. However, the crystallization of a solid
substance can be induced from a supersaturated vapour by the process
generally known as "sublimation". Sublimation refers only to a phase change
of solid to vapour without the intervention of a liquid phase. In its industrial
application, however, sublimation is include the condensation process as well,
i.e. solid to vapour to solid. Organic compounds which can be purified by
sublimation include naphthalene, camphor, benzoic acid and salicylic acid
(Mullin, 1993).
1.2.6.6 Cooling of a melt
In this case, a melted compound is cooled and if the melt is not pure, the
crystals appearing above the eutectic temperature are pure. This method is
not generally used. Rapid cooling of the melt often produces amorphous
solids.
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1.3 SOLID AND CRYSTALLINE STATES
Characterization of a solid involves verifying its chemical nature, determining
the internal structure and describing the habit of its crystals. The internal
structure of a compound can be classified in a variety of ways, as shown in
figure 1.2. Drugs are mostly organic compounds and are usually crystals or
amorphous substances. Therefore, the first major distinction is whether the
solid is crystalline or amorphous.
CHThIICAL COMPOUND
I	 I
HABiT	 INTERNAL STRUCT(JRE
I	 I
CRYSTALLINE	 AMORPHOUS
I	 I
SINGLE N1TIY
	
MOLECULAR ADDUCTS
I	 I
POLYMORPHS	 I	 I
NONSTOICHIOMETRIC	 STOICHIOMETRIC
INCLUSION COMPOUNDS	 SOLVATES (HYDRATES)
I	 I
CHANEL	 LAYER	 CAGE
(CLATHRATFJ
Figure 1.2 Outline of the differentiation of habit and crystal chemistry of a
compound (after Haleblian, 1975).
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1.3.1 INTERNAL STRUCTURE
Internal structure is the arrangement of building units (atoms, molecules or
ions) in a solid, which are responsible for the characteristics of the substance.
The internal structure of a solid may be investigated by X-ray diffraction.
1.3.2 CRYSTALLINE SOLIDS
A crystalline substance is one in which the molecules, atoms or ions are
positioned and arranged in fixed geometric patterns or lattices. The crystal
lattice can be regarded as a highly ordered structure which repeats itself
regularly in three directions. Crystalline solids show definite melting points,
passing rather sharply from the solid to the liquid state. Most crystals are
anisotropic, i.e. their physical properties such as hardness or optical
properties, can vary according to the direction in which they are measured.
However, crystals belonging to the cubic system are the exception to this rule,
their highly symmetrical internal arrangement renders them isotropic
(Mullin, 1993).
1.3.2.1 Types of crystalline solids
Four main types of crystalline solids may be specified according to the
method of bonding in the solid state, i.e. ionic, covalent, molecular and
metallic.
1- Ionic crystals, e.g. sodium chloride, are composed of charged ions held in
place in the lattice by electrostatic forces.
2- Covalent crystals, e.g. diamond, in which the constituent atoms do not
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carry effective charges, they are connected by a framework of covalent bonds,
the atoms sharing their outer electrons.
3- Molecular crystals, e.g. organic compounds such as paracetamol, are
composed of discrete molecules held together by weak attractive forces like
it-bonds or hydrogen bonds.
4-Metallic crystals, e.g. copper, are comprised of ordered arrays of identical
cations. The constituent atoms share their outer electrons, but these are so
loosely held that they are free to move through the crystal lattice and confer
metallic properties on the solid.
1.3.3 AMORPHOUS SOLIDS
Amorphous solids may be considered as substances in which the molecules
are arranged in a random manner somewhat as in the liquid state. In fact,
the unit building blocks are put together in a non-uniform array. Amorphous
solids are isotropic, i.e. their physical properties are the same, no matter in
which direction they are measured (Mullin, 1993).
Amorphous forms are typically prepared by rapid precipitation, lyophilization,
spray drying or rapid cooling of a melt. Lyophilization of fluprednisolone in
tert-butanol produced the amorphous form of the drug (Haleblian & Koda,
1971). Mullin and Macek (1960) identified two forms ofnovobiocin; crystalline
and amorphous. The crystalline form was more stable chemically but poorly
adsorbed orally. Production of an amorphous form of frusemide using spray
drying was reported by Matsuda et al (1992).
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1.3.4 POLYMORPHISM
Polymorphism is the ability of a compound to crystallize in more than one
crystalline state with a different internal lattice. The best examples of
polymorphs are diamond and graphite. Both are pure carbon but the
arrangement of the atoms is different. Polymorphs generally have different
properties such as melting points, X-ray diffraction patterns, density,
hardness, crystal shape, solubilities, dissolution rate and bulk behaviour,
even though they are chemically identical. They consist of the same atoms,
molecules or ions but in different arrangements (Haleblian & McCrone, 1969).
Two polymorphic forms of tolbutamide have been reported to posses different
powder flow and compaction characteristics (Simmons et al, 1972).
Polymorphic form B was responsible for both powder bridging in the hopper
and extensive capping problems during tabletting. This behaviour was
attributed to the plate-shaped crystals of form B and could be corrected by
using the non-plate-like form A. Tulodhar et al (1981) reported different
dissolution characteristics for phenylbutazone polymorphs. Summers et al
(1977) demonstrated that different polymorphs of suiphathiazole, barbitone
and aspirin differed significantly in their compression characteristics. The
diuretic frusemide has been reported to occur only in one crystal form.
However, Doherty and York (1988), demonstrated that a second polymorph
of frusemide can be crystallized under certain conditions. This polymorph
exhibited a 63% increase in aqueous solubility and a 58% increase in the
dissolution rate, relative to usual form.
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1.3.5 SOLVATES OR STOICHIOMETRIC ADDUCTS
A solvate is a molecular complex in which the molecules of crystallizing
solvent have been incorporated into specific sites within the crystal lattice.
When the incorporated solvent is water, the complex is called a hydrate.
Attention must be given to potential solvate formation during crystallization
as well as wet granulation, since the latter process involves the use of a
solvent. Alternatively if the crystal form is initially a solvate, the drying
process associated with many manufacturing procedures may cause transition
to a desolvated form and alter its properties (York, 1983).
Different dissolution behaviours of the dihydrate, monohydrate and
anhydrate of erythromycin (Allen et al, 1978) and differences in the
dissolution rates and therefore absorption rates of ampidillin in its trihydrate
and anhydrate forms have been reported (Poole et al, 1968). Muller (1977)
suggested that the different crystalline forms of pure magnesium stearate,
plate and needles, were associated with different hydration states and
indicated that its lubricating efficiency could be correlated with its crystalline
structure. Abugela and Grant (1979), and Grant and Abugela (1981) reported
that griseofulvin can form solvates with n-alkanoic acids (C1-C9) during
crystallization from these fatty acids. It has been reported that the
crystallization of nitrofurantoin from a mixture of formic acid and water
caused the production of a monohydrate (Marshall & York, 1987, 1989).
Agbada and York (1991), found different mechanical properties for the
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anhydrous and monohydrate forms of theophylline. The hydrate form showed
better compressibility and produced tablets with higher crushing strengths
compared to anhydrous form. Lerk et al (1983) demonstrated that
dehydration of a-lactose monohydrate strongly increased its binding
properties during compaction.
1.3.6 CLATHRATES OR NONSTOICHIOMETRIC ADDUCTS
A crystalline compound may contain non-stoichiometric amounts of
crystallization solvent which are entrapped solvent molecules within cavities
provided by the crystal lattice. Usually these adducts are undesirable, owing
to a lack of reproducibility and should be avoided (Haleblian, 1975).
1.3.7 CRYSTAL HABIT
Habit is the description of the outer appearance of crystals. The environment
of a crystal may affect its habit. Although crystals can be classified according
to six general systems (cubic, tetragonal, hexagonal, rhombic, monoclimc and
triclinic) (Martin et al, 1983), the relative size of the faces of a particular
crystal can vary considerably. Crystal habit may be modified under certain
conditions of crystallization procedures (see sections 1.2.4 and 1.2.5).
1.3.8 IMPERFECTIONS IN CRYSTALS
As mentioned in section 1.3.2, the crystal lattice can be regarded as a highly
ordered structure which repeats itself regularly in three directions. However,
in practice, disturbances and imperfections are extremely numerous within
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a crystal. In fact, crystals are never completely ordered and perfect, because
during crystal growth the lattice undergoes some imperfections. Spray drying
may cause a relative high degree of imperfection and disorder (Huttenrauch,
1983).
1.3.8.1 Different types of lattice imperfections
There are three main types of lattice imperfection; point defects, line defects
and surface defects. The common point defects are shown in figure 1.3. The
two main types of line defect which can play an important role in the mode
of crystal growth are edge and screw dislocations (figure 1.4). Both of these
are responsible for slip or shearing in crystals. A variety of surface
imperfections, or mismatch boundaries, can be produced in crystalline
materials as a result of mechanical or thermal stresses or irregular growth
(Mullin, 1993).
Figure 1.3 Representation of some common point defects: (A) interstitial
impurity, (B) substitutional impurity, (C) vacancy (after Mullin, 1993).
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Figure 1.4 Two types of line distortion: (a) movement of an edge dislocation
through a crystal, (b) screw dislocation ( after Mullin, 1993).
These defects can influence some important physical and mechanical
properties of crystalline drugs during processing (York, 1983). The frequency
of defects can be related to the ease of fracture during milling (Pilpel, 1977)
as well as deformation during compression (Wert & Thomson, 1970;
Huettenrauch, 1977). The fracture of crystals in brittle materials is also
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associated with crystal lattice defects and imperfections (Hess, 1978).
1.4 COMPACTION OF PHARMACEUTICAL POWDERS
A pharmaceutical powder is a complex physico-chemical system comprising
of particles with different size and shapes. The process of forming powders
into tablets was first described by Brockendon (1843). A tablet is produced by
the compression and consolidation of a known weight of powder between two
punches in a die cavity to a coherent unit as a result of applied pressure.
Variation in the physico-chemical properties of powders may have significant
influence on their compaction behaviour (Jones, 1981).
1.4.1 DIRECT COMPACTION
Direct compression is the process of preparing tablets from mixtures of drag
and excipient powders. The simplicity of this process leads to improved
reliability with a reduction in the complexity of the tablet formulation. The
oldest and widely used tableting technique requires the preparation of
granules. Figure 1.5 highlights the relative complexity of granulation
techniques compared to direct compression. Thus, granulation is a multi-
stage process, certainly involving additional expenditure on equipment,
material handling, personnel and time (Armstrong, 1986). Therefore, the most
important advantages of direct compression are the low cost and rapid
production.
Since, the manufacture of tablets by direct compression offers advantages
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over conventional granulation procedures, the question that may be asked is
"Why are not more tablets made by the direct compression route?" The
answer is that some compounds can not be compressed into tablets without
preliminary treatment such as granulation.
RAW MATERIALS
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COMPRESSION
Figure 1.5 Tablet production by granulation techniques and direct
compression.
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The great majority of drugs do not have the necessary compressibility, but
many of them do not need to. Approximately one third of marketed tablets
contain less than 10 mg of drug and another third contain 10 to 100 mg of
drug (Armstrong, 1986). These two groups of drugs can be compressed into
tablets using a large amount of a suitable direct compression excipient. It is
clear that for these two groups the compressibility of the direct compression
excipient will be the major controlling factor in the compressibility of blends.
Since, the maximal carrying capacity of a direct compression excipient is
limited to 25% of a non-compressible drug (Armstrong, 1986), a drug of a
dosage >100 mg could not be directly compressed because the weight of tablet
will be too large.
1.4.2 MECHANISM OF COMPACTION
Compaction is the general term used to describe the situation when a powder
mass is subjected to some level of mechanical force in a die. The effects of
such forces are particularly important in the manufacture of tablets.
Densification of powders was initially described in terms of "compressibility"
and "compactibility" by Schwarzkof (1947). Leuenberger (1982) defined
compressibility as the ability of a powder to decrease in volume under
pressure while, compactibility was defined as the ability of a powder to be
compressed into a coherent compact of specific strength. A tablet is produced
by the compression and consolidation of a two-phase (particulate solid-gas)
system, due to applied force. Compression means a reduction in the bulk
volume of the material as a result of displacement of the gaseous phase and
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consolidation is an increase in the mechanical strength of material resulting
from particle-particle interaction.
1.4.3 STAGES OF POWDER COMPACTION
Seelig and Wuif (1946) suggested that the process of compaction of powders
in a die may be divided into three stages: a) packing, b) elastic and plastic
deformation and c) cold-working with or without fragmentation. Later the
compression of powders was considered to be as a three stage process: a) die
filling, b) particle movement and rearrangement and c) particle deformation
(Heckel, 1961a,b). All the stages involved during powder compaction
(including compression and decompression) are illustrated in figure 1.6. These
phases do not necessarily occur sequentially and there is sometimes
considerable overlap of the various stages.
1.4.3.1 Die filling
The first step in the compaction process is the filling of the die cavity. In a
single punch tablet press, die filling is achieved by passing a feed hopper
containing the powder over the die space, leading to the formation of a
powder bed. Free flowing powders or granules will permit the uniform filling
of the die specially in a high speed tabletting machine. Poor flow properties
cause a high variation in tablet weights. Particle size and shape have a major
effect on this process. With a small particle size, the initial powder packing,
due to die filling, is decreased. This has been attributed to an increase in the
number of contact points and therefore higher interparticular cohesive forces
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between particles which oppose dense packing (York, 1978).
1.4.3.2 Particle slippage and rearrangement
When powder flows into a die cavity, it will have an untapped (bulk) density.
The onset of compaction load, when the upper punch makes contact with the
surface of crystals, is usually accompanied by closer repacking of the powder
particles. In most cases, this is the main mechanism of initial volume
reduction as shown in figure 1.6. This process is referred to as particle
rearrangement. Heckel (1961b) reported that the amount of particle
rearrangement is dependent upon the particle size and shape while the type
of material has no recognizable effect on this process. Dc Blaey (1972)
reported that the magnitude of the applied pressure required to cause
particle slippage and rearrangement depends on the particle size, particle
shape and the surface characteristics of the particles.
1.4.3.3 Plastic and elastic deformation
During compaction, as the load increases, further compression involves some
type of particle deformation. When any solid particle is subjected to opposing
forces, there is a finite change in its geometry, depending upon the nature of
the applied load (Marshall, 1986). The relative amount of deformation
produced by such forces is a dimensionless quantity called strain. Three of
the commonest types of strain are illustrated in figure 1.7. For example, if a
solid particle (figure 1.7b) with initial length, H 0, is compressed by forces
acting to each end to cause a reduction in length of
	 then the compressive
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Figure 1.6 Diagram of the effect of compressiona force on a bed of powder.
strain Z is given by equation 1.2:
Z = MI/H0	 Equation 1.2
The ratio of force F necessary to produce this strain to the area A over
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which it acts, is called the stress a, as shown in equation 1.3:
a = F/A	 Equation 1.3
If on removal of the load, the deformation is to a large extent spontaneously
reversible, i.e., if it behaves like rubber, then the deformation is said to be
elastic. All solids undergo some elastic deformation, when subjected to
external forces. In other groups of solids, the resulting deformation is not
immediately reversible on removal of the applied force. Bulk volume
reduction in this case results from the plastic deformation, where the
particles are squeezed into the remaining spaces. The ability of a powder th
undergo irreversible plastic deformation during compaction is essential for
tableting. The mechanism of plastic deformation predominates in materials
where the shear strength is less than the tensile or breaking strength (figure
1.7). Conversely, when the shear strength is greater, particles may be
preferentially fractured and the smaller fragments then help to fill up any
adjacent air space. This is most likely to occur with hard, brittle particles and
in fact is known as brittle fracture.
Train (1956) investigated the mechanism of powder compaction using
magnesium carbonate. He suggested that two types of ideal powder
compaction mechanisms exist, namely brittle fracture and plastic flow.
During the compression event, most powders exhibit an initial fragmentation
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Figure 1.7 Changes in the geometry (strain) of a solid body resulting from
various types of applied force: (a) tensile strain, (b) compressive strain and
(c) shear strain (after Marshall, 1986).
stage followed by plastic flow. Ionic crystalline materials such as sodium
chloride and potassium chloride are compressed by plastic deformation (Cole
et al, 1975). Potassium chloride exhibits ideal plastic behaviour due to the
presence of a highly symmetrical ionic crystal lattice containing numerous
slip planes (Hess, 1978).
1.4.3.4 Consolidation (particle bonding)
The ability of a powder mass to reduce in volume during compression does
not ensure the formation of a tablet. It is essential that the powder should
cohere into a suitable form after removal of the applied load. Therefore
plastic deformation and less elasticity are necessary for compression but are
not enough for tableting. There are two hypotheses which purport to explain
the bonding between particles during compaction.
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1- When the surfaces of two particles approach each other closely enough
(less than 50 nm), their free surface energies result in an attractive force
which is known as cold welding. The nature of the bonds so formed are
similar to those of the molecular structure of the interior of the particles.
This hypothesis is favoured as a major reason for the increase in the
mechanical strength of a bed of powder, when subjected to rising compressive
forces (Higuchi et al, 1953; Armstrong & Griffiths 1970; Marshall, 1986).
2-Another hypothesis is fusion bonding (asperitic bonding). Any load applied
to the powder bed must be transmitted through the interparticulate contacts.
Under appreciable forces, this transmission may result in the generation of
considerable frictional heat. If this heat is not dissipated, the local rise in
temperature could be sufficient to cause melting of the contact areas of the
particles. On solidifying, the mechanical strength of the mass is increased.
Asperitic bonding primarily occurs in materials with low melting points (York
& Pilpel 1972, 1973; Marshall, 1986).
In both cold and fusion welding, the process is influenced by several factors,
including the chemical nature of the materials, the extent of available
surface, and the inter-surface distance. In general, the type of crystal in a
particular material influences its consolidative behaviour under applied force.
More importantly, different polymorphic forms and crystal habits of the same
compound may not behave in the same way during compaction (Milosovich,
1963; Marshall, 1986).
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1.4.3.5 Removing compression (decompression)
At the end of a compression cycle, when the upper punch rises, pressure on
the compact is released and the elastically deformed particles start expanding
toward their original volume and shape. In this process, the weak bonding
between particles is broken. At zero pressure, the bed has expanded and the
degree of bonding is reduced greatly. The expansion and subsequent rupture
of bonds between particles may cause a cleavage and the tablet can be readily
separated into two parts. This phenomena is called capping. In general, in
the case of a high degree of elastic deformation, the tablet would be soft and
unacceptable (Miosovich, 1963).
When the particles undergo plastic deformation, materials can be compressed
into good tablets. On increasing the compression pressure, at the point where
elastic deformation begins, plastic flow also occurs. As the pressure is
removed there will be some expansion in the tablet, but it will be much less
than described above since less elastic deformation occurred.
1.4.4 CAPPING TENDENCY
Capping is a problem which frequently occurs in tablet manufacture in which
the top of tablet lops off after compression. Capping has been attributed
either to the expansion of air trapped within interstices of tablet or to the
deformational (plastic or elastic) properties of the material.
The presence of air entrapped in the pores of tablets during compression,
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which then expands on decompression, has been reported to cause failure and
capping (Gregory 1962; Burlinsun 1968). However, it has been shown that
there was no significant difference in the capping tendency of tablets made
in vacuum or at normal atmospheric pressure (Shotton & Ganderton 1961;
Ritter & Sucker 1980). Mann et al (1983) examined the effect of air pressure
on the capping tendency of two formulations at high compression speed.
Reducing the surrounding air pressure caused a reduction in the incidence
of capping. However, lamination replaced the capping and apparently was
unaffected by changes in air pressure. Mann et al (1981) investigated the
influence of punch and die tolerance (the gap between the punch and die
which allows the release of air from the powder bed) and compression speed
on the capping behaviour of three formulation. They observed that if the rate
of release of air was restricted by reducing the punch tolerance or by
increasing the compression speed, the capping tendency was increased.
As early as 1963, Milosovich attributed capping to the expansion of elastically
deformed particles and subsequent rupture of interparticulate bonds.
Malamataris et al (1984) noted that the incidence of capping and lamination
during production of tablets following ejection from the die, depended on the
plastic and elastic behaviour of the materials. Ritter and Sucker (1980)
studied extensively different variables during compression. They reported
that with increase in compression force, the capping tendency increased. This
was attributed to an increase in the elastic energy of the tablets with
increasing compaction force. Ritter and Sucker (1980) found that the ability
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of particles to deform elastically or plastically is important determinant of
capping. Materials which deform plastically, such as Avicel (microcrystalline
cellulose), with very low elastic deformation show no evidence of capping.
Garr and Rubinstein (1991a) reported that increase in the elastic
energy/plastic energy ratio with increase in compression speed are important
factor, which increase the tendency of paracetamol tablets to cap.
1.4.5 INTERPRETATION OF COMPACTION DATA
Powder compaction was initially quantitatively described by pressure/volume
relationships and subsequently by relating compaction pressure to tablet
hardness. The use of compaction simulators and instrumented tablet
machines, which monitor upper and lower punch pressures and
displacements, has lead to the availability of a large number of parameters
which may be used to evaluate compaction and the compressibility of
pharmaceutical powders.
The criteria most widely employed for interpreting compaction data are the
crushing or tensile strengths of tablets, the energy required for elastic and
plastic deformation using force-displacement curve, pressure/density (volume)
relationships and elastic recovery measurements.
1.4.5.1 Mechanical properties of compacts
One of the most direct means of comparing the tableting characteristics of
powders is to plot tablet crushing force against compaction pressure. The
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evaluation of tablet strength consists of breaking or crushing the compacts
by application of a compressive load. The crushing strength is dependent on
tablet dimensions, thus it is difficult to compare the strengths of tablets of
different sizes. However, Fell and Newton (1970) overcame this problem by
introducing the radial tensile strength (T8) of tablets. This can be calculated
from the equation 1.4.
T8 = 2PhtDT Equation 1.4
P is the load necessary to cause diametral fracture, D is the tablet diameter
and T is the tablet thickness. Newton et al (1971) found that tensile
strengths determined by equation 1.4 were satisfactory except for thin
tablets.
1.4.5.2 Pressure-density relationships based on the Heckel equation
There are a large number of equations used to describe the degree of
densification of a powder bed under an applied load (Walker, 1923; Bal'shin,
1938; Heckel, 1961a,b; Lude & Kawakita, 1966). The Heckel equation
(equation 1.5) is the most informative because it provides information on the
mechanisms of powder consolidation and, in addition, the Heckel's constants
K and A have valuable physical significance (Hersey & Rees, 1970; Hersey et
al, 1972).
In the Heckel equation (equation 1.5), D is the relative density (the ratio of
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tablet density to true density of the powder) at applied pressure P; A and K
are constants.
ln[1/(1 - D)] = KP + A	 Equation 1.5
A schematic diagram of a Heckel plot based on equation 1.5 is illustrated in
figure 1.8. The initial curved region is due to densification as a result of
particle slippage and rearrangement. The linear region at higher pressures
is a result of deformation of the particles. From B, the place where the
Heckel plot intercepts the ln 1/1-D axis, the density of powder at zero
pressure, D0, is obtained (equation 1.6). D0 can be defined as the densification
due to the die filling or to initial powder packing.
D0 = 1 - e	 Equation 1.6
From the intercept of the linear portion of this plot, A, the total densification
of a powder bed due to die filling and particle slippage and rearrangement,
Da, may be obtained, from equation 1.7.
Da = 1 - e	 Equation 1.7
The extent of particle slippage and rearrangement, (Db), is determined by
subtracting of D0 from Da. The values of D0, Da and Db are dependent on the
shape and size of the particles (Heckel, 1961b).
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The constant K is the slope of the straight line region of the Heckel plot and
the reciprocal of K is known as the mean yield pressure, which is an
important compressibility index. Mean yield pressure is considered to be a
material constant. Low values of mean yield pressure reveal an ability of a
material to deform plastically and high values are indicative of brittle
materials.
Rue and Rees (1978) suggested that the Heckel equation should be used with
caution, since the Heckel plot for a given material would vary, depending on
the experimental conditions. Fell and Newton (1971) demonstrated that the
mean yield pressures obtained from Heckel plots depended on whether the
Compression pressure (MPa)
Figure 1.8 A schematic diagram of a Heckel plot.
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volume of the tablets was measured under load or after ejection from the die.
They concluded that volume measurements recorded with the compacts under
load included an elastic component which increased the value of ln 1/1-D,
especially at higher compaction forces. This gave a false, low value of the
mean yield pressure.
The limitation in using a Heckel plot to distinguish between elastic and
plastic deformation, evaluated from the slope of the linear portion of profile,
has been emphasized by some workers (Humbert-Droz, 1983; Duberg &
Nystrom, 1986). Duberg and Nystrom (1986) applied the Heckel equation to
both compression and decompression phases in an attempt to distinguish
between the plastic and elastic deformations of materials. They divided the
Heckel plot into three stages, as illustrated in figure 1.9.
During phase I, when the applied pressure is low, particle slippage and
rearrangement take place. At higher pressure (phase II) elastic and/or plastic
deformation are the dominating mechanism. During decompression (phase
III) the elastic propensities of the particles could result in an increase in
porosity or a decrease in the density of the tablets. The decompression curve
should be approximately horizontal when no elastic deformation is present
i.e. the instantaneous elastic expansion of the tablet is negligible (the
continuous line, figure 1.9). A considerable deviation from the horizontal in
phase III (dashed line, figure 1.9) indicate the elastic behaviour of material
under pressure. Of course a false low value of the mean yield pressure in this
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case is obtained. Therefore a low value of the mean yield pressure, is real and
acceptable when the decompression phase (phase III) does not show a large
deviation from the horizontal i.e. the tablet does not undergo a massive
elastic deformation.
Colnpres5ion pressire MPa)
Figure 1.9 Schematic diagram of a Heckel plot showing compression and
decompression cycles.
1.4.5.3 Force-displacement curves
By simultaneously monitoring the displacement of the upper punch and the
force it applies during compression, force-displacement curves can be
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constructed. This was first performed by Higuchi et al (1952, 1954) who
suggested that the area under such curves is equal to the work of
compression.
De Blaey and Polderman (1970, 1971) and De Blaey et al (1971) investigated
the force-displacement curves for the total compression cycle (figure 1.10).
The area under the curve CBD is elastic energy due to expansion of the
compact during the compression cycle. The area ABD is the gross energy of
compression. The area under curve ABC is the net compaction energy, which
is utilized by die wall friction, interparticle friction, particle slippage and
rearrangement, plastic deformation, fragmentation and the formation of
bonds. The work of die wall friction is the difference between the upper and
lower punch work. The lower punch work can be plotted as the force
transmitted to the lower punch against the displacement of the upper punch.
De Blaey et al (1971) mentioned that no distinction can be made between the
amount of work used for plastic deformation and the amount of work for
formation of bonds.
Compression energy is a powerful tool for comparing the compaction
properties of different materials in preformulation studies (Graffner et al,
1985). The mechanical properties of compacts versus compaction energy,
appears to be a useful parameter for evaluating the utilization of the
compression energy (Hiestand et al, 1981).
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Figure 1.10 Schematic diagram of a force-displacement plot.
1.4.5.4 Determination of elastic recovery
Elastic recovery is axial expansion of tablet following the removal of the
compression force. The precise quantification of elastic recovery is useful in
elucidation of the dominant mechanisms of powder consolidation. Elastic
recovery has been associated with the storage of elastic energy during
compression as deformation energy under stress and subsequent release of
this energy after the removal of axial pressure. Huffine and Bonilla (1962)
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measured the percentage axial recovery of compacts in the die. Carless and
Leigh (1974) observed that the percentage of elastic recovery of tablets after
ejection was considerably higher than in the die.
The most widely used equation for measuring the elastic recovery (ER) was
proposed by Armstrong and Haines-Nutt (1972), in which elastic recovery was
defined as equation 1.8.
ER = [(H - H)IH] x 100 Equation 1.8
H and H are the heights of the compact under pressure and 24 h after
ejection, respectively. In the case of measuring the elastic recovery in the die,
the value of H (equation 1.8) would be the height of tablets after the
compression force is removed.
1.4.6 ESTIMATING THE DEGREE OF FRAGMENTATION OF PARTICLES
DURING COMPACTION
A pharmaceutical powder may be classified into one of three main categories
according to their mechanism of densification during compaction, i.e. those
mainly undergoing plastic deformation, those mainly undergoing
fragmentation and those undergoing both plastic deformation and
fragmentation (Humbert-Droz et al, 1983).
Fragmentation is defined as the formation of smaller discrete primary
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particles from an initial particle. Therefore an adequate approach for
characterizing fragmentation seems to be measurement of the surface area
of the material before, during or after compaction (Alderborn et al, 1985).
Higuchi et al (1953) measured the surface area of suiphathiazole compacts
as a function of compaction pressure. They observed an initial increase in
surface area due to brittle fracture, followed by a decrease ascribed to
bonding between particles. Huffine (1953) reported that the surface area of
sodium chloride compacts decreased as the compression pressure increased
suggesting that sodium chloride consolidated by plastic deformation.
Alderborn et al (1985) measured tablet surface area by a permeametry
technique. They observed that sodium chloride showed a small increase in
tablet surface area with increase in pressure whereas Emcompress (dicalcium
phosphate dihydrate) showed a dramatic increase in surface area with
increase in pressure. These observations confirmed that sodium chloride
consolidated mainly by plastic deformation but Emcompress fragmented
extensively during compaction.
Duberg and Nystrom (1986) suggested that during phase I of the Heckel plot
(figure 1.9) when the applied pressure is relatively low, many materials
undergo particle fragmentation. At this stage, the interparticulate friction
may be sufficient to cause fragmentation of weaker particles (Armstrong &
Haines-Nutt, 1970). The curvature of the plot at phase I, which can be
evaluated as the deviation from straight line, indicates fragmentation
(Humbert-Droz, 1983). The correlation coefficient of this region (phase I) can
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serve as a tool to quantify the degree of fragmentation. A linear segment
(with a high value of the correlation coefficient) is obtained for non-
fragmenting materials such as sodium chloride. A non linear curve (with a
low correlation coefficient) for phase I and a high mean yield pressure should
correspond to material which consolidates by fragmentation rather than
plastic deformation, e.g. Emcompress (Duberg & Nystrom, 1982).
By using scanning electron microscopy, it is possible to see if changes in
particle size or shape have occurred during compression. Harciman and Lilley
(1970), and Duderg and Nystrom (1982), using scanning electron microscopy,
showed that there was no particle fragmentation for sodium chloride particles
after compaction, although a slight change in the shape of the particles was
observed. It was impossible to distinguish any original particle of sucrose or
Emcompress after compaction, because of the high degree of fragmentation
of these particles.
Another useful method for estimating the degree of fragmentation is
measuring the strength of tablets with or without a lubricant such as
magnesium stearate (Duberg & Nystrom, 1982). In the case of a plastically
deforming material (e.g. sodium chloride), addition of lubricant decreased the
adhesion and bonding properties between the particles and therefore the
crushing strengths of tablets were decreased dramatically. Tablets made from
fragmenting materials, such as Emcompress, showed little or no reduction in
their strength on addition of the lubricant. This was attributed to the
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formation of new, fresh, clean and unlubricated surfaces which were able to
form bonds between particles (Boihuis et al, 1975; De Boer et a!, 1978).
Changes of mean yield pressure with compaction speed can be quantified
using equation 1.9 which defines strain rate sensitivity (SRS) (Robert &
Rowe, 1985).
SRS = [(P 2 - P 1)fP 2] x 100 Equation 1.9
P., 1 and P 2 are the mean yield pressure at minimal and maximal punch
speed, respectively. SRS is a useful index which can show the plastic or
brittle nature of a material. Due to the time dependent nature of plastic
deformation, the mean yield pressure increases with increasing punch
velocity for plastic materials such as Avicel and sodium chloride, which
consequently show higher values of SRS (Robrts & Rowe, 1987a). Materials
which consolidate by fragmentation such as Emcompress or magnesium
carbonate showed no change in their mean yield pressure with increase in
compaction speed. A low value of SRS was obtained for them (Roberts &
Rowe 1985, 1987).
Since plastic deformation is a time dependent phenomenon, it has long been
recognised that compaction speed will affect significantly the extent of plastic
flow. Decrease in the crushing strengths of compacts with an increase in the
rate of compaction, has been ascribed to a reduction in the time available for
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plastic deformation and thus interparticulate bond formation (Seitz &
Flessland, 1965; Hiestand et al, 1977). David and Augsburger (1977) observed
that an increase in the duration of the compression cycle resulted in a
significant increase in the tensile strength of tablets prepared from Avicel,
but not for lactose suggesting that the former underwent plastic deformation
while the latter underwent fragmentation. The crushing strengths of tablets
made from plastic materials such as Avicel exhibited a dramatic decrease
with increase in compaction speed, while tablets made from Emcompress
which consolidates by a dominant fragmentation mechanism were
independent on compression speed (Garr, 1992). Therefore measuring the
crushing strength of tablets at different compression speeds serves as a
useful technique for estimating the degree of fragmentation during
compaction.
1.5 STUDIES ON THE COMPACTION OF PARACETAMOL
1.5.1 PROBLEMS IN COMPACTION OF PARACETAMOL
It is well known that paracetamol exhibits poor compressibility during
compaction, often resulting in weak and unacceptable tablets with a high
tendency to cap (Krycer et al, 1982). In general, production of weak and
capped compacts of paracetamol has been attributed to a low degree of plastic
flow and high elasticity (Duberg & Nystrom, 1986), weak bonding (Obiorah
& Shotton, 1976; Doelker & Shotton, 1977) and a high brittle fracture
propensity (Hiestand et al, 1977; Alderborn et al, 1985) during compaction.
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Garr and Rubinstein (1991a) reported that the relative high elastic energy
due to elastic deformation of paracetamol particles during compaction,
appeared to be an important factor in tendency of paracetamol tablets to cap.
In section 1.4.1, the advantages of direct compression, compared to
granulation techniques, were reviewed. Low cost and rapid production were
most important aspects of direct compression. Paracetamol is a widely used
analgesic. Therefore it would be useful to improve the direct compression
characteristics of paracetamol.
1.5.2 TABLET FORMATION OF PARACETAMOL MIXTUBES WITH
DIRECT COMPRESSION EXCIPIENTS
Wells and Langridge (1981) evaluated dicalcium phosphate dihydrate-
microcrystalline cellulose binary mixtures as direct compression vehicles.
Where in excess of 50% microcrystalline cellulose was present, using normal
compression forces, tablets of high tensile strength and low friability were
obtained. Wells and Langridge (1981) investigated the capacity of these
binary mixtures (>50% microcrystalline cellulose) to form tablets with
paracetamol. Good tablets were prepared from formulations containing 20%
paracetamol. Unsatisfactory tablets were produced with formulation
containing above 30% paracetamol due to poor flow, capping and lamination.
Malamataris et al (1984) investigated the compaction properties of various
mixtures of paracetamol and Avicel. They found that by increasing the
amount of Avicel in the mixtures, more acceptable tablets could be produced.
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They also found that the incidence of capping and lamination of tablets was
greatest when the fraction of Avicel was less than 25% w/w. In a similar
study, Yu et al (1988) reported that as far as tensile strength, friability and
absence of capping were concerned, the optimal mixture of the two powders
was 50% w/w Avicel and 50% w/w paracetamol. Mollan and Celik (1994)
evaluated the tabletability of five maltodextrin-paracetamol mixtures.
Maltodextrins exhibited adequate binding potential at drug loading levels of
up to only 25% w/w paracetamol.
As was mentioned in section 1.4.1, in the case of tablet formulations which
require a high amount (>100 mg) of a non-compressible drug, direct
compression excipients can not be used, because the weight of tablet will be
too large. Paracetamol tablets are mainly formulated as tablets containing
300 to 500 mg of drug. The above studies clearly show that, for example, in
the case of using 25% w/w of paracetamol mixed with direct compression
excipients, the weight of a formulated tablet will be between 1200 to 2000
mg. Obviously, this is an unacceptable weight for oral tablets.
1.5.3 MODIFICATION OF PARACETAMOL CRYSTALS TO IMPROVE ITS
COMPRESSIBILITY
Crystal and particle engineering of drugs play a significant role in the design
of materials for direct compaction. Therefore, the driving force for controlled
modification must be to provide the required properties for direct compression
or good compressional behaviour and to overcome the deficiencies in the
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unmodified material which lead to problems in tableting and compaction
(York, 1992).
In recent years, some attempts have been made to modify the properties of
paracetamol crystals using different crystallization techniques, in order to
improve the compaction properties of unmodified crystals. Fachaux et al
(1992, 1993) prepared a sintered form of paracetamol crystals by
crystallization from dioxane followed by a controlled drying process. The
paracetamol interacted with this solvent to form a solvate. The porous texture
of desolvated crystals induced plasticity and improved the compressibility of
paracetamol. One disadvantage of this form of paracetamol was the difficulty
in the complete elimination of residual solvent from the final product.
Di Martino et al (1994, 1995, 1996) prepared a polymorph of paracetamol
(orthorhombic form) by melting the drug at 170°C in an anhydrous nitrogen
atmosphere. After slow cooling to room temperature, the solidified material
was ground. The obtained crystals exhibited better compressibility than
untreated crystals. The increased compressibility was attributed to the
presence of sliding planes in the crystal structure which lead to a possible
increase in plasticity. The disadvantage of this work was that a high
temperature was required and therefore the atmosphere and time have to be
strictly controlled.
Abdelillah et al (1995) prepared agglomerated particles of paracetamol using
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a spherical crystallization technique. The agglomerated particles were
obtained by adding a paracetamol solution in tetrahydrofuran into either
hexane or a hexane/chioroform mixture. The agglomerated particles exhibited
good compressibility compared to untreated paracetamol. The most obvious
disadvantage of this method was that a relatively high tetrahydrofuran
content remained in the final agglomerates even after drying.
1.6 AIMS AND OBJECTWES
Paracetamol is a model drug with well known poor tableting properties. As
detailed in section 1.2.4 and 1.2.5, the crystal morphology of a drug plays an
important role in its physico-mechanical behaviour. Therefore the main aim
of this project was to study the consequences of altering the crystal properties
of paracetamol on its compaction behaviour. The main objectives of this work
were:
-to modify the crystal habit of paracetamol by using selected
crystallization techniques in the presence or absence of
polyvinylpyrrolidone as an additive.
-to assess the solid state characteristics of the modified crystals.
-to investigate the role of these modifications on the compaction
properties.
The following is a brief outline of the contents of this thesis. Chapter 2
describes the general materials and methods used in this study. A
comprehensive study of the compaction properties of untreated paracetamol
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crystals is given in chapter 3. Chapter 4 describes the effect of crystallization
solvent and crystallization temperature on the production of some modified
paracetamol crystals. The compaction properties of these modified crystals
are investigated in chapter 5.
Since polyvinylpirrolidone (PVP) was used as an additive during the
crystallization of paracetamol, chapter 6 details the possible interactions
between PVP and paracetaniol. Chapter 7 describe the modification of
paracetamol particles using crystallization in the presence of PVP. The
compaction properties of these particles are given in chapter 8. The
dissolution characteristics of the paracetamol particles obtained in the
presence of PVP are detailed in chapter 9. Whilst the conclusions of each
chapter are presented following a discussion of the results, a general
discussion of the main findings of the project is provided in chapter 10.
Suggestions for further work, and a summary of the contents of this thesis
is presented in chapter 11.
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CHAPTER 2. MATERIALS AND EXPERIMENTAL METHODS
2.1 MATERIALS
The following materials were used throughout this study:
2.1.1 PARACETAMOL
Paracetamol (para-hydroxy-acetanilide) (figure 2.1) is a white crystalline
powder, soluble 1:70 in water at 25°C, 1:20 in boiling water, 1:7 to 10 in
ethanol, 1:9 in propylene glycol, 1:13 in acetone, (all at 25°C), slightly soluble
in chloroform, insoluble in ether and benzene, and soluble in a solution of
alkaline hydroxide (El-Obeid & Al-Badr, 1985). Its melting point is 169-
172°C. Its ultraviolet spectrum in water has a maximum absorbance between
244-247 nm (Moffat et al, 1986).
C8H9NO2
HO -NHCOCH3	 Mol. Wt=151.16
Figure 2.1 The chemical structure of paracetamol.
Paracetamol is very stable in aqueous solution and its maximum stability is
in the pH range 4 to 7 (Koshy & Lach, 1961; Connors et al, 1976). Instability
of paracetamol is due to its hydrolysis which yields p-aminophenol and acetic
acid.
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Paracetamol used in this study was obtained from Sterling Organics,
Northumberland, U.K.
2.1.2 POLYVINYLPYRROLIDONE
Four soluble grades of polyvinylpyrrolidone (PVP) were obtained from BASF,
Aktiengesellschaft, 67056 Ludwigshafen, Germany, as trade names Kollidon
12PF, Kollidon 17PF (PF = pyrogen free), Kollidon 30 and Kollidon 90.
Soluble grades of PVP are obtained by free radical polyrnerisation of
vinylpyrrolidone in water or isopropanol, yielding the chain structure of
polyvinylpyrrolidone as shown in iigure 2.2
"-CH-CH2-CH-CH2-CH-CH2----
Figure 2.2 The chemical structure of polyvinylpyrrolidone.
One of the interesting features of the soluble grades of PVP is their universal
solubility, which extends from extremely hydrophillic solvents, such as water,
to hydrophobic liquids, such as butanol. In general they are soluble in water,
alcohol and in chloroform but practically insoluble in ether (Raynolds, 1993).
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However, higher molecular weights of PVP, specially Kollidon 90, dissolve
more slowly than the lower molecular weight grades (Kollidon, Technical
information, 1992).
The average molecular weights of Kollidon grades are given in table 2.1.
Recent results do not always agree well with older results, as the techniques
used have been improved significantly over the years. However, the products
themselves have not changed.
Table 2.1 The average molecular weights of soluble grades of Kollidon
(Kollidon, Technical information, 1992).
Average molecular weight
Kollidon grade
Kollidon 12 PF
Kollidon 17 PF
Kollidon 30
Kollidon 90
Recent determinations
2000- 3000
7000- 11000
44000- 54000
1000000-1500000
Measured before 1975
2500
9000
40000
700000
The viscosities of aqueous solutions of the soluble grades of Kollidon, which
depend on their average molecular weight, are considerably different. The
average molecular weights of the soluble grades of Kollidon are expressed in
terms of the K-value in pharmacopoeias used in Europe and the USA. The K-
value is calculated from the relative viscosity in water and always forms a
part of the commercial name. Table 2.2 shows the K-values and typical
viscosities for 10% w/v solutions of various grades of Kollidon in water at
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20°C.
Table 2.2 K-values and typical viscosities of 10% w/v solutions of Kollidon in
water at 20°C (Kollidon, Technical information, 1992).
Product	 K-value range	 Typical viscosity range
Kollidon 12 PF	 11-14	 1.3-2.3 mPa s
Kollidon 17 PF	 16-18	 1.5-3.5 mPa s
Kollidon 30	 28-32	 5.5-8.5 mPa s
Kollidon 90	 85-95	 300-700 mPa s
The various grades of Kollidon, Kollidon 12 PF, Kollidon 17 PF, Kollidon 30
and Kollidon 90, are expressed according to their molecular weight in this
study as PVP 2000, PVP 10000, PVP 50000 and PVP 10000000, respectively.
2.1.3 ETHANOL
Absolute ethanol B.P, containing not less than 99.5% v/v of C2H5OH, used in
this study was obtained from Hayman Ltd, Witharn, Essex, UK.
2.1.4 OTHER REAGENTS USED IN THIS STUDY
Resublimed iodine, potassium iodide, anhydrous citric acid, magnesium
stearate, acetone (all General Purpose Reagents) and potassium bromide
(Analar Grade) were obtained from British Drug Houses (BDH) Chemicals
Ltd, Poole, Dorset, UK.
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2.2 EXPERIMENTAL METHODS
2.2.1 CRYSTALLIZATION PROCESSES
For the purposes of convenience, the techniques for crystajlization used in
this study are explained in the relevant chapters.
2.2.2 X-RAY POWDER DIFFRACTION (XPD)
An important technique for establishing the reproducibility of a crystalline
form is X-ray powder diffraction. Random orientation of a crystal lattice in
a powder sample causes the X-ray to scatter in reproducible patterns of peaks
at distinct angles (Fiese & Hagen, 1986). If the patterns are identical, the
crystals have the same internal structure. If the patterns are different, then
the crystals have different internal structures and are different poymorphs.
Amorphous forms do not produce a distinct pattern (Byrn, 1982). This method
is very useful to determine whether a pair of crystals are polymorphs or
crystal habits.
2.2.2.1 Methodology
X-ray diffraction spectra of powder samples were obtained using an X-ray
generator model Phillips, PW 1729 fixed with PW 1710 diffractometer
(Phillips, Almelo, Netherlands). The cavity of the metal sample holder was
filled with the powder sample which had previously been ground by a mortar
and pestle, and then smoothed with a spatula. A scanning rate of 0.04°29 s
over the range of 10 to 70029 was used to produce each spectrum.
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2.2.3 INFRARED SPECTROSCOPY (IR)
Infrared spectroscopy is a useful method for the analysis of solids. The
infrared spectrum is extremely sensitive to structure and conformation of a
compound and thus can be used to compare the structure of a compound in
different solid states (Byrn, 1982).
2.2.3.1 Methodology
Infrared spectra were recorded using a Perkin Elmer FTIR 1600
spectrophotometer (Norwalk, Connecticut, USA) utiising potassium bromide
discs. These discs were made by grinding 2-3 mg of paracetamol crystals with
25-50 mg of potassium bromide and compressed by a hydraulic press model
M-30 (Industrial instruments Co Ltd, UK) at 10 tons pressure for 2 mm.
2.2.4 THERMAL ANALYSIS (TA)
Thermal analysis is a method which can be used to characterize the
alterations of physical or chemical properties of substances induced by
temperature changes. Melting, desolvation, sublimation, polymorphic
transition (solid-solid transformation), degradation and crystallization may
be examined. The most common types of thermal analysis are differential
scanning calorimetry, differential thermal analysis, thermomechanical
analysis and hot stage microscopy (Ford & Timmins, 1989).
2.2.4.1 Differential sciinning calorimetry (DSC)
Differential scanning calorimetry measures the heat loss or gain resulting
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from physical or chemical changes within a sample as a function of
temperature (Fiese & Hagen, 1986). Differential scanning calorimetry is a
very useful method for studying solid states and can be used to determine the
accurate temperature and enthalpy of phase transformations (Byrn, 1982).
2.2.4.1.1 Calibration of DSC
DSC measurements were carried out with a Differential Scanning
Calorimeter model DSC7 (Perkin Elmer, Baconsfield, UK) which was
controlled by a Perkin Elmer TAC7. The differential scanning calorimeter
was calibrated using indium (melting temperature, 156.6°C and AHf 28.45 J
g') and zinc (melting temperature, 419.47°C). Samples (2-4 mg) were heated
at 10°C min' in crimped aluminium pans under a nitrogen atmosphere. A
similar empty pan was used as reference. Melting points and enthalpies of
fusion of samples were automatically calculated by the instrument. The
calculated enthalpy of indium and the melting temperatures of indium and
zinc were programmed into the DSC as calibration data.
2.2.4.1.2 DSC methodology
Samples of paracetamol crystals (2-4 mg) were heated at 10°C min d in
crimped aluminium pans under a nitrogen atmosphere. A similar empty pan
was used as the reference. Melting points, onset temperatures and enthalpies
of fusion were automatically calculated. The onset temperature is the point
of intersection of the extrapolation from the peak to the baseline. Thus the
onset temperatures used in this study are extrapolated onset temperatures
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(Ford & Timmins, 1989). A minimum of four determinations for each sample
was carried out.
2.2.4.2 Hot stage microscopy
This method involves the direct observation of the behaviour of materials
during heating or cooling. This technique is useful for studying the melting,
desolvation and polymorphic transitions in solids.
2.2.4.2.1 Methodology
For each sample, about 1 mg was spread on a microscope slide and covered
with a cover slip. The sample was observed using an optical microscope
during heating at 5°C/mm using a Mettler FP82 Hot Stage and FP8O central
processor.
2.2.5 SCANNING ELECTRON MICROSCOPY (SEM)
Scanning electron microscopy is a powerful tool for studying the crystal habit,
surface properties of crystals and structural imperfections and dislocations
in crystals (Byrn, 1982).
2.2.5.1 Methodology
Electron micrographs of powder samples were obtained using a scanning
electron microscope (Jeol model JSM T200, Tokyo, Japan). The specimens
were mounted on a metal stub with double sided adhesive tape. The stubs
were then placed in the coating chamber of a Polaron E5000 diode sputter
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coating unit (Holywell Industrial Estate, Watford, England). The chamber
was evacuated, refilled with argon and samples coated with gold emitted at
1.2 kV. The coated samples were individually placed on the specimen holder
of scanning electron microscope in a vacuum chamber. The chamber was
evacuated and a voltage of 15 kV was selected for accelerating the electrons
from the electron gun onto the specimen. The image formed was viewed
directly via a screen or recorded photographically.
2.2.5.2 Particle size measurement
Particle size measurements were carried out directly from the scanning
electron micrographs. For grain-like crystals the longest dimension was taken
as the length and the shortest dimension as width. The thickness of the
grain-like crystals was approximately equal to their width. The thickness was
only determined for plate-like crystals. Each determination was carried out
on a minimum of 30 crystals and the distributions of size reported.
2.2.6 QUANTIT1VE DETERMINATION OF PVP IN AQUEOUS SOLUTION
2.2.6.1 Basic principle of method
The reaction of iodine and PVP (figure 2.3) is considered as a sensitive
photometric method for determining small quantities of PVP in aqueous
solution (Levy & Fergus, 1953). This reaction causes a considerable
intensification of the iodine colour, such that very small quantities of PVP
can be determined. A linear relationship between absorbance and PVP
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OHt"O
CH2-CH CH2	 CH-CH2
concentration between 5-50 pg mt' was obtained (Levy & Fergus, 1953). The
enhancement of colour, was achieved by control of pH, by carrying out the
reaction in citric acid solutions. The colour intensity is dependent on the
molecular weight of PVP (Levy & Fergus, 1953). For this reason calibration
curves were produced for each grade of PVP.
Figure 2.3 Complex formation between PVP and iodine (Schenck et al, 1979).
2.2.6.2 Calibration curve for different grades of pvp
Aqueous solutions of the four different grades of PVP, concentration of 10, 30
or 50 pg ml', were prepared. 50 ml of these solutions were taken and mixed
with 25 ml of 0.2 M aqueous citric acid and 10 ml of 0.006 N iodine solution
(appendix 1). After 5 mm, the absorbances of these solutions were measured
against a blank solution without PVP (appendix 1) at 470 rim, using a Philips
spectrophotometer (PU 8625, Cambridge, UK) (Kollidon, Technical
information, 1992). Each determination was carried out three times and the
mean values were reported. Figure 2.4 shows the calibration curves of
different grades of PVP. The best fit equations for the Beer's law plots of the
UV absorbance versus concentration of PVP 2000, PVP 10000, PVP 50000
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and PVP 1000000 are given by equations 2.1, 2.2, 2.3 and 2.4, respectively.
Y = 0.005 + 0.009 C	 (r = 0.9992)	 Equation 2.1
Y = 0.007 + 0.013 C	 (r = 0.9994)	 Equation 2.2
Y = 0.012 + 0.018 C	 (r 0.9992)	 Equation 2.3
Y = 0.011 + 0.020 C	 (r = 0.9993)	 Equation 2.4
1.0
• PVP 2000
-o-PVP 10000
0.8	 • PVP 50000
---PVP 1000000
z.
0
0.2
0.0
0	 10	 20	 30	 40	 50	 60
PVP CONCENTRATION (pg mF5
Figure 2.4 Ultraviolet absorbance against PVP concentration (jig m1') for
different grades of PVP at 470 nm (each point is the mean ±SD of three
determinations).
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In equations 2.1 - 2.4, Y is the absorbance of solution at 470 mn and C is the
concentration of relevant grades of PVP in solutions (jig m11)
2.2.6.3 Experimental method
The amount of PVP present in paracetamol particles crystallized from media
containing PVP, was determined by photometric analysis as described above.
An appropriate amount of sample (about 30 mg) was dissolved in 50 ml of
water. This solution was then mixed with 25 ml of 0.2 M aqueous citric acid
and 10 ml of 0.006 N iodine solution (appendix 1). After 5 mm, the intensity
of the colour was measured as described in section 2.2.6.2. The PVP contents
were determined from the calibration curves for the relevant grade of PVP
(figure 2.4). Each test was carried out at least three times.
2.2.7 CALIBRATION CURVE OF PARACETAMOL
The UV absorbance for solutions containing different concentrations of
paracetamol (0.0 th 0.035 mg ml4) in freshly distilled water at 244 nni were
determined (figure 2.5), using a Diode Array spectrophotometer (Hewlett
Packard HP 8452A, Waldbronn, Germany). The best fit equation for the
Beer's law plot of UV absorbance versus paracetamol concentration is given
by equation 2.5.
Y = 0.007 + 62.9 C	 (r=0.9993)	 Equation 2.5
In equation 2.5, Y is the absorbance of paracetamol solution at 244 rim and
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Figure 2.5 Ultraviolet absorbance against concentration (mg ml') of
paracetamol in distilled water at 244 nm (each point is the mean ±SD of
three determinations).
2.2.7.1 Determination of paracetamol solubility
In order to investigate the aqueous solubiity of paracetamol, the following
was carried out. Samples (2.5 g) of paracetamol were dispersed in 100 nil of
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freshly distilled water or aqueous solution of PVP in stoppered 100 ml conical
flasks in a shaking water bath (Companstat 882942, England) at 37°C for 24
h. Then the suspended solids were allowed to settle and the supernatants
were sampled and filtered through a Whatman No. 1 filter paper. The first
10 ml of the each filtrate was discarded. The paracetamol concentrations
were determined spectrophotometricafly at 244 nm after appropriate dilutions
using equation 2.5. The mean of three determinations was used to calculate
the solubility of paracetamol in aqueous media.
2.2.8 DISSOLUTION TESTING OF PARACETAMOL POWDERS
The dissolution rates of paracetamol samples were determined using a
Pharmatest dissolution tester (GmbH, Hamburg, Germany), coupled with a
Diode Array spectrophotometer (Hewlett Packard HP 8452A, Waldbronn,
Germany). The USP XXII apparatus II was used, at 50 rpm rotating in 1000
ml distilled water at 37±1°C. Paracetamol powder was weighed accurately (35
mg) and placed into small bags (2 x 3 cm) made from metal gauze with 25
pm mesh size. The metal mesh bags containing drug powder were placed into
dissolution medium under the dissolution paddles. The media were
automatically sampled at every minute using an Ismatec peristaltic pump
(IPS 8/B, Carshalton, UK) at 50 ml miff' flow rate. The amount of dissolved
paracetamol was analyzed spectrophotometrically at 244 nm.
2.2.9 DETERMINATION OF TRUE DENSITY OF POWDERS
The ratio of mass to volume is known as density of a material. If the true
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volume (the volume of a sample excluding its pores) of a known weighed solid
particles is measured, then the true density may be calculated. The true
densities of powder materials used in this study were determined using an
air comparison pycnometer Model 930, Beckman Instruments Ltd, UK. Each
determination was carried out five times and the mean values obtained.
2.2.10 COMPACTION SIMULATOR
Initial research into compaction behaviour of materials began in 1954 when
Higuchi et al employed an instrumented tableting press. They attached strain
gauges to various parts of a tableting machine to facilitate the accurate
measurement of force. Subsequently, instrumentation of single punch
machines developed. Piezoelectric transducers and linear variable differential
transformers (LVDTs) were applied to monitor the force and punch
displacement during compaction (Shotton et al, 1963; De Blaey & Polderman,
1971). Although, some useful data may be obtained by such machines, it was
not always possible to establish a correlation with the actual production
simulation where high speed rotary machines are employed.
Hunter et al (1976) presented the design of a compaction simulator to mimic
the compression and ejection cycle of any tableting process in real time and
to record all important parameters during a compaction cycle. Celik and
Travers (1985) used a compaction simulator, which was controlled by a
computer. This machine consisted of a servo controller hydraulic actuator
mounted in a frame.
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Compaction simulators have numerous potential applications in
pharmaceutical research, development and production. The basic compaction
mechanisms of materials and process variables on tablet properties, and also
the effect of particle characteristics of a drug or excipient on their compaction
properties may be investigated using compaction simulators.
2.2.10.1 Design of compaction simulators
All simulators have similar design and construction. Compaction simulators
are essentially high speed hydraulic presses modified for making tablets. A
compaction simulator, such as that one used in this study, consists of three
main sections; the load frame, the hydraulic power supply and electronic
console. These sections are shown in figure 2.6.
(1) The load frame
The load frame consists of upper and lower actuators and a die table which
are supported by four vertical columns. One ±25 mm LVDT is rixointd ox
each actuator to control their movement. A ±50 kN load cell is located at the
other end of each actuator. The die is positioned in the centre of die table
along with two ±10 mm LVDTs which monitor the punch movement within
the die.
(2) Hydraulic unit
This provides the energy to move the actuators. It consist of an oil reserv-ior
pressurised to 4000 psi by an electric pump.
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(3) The control unit
The control unit consists of two consoles which control the major parameters
of load, position and strain associated with each punch. Data are captured via
a microlink transient recorder, which provides a hard copy and a computer
link for analysis.
2.2.10.2 Mode of operation
The microcomputer is able to generate a displacement-time profile similar to
that experienced by the upper and lower punches of the tableting machine
which is being simulated. The data points of the profile are output at a
predetermined rate via a digital/analogue converter to the servo controller in
the main control unit and on to the control valves situated on the load frame.
The signal supplied to the valves determines the flow of hydraulic fluid from
the power pack through the valves to the actuators. It is this flow of fluid
which causes movement of the actuators according to the intended profile.
The amount of powder used is that required to produce one tablet, may be
hand-filled into the die. During a compression event, force and displacement
data from the upper and lower load cells and LVDTs are captured using the
transient recorder. The data may then be plotted or transferred via the
microcomputer to the mainframe computer for analysis.
2.2.11 COMPRESSION PROCEDURE
All compressions were carried out using the High Speed Compaction
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Simulator (ESH Testing Ltd Brierley Hill, West Midlands, U.K.) modified by
the Liverpool School of Pharmacy and Chemistry, fitted with 12.5 mm flat
faced punches. This simulator is capable of compacting powders at rates up
to 3000 mm s' and at forces up to 50 kN. A sawtooth time-displacement
profile was used to control both upper and lower punches.
The die wall was cleaned with acetone and prelubricated with 4% w/w
magnesium stearate in acetone before each compression. Particle size
fractions of paracetamol (see section 2.2.13) were hand filled into the die.
Four tablets were produced at compression speeds of 10, 50, 100 or 250
mm s. up to a maximum 30 kN compaction force. A constant weight of 400
mg was maintained for all the samples.
2.2.12 ANALYSES OF COMPACTION DATA
From the data obtained during compaction, it was possible to calculate the
energy involved, the Heckel constants and the percentage of elastic recovery
in the die for each tablet.
2.2.12.1 Energy analysis
For a system in which both punches are mobile, the punch separation may
be plotted against upper punch force. The area under this curve will be the
work done or energy (section 1.4.5.3). The net work of compaction (plastic
energy) and expansion work (elastic energy) of compaction were measured
using energy analysis on force-punch separation plots. Plastic energy is
76
ir
0
0
4.4
0
Sri'
a)
14
c14
E
0
0
'I	 U	 A
2.2	 2.4	 2.6	 2.8	 3.0	 3.2	 3.4	 3.6	 3.8
Punch separation (mm)
Figure 2.7 Typical force-punch separation plot for untreated paracetamol
(particle size 105-210 pm) obtained at a compression speed of 10 mms'.
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energy permanently imparted to the tablet but elastic energy is energy of
expansion of tablet which is transferred to the punch during decompression
phase.
Figure 2.7 illustrates a typical force-punch separation plot, where A is the
punch separation at the first measurable force. B is the peak force at minimal
punch separation, C represent the minimum punch separation and D is the
separation after decompression. The area ABC gives the gross energy, and
the area under curve CBD corresponds to the decompression energy or elastic
energy. The net compaction energy or plastic energy (the area under curve
ABD) was determined from the difference between area ABC and area CBD.
A computer programme was employed to calculate gross, plastic and elastic
energies from data obtained during compaction.
2.2.12.2 Heckel analysis
A computer programme was employed to fit data obtained during compaction
to Heckel equation (equation 2.6).
In [11(1 - D)] = KP + A	 Equation 2.6
Details of Heckel equation were described in section 1.4.5.2. Figure 2.8
illustrates a typical Heckel plot. Regression analyses were carried out on the
Heckel plots for data obtained between 20 to 65 MPa and the slope of these
straight line portions and subsequently the mean yield pressures determined.
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Figure 2.8 Typical Heckel plot for untreated paracetamol (particle size 105-
210 pm) obtained at a compression speed of 10 mms'.
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The relative densities of the powders, D0, at the point when a measurable
force is applied, and the relative densities, Da, obtained from the intercept of
the Heckel plot (figure 2.8), were also calculated.
2.2.12.3 Determination of elastic recovery of tablet in the die
Tablets made from untreated and some of the modified forms of paracetamol
were too weak and capped after ejection, so that it was impossible to handle
them and monitor their thickness outside the die. Therefore, the percentage
of elastic recovery in the die of each tablet was calculated using equation 2.7.
% Elastic recovery = [(H - H)fH] x 100 Equation 2.7
where H and H are the thickness of tablet under maximum pressure and
after the compression force has been removed, respectively.
2.2.13 PARTICLE SIZE FRACTIONS
Particle size fractions (<90 and 105-2 10 pm) of untreated and modified
paracetamol were obtained by sieving the materials through test sieves
(Endecotts Ltd., London, U.K) on a mechanical sieve shaker (Pascall Ltd,
Sussex, England).
2.2.14 DETERMINATION OF TABLET CRUSHING STRENGTH
The crushing strength was determined from the force required to fracture
tablets by diametral compression on a motorised tablet hardness tester
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(Schleuniger, Model 2E, Switzerland). Crushing strengths were employed
instead of tensile strengths because it was not possible to determine an
accurate thickness of paracetamol tablets due to their tendency to cap.
2.2.15 STATISTICAL METHODS
All compaction data were analyzed statistically by two way analysis of
variance ancllor Tukey's multiple comparison test. Results are quoted as
significant where P<O.05.
Two way analysis of variance estimates the effects of two independent
variables on a dependent variable. For example, in figure 3.4 the dependent
variable is elastic recovery of tablet, one of the independent variables is
particle size (<90 and 105-210 pm) and other is compression force. Two way
analysis of variance showed that there is significant difference between the
elastic recoveries of tablets made from the two different particle sizes of
paracetamol. The next step was to determine for which compression forces
the differences were significant. The Tukey's multiple comparison test is used
for this purpose.
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CHAPTER 3. COMPACTION PROPERTIES OF UNTREATED
PARACETAMOL
3.1 INTRODUCTION
Paracetamol exhibits poor compressibility during compaction, resulting in
weak and unacceptable tablets with a high tendency to cap (Krycer et al,
1982). Malamataris et al (1984) noted that the incidence of capping and
lamination during the production, and following ejection of tablets from the
die, depended on the plastic and elastic behaviour of the material used. It has
been suggested that materials undergoing plastic deformation, in contrast to
elastic deformation, display enhanced bond formation and produce strong
tablets (Duberg & Nystrom, 1982).
In general, the strength of a compact depends on the inherent ability of the
powder to reduce in volume during compression and the amount of
interparticulate attraction in the final compact (Miosovich, 1963). The
decrease in compact volume with increasing compression load is attributed
normally to particle rearrangement, elastic deformation, plastic deformation
and particle fragmentation. Pharmaceutical materials normally consolidate
by more than one of these mechanisms (De Boer et al, 1978, Duberg &
Nystrom, 1986).
The aim of the work presented in this chapter was to investigate the
fundamental compression characteristics of paracetamol. Two different
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particle size fractions ofparacetamol were compressed at different compaction
forces and compaction speeds. Heckel analyses, elastic recoveries, elastic
energies and plastic energies were studied.
3.2 MATERIALS AND METHODS
3.2.1 MATERIAL
Paracetamol powder, as described in section 2.1.1, was used.
3.2.2 METHODS
3.2.2.1 Particle size fractions of paracetamol
Two different sieve fractions of paracetamol, <90 pm and 105-2 10 pm, were
obtained as detailed in section 2.2.13. Figure 3.1 exhibits the scanning
electron micrographs of these two particle size fractions.
(a)	 (b)
Figure 3.1 Scanning electron micrographs of untreated paracetamol: a) the
<90 pm and b) the 105-210 pm fractions (magnification xlOO).
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3.2.2.2. Compression
Compression was carried out using the compaction simulator (section 2.2.11).
Four tablets, 400 mg weight each, were made at compression speeds of 10,
50, 100 or 250 mm s' up to a maximum compaction force of 30 kN. To
eliminate the effect of moisture on the compaction properties of paracetamol
(Garr & Rubinstein, 1992), the sieved fractions were dried in an oven at 55°C
for 24 h and stored in tightly closed jars before use.
3.2.2.3 Analyses of compaction data
Analyses of the data according to the Heckel equation were carried out as
detailed in section 2.2.12.2. Mean yield pressures (MYP), the relative
densities of the powders at zero pressure (D0) and before appreciable load
(Da), and the extent of particle rearrangement (Db) were determined.
The plastic and elastic energies were measured using energy analysis on the
force-punch separation plots (section 2.2.12.1).
Paracetamol tablets were too weak and capped after ejection, and it was
impossible to monitor their thickness outside the die. Therefore the
percentage of elastic recovery in the die at different compaction forces were
determined, as detailed in section 2.2.12.3.
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3.3 RESULTS AND DISCUSSION
3.3.1 CRUSHING STRENGTHS
Compression of both particle size fractions of paracetamol at all compression
forces, even at the lowest compression speed, produced extremely weak
tablets which had no measurable strength and a high tendency th cap. It was
obvious that the capping and failure increased with increase in either
compaction force or compaction speed.
3.3.2 HECKEL ANALYSES
Figure 3.2 shows typical Heckel plots of the different particle size fractions
of paracetamol obtained at a compaction speed of 10 mms. This figure
indicates that the larger particles (105-210 pm) exhibited higher relative
densities for a given applied pressure than the small fractions (<90 pm).
Thus, the degree of densification that occurred during compression was
greater for the larger particle size fraction. This can be attributed to
increased frictional and cohesive forces associated with the smaller size
range, which tend to restrict particle sliding and thus reduce densification
(York, 1978; Roberts & Rowe, 1986). Furthermore, during compaction, the
smaller particles yielded from fragmentation of the larger angular shaped
particles (figure 3.la), could tend to fill the remaining interparticulate voids
between the crystals. This could lead to a further increase in the relative
density of the compacts made from larger particle fractions. In contrast, it
would be expected that only a relatively small amount of fragmentation
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Figure 3.2 Typical Heckel plots of the <90 jim or 105-2 10 pm size fractions
of paracetamol obtained at a compaction speed of 10 mm s.
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would occur in the small particle size fractions (<90 pm) due to the spherical
shape of these particles (figure 3.lb) as reported by McKenna and McCafferty
(1982) and Roberts and Rowe (1986).
Figure 3.2 also exhibits that the slope of Heckel plot for the 105-2 10 p.m
fraction was greater than for the <90 pm fraction. Table 3.1 indicates that
the value of slope (K) was greater for the larger fraction and therefore the
reciprocal of K, which is mean yield pressure, was lower. The values of Da,
Table 3.1 The values derived from the Heckel plots of figure 3.2 of the <90
pm or 105-2 10 pm fractions of paracetamol compressed at a compaction speed
of 10 mm s.
(105-2 10 pm)	 (<90 jim)
K	 0.029	 0.022
1fK=Mean yield pressure (MPa)
	
34.2	 45.5
Da	 0.72	 0.70
D0	 0.67	 0.65
0.957	 0.972
r**	 0.996	 0.992
r*=Correlation coefficient of initial curve of Heckel plot (0-20 MPa)
r**=Correlation coefficient of straight line portion of Heckel plot (20-65 MPa)
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D0 and Db (table 3.1) indicate that densification due to die filling and particle
rearrangement for the tablet made from the 105-210 pm particles was higher
than for the tablet made from the <90 pm fraction.
The correlation coefficient of the initial part of Heckel plot (0-20 MPa) was
lower for the 105-210 im fraction (table 3.1), indicating a higher degree of
fragmentation for the larger particles than smaller particles (Duberg &
Nystrom, 1986; Humbert-Droz et al, 1983). As mentioned in section 1.4.6, the
correlation coefficient of the initial curve of Heckel plot serves as a tool which
may be used to quantify the tendency of particles to fragment.
The Heckel plot and the constants derived from it, were thus dependent on
the particle size of paracetamol.
A low mean yield pressure (less than 50 MPa) obtained for materials such as
Avicel®
 (microcrystalline cellulose), indicates a high degree of plastic
deformation under pressure (Roberts & Rowe, 1987b; Garr & Rubinstein,
1991b). York (1978) and Duberg and Nystrom (1986) reported that the value
of mean yield pressure derived from the slope of the linear portion of the
Heckel plot depends on the elastic and plastic deformation of the material
under applied load. Therefore, for elastic materials a false, low mean yield
pressure is obtained (Fell & Newton, 1971). It is difficult to distinguish
between elastic and plastic deformation evaluated from the slope of the linear
portion of Heckel plot. In an attempt to distinguish between plastic and
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Figure 3.3 Heckel plot, including compression and decompression phases, of
the 105-2 10 pin fraction of paracetarnol, obtained at a compression speed of
10 mm s•'.
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elastic deformation of materials, Duberg and Nystrom (1986) divided the
Heckel plot into three stages as illustrated in figure 1.9. As was mentioned
in section 1.4.5.2, a considerable deviation from the horizontal in phase III
indicate elastic behaviour of material under pressure. Figure 3.3 shows the
whole compression cycle (compression and decompression phases) for the 105-
210 pm fraction of paracetamol. The large deviation from horizontal during
decompression (phase III) is indicative of a high degree of elastic propensity
of these particles under pressure. Therefore the low mean yield pressure
found for paracetamol (table 3.1), is attributed to its elastic behaviour not to
plastic deformation. The high values of elastic recovery and elastic energy of
paracetamol tablets, which will be discussed later in sections 3.3.3 and
3.3.4.2, confirm the extensive elastic behaviour of paracetamol particles
during compaction.
3.3.2.1 Influence of compression speed on Heckel constants
The effects of compression speed on the constants derived from Heckel plot
(mean yield pressure, D0, Da and Db) of the two particle size fractions of
paracetamol were investigated and the results are presented in this section.
The effects of compression speed on MYP of the <90 pm and 105-210 pm
fractions are shown in table 3.2. As the compaction speed increased, the
mean yield pressure for each particle size increased. One way analysis of
variance showed that there was a significant difference (P<0.05) between the
mean yield pressures obtained at different compaction speeds for both
particle fractions. Tukey's test revealed that there were no significant
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differences (P>0.05) between the mean yield pressures obtained at 10 and 50
mm s4 for both fractions. Additionally, the mean yield pressures obtained at
100 and 250 mm s' for the <90 pm fraction could not be differentiated.
Table 3.2 The effect of compression speed on the mean yield pressures (MYP)
of the <90 pm and 105-2 10 pm particle size fractions of paracetamol.
Compression speed	 MYP±SD (MPa)
(mm s)	 (105-210 pm)	 (<90 pm)
10	 34.4±2.0	 44.5±1.5
50	 35.5±1.2	 44.8±1.2
100	 38.6±0.6	 48.7±1.5
250	 42.3±1.6	 51.5±2.7
The changes of mean yield pressure with compaction speeds can be quantified
using equation 3.1 which allows the calculation of percentage of strain rate
sensitivity (SRS) (Roberts & Rowe, 1985).
SRS = [(P 2 - P 1)fP 2] x 100	 Equation 3.1
P, 1 and P 2 are the mean yield pressure at 10 mm s' and 250 mm s' punch
velocity, respectively. The calculated values of SRS for the <90 pm and 105-
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210 im fractions of paracetamol were 13.6 and 18.7%, respectively.
SRS is a useful index which can show the plastic or brittle nature of a
material (see section 1.4.6). Due to the time dependent nature of plastic
deformation, the mean yield pressures increase with increasing punch
velocity for plastic materials such as Avicel ®
 and sodium chloride, which
consequently show high value of SRS (>40%) (Roberts & Rowe, 1985, 1987a)..
However, for lactose, which deforms by a combination of particle fracture and
plastic deformation, the SRS was about 16% (Roberts & Rowe, 1985).
The rather low degree of SRS found for both particle size of paracetamol, is
indicative that fragmentation is the dominant mechanism during compaction.
Roberts and Rowe (1985) and Duberg and Nystrom (1986) studied the Heckel
equation during compaction of paracetamol and similarly reported that the
dominant mechanism of compaction of paracetamol is by extensive
fragmentation.
Table 3.2 also indicates that, at each punch velocity, the mean yield pressure
increased as the particle size decreased. This supports the findings of Hersey
et al (1973) and Roberts and Rowe (1986, 1987a) who suggested that as
particle size decreases, the stress necessary to cause fracture of particles
increases. It would be expected that as the particle size decreases, the
brittleness of particles would be reduced because of the lower probability of
cracks being present in the crystal structure. Roberts and Rowe (1989)
92
showed that larger particle size of sodium chloride undergo some degree of
fragmentation during compaction whereas smaller particles (<35 pm) undergo
plastic deformation, with no evidence of fragmentation.
It has been reported that for plastically deforming materials such as sodium
chloride and potassium chloride (Hersey et al, 1973; Humbert-Droz et al,
1982), microcrystalline cellulose (Roberts & Rowe, 1986) and starch
(McKenna & McCafferty, 1982), the measured mean yield pressures were
independent of particle size. However for materials that deform by particle
fragmentation such as lactose and calcium carbonate, the mean yield
pressures increased with reduction in particle size (Hersey et al, 1973; York,
1978; Roberts & Rowe, 1986).
The findings of this study indicate that paracetamol belongs to group of
materials which deform by fragmentation. The massive fracture of
paracetamol particles under applied load has been also confirmed by other
techniques such as permeametry (Alderborn et al, 1985).
Table 3.3 shows the values of D0, Da and Db derived from Heckel plots at
various compaction speeds. For each particle size, the values of D0 and Da
generally tended to decrease with increasing punch speeds. One way analysis
of variance showed that there were significant differences (P<O.05) between
the values of both D0 and Da, obtained at different compaction speeds, for
both particle fractions. Tukey's test revealed that there were no significant
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differences (P>0.05) between the values of D0 at 10 and 50 mm s 1 for both
particle sizes, and also between the values of Da at 10 and 50 mm s' for the
105-210 pm fraction, and between values of D0 at 100 and 250 mm s1 for 105-
210 pin fraction. The decreases of relative densities with increasing
compaction speed may be due either to an increase in the frictional and
adhesive forces between particles or due to restriction of the air escape from
the powder bed (Roberts & Rowe 1985).
Table 3.3 The values of Da, D0 and Db (x10 1 ) (±SD) of different particle size
fractions of paracetamol at different punch speeds.
Speed105-2 10 pm	 ________ <90 pm _______
(mm ')
_______ 
D0	 Da	 Db	 D0	 Da	 Db
10	 6.57	 7.18	 0.61	 6.45	 7.03	 0.58
	
±0.08	 ±0.04	 ±0.08	 ±0.05	 ±0.04	 ±0.04
50	 6.50	 7.10	 0.63	 6.45	 6.93	 0.48
_________ ±0.08
	 ±0.07	 ±0.08	 ±0.05	 ±0.04	 ±0.04
100	 6.25	 6.90	 0.63	 6.16	 6.72	 0.56
_________ ±0.05
	 ±0.04	 ±0.07	 ±0.05	 ±0.04	 ±0.04
250	 6.20	 6.70	 0.53	 5.93	 6.48	 0.55
	
±0.00	 ±0.04	 ±0.05	 ±0.04	 ±0.05	 ±0.05
Table 3.3 also indicates that at each compaction speed, the smaller particle
fraction of paracetamol showed apparently lower values of D0 and Da than the
larger fractions. Two way analysis of variance showed that there were
significant differences (P<0.05) between the <90 pm and the 105-210 pm
particle fractions in terms of D0 and Da. Tukey's test revealed that the values
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of D0 obtained for the two fractions were significant only at 250 mm s'
(P<0.05). However, the differences between the values of Da were significant
(P<0.05) at all compaction speeds. Decrease in values of D0 and Da for smaller
particles, may be attributed to increase frictional and cohesive forces between
the smaller size fractions and/or more fragmentation of the 105-2 10 p.m
fraction as compared to the <90 p.m fraction, which were discussed earlier.
3.3.3 INFLUENCE OF COMPACTION FORCE ON THE ELASTIC
RECOVERY OF PARACETAMOL TABLETS
The effect of compression force on the elastic recoveries in the die of tablets
made from the two size fractions of paracetamol are shown in figure 3.4.
Increasing the compaction force resulted in an increase in the elastic
recoveries of the tablets. Tablets made from the <90 pm fraction exhibited
higher elastic recoveries than larger particles. Two way analysis of variance
showed that there were significant differences (P<0.05) between the elastic
recoveries of the tablets made from the <90 p.m fraction and tablets made
from the 105-2 10 p.m fraction. However, there were no significant differences
(using Tukey's test) between the elastic recoveries of the tablets made from
the two particle sizes at 20 and 25 kN (P<0.05).
Although the paracetamol tablets made from either particle sizes had no
measurable hardness, the values of elastic recoveries, which were lower for
the larger particles, may indicate a higher interparticulate bondings for the
105-2 10 pm fraction. At all compaction pressures, the larger particles produced
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Figure 3.4 Effect of compression force on the elastic recovery in the die of
tablets made from <90 pm or 105-2 10 pm fractions of paracetamol, at a
compression speed of 10 mm s'.
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denser compacts than the smaller particles (section 3.3.2). It may be argued
that the increased fragmentation of the larger size fraction of paracetamol,
should result in increased interparticulate bonding due to the formation of
fresh and clean surfaces (McKenna & McCafferty, 1982).
For materials which fragment during compaction, such as Emcompress
(dicalcium phosphate dihydrate), the main mechanism of particle bonding is
due to the creation of numerous new, fresh and clean surfaces which are able
to form bonds (Duberg & Nystrom, 1982; Nystrom & Glazer, 1985; Alderborn
et al, 1985). Therefore for a brittle substance, the greater fragmentation,
producing more fresh and clean surfaces, results in the more bondings
between particles.
3.3.4 ENERGY ANALYSIS OF PARACETAMOL TABLETS
3.3.4.1 Effect of compression force or speed on the gross energies
The effects of compaction force or compaction speed on the gross energies of
tablets made from the <90 pm and 105-2 10 pm fractions of paracetaniol are
illustrated in figures 3.5 and 3.6, respectively. Increasing the compaction
force or compaction speed, resulted in an increase in gross energies for both
particle size fractions. These figures also indicate that at all compaction
forces or speeds the gross energies of tablets made from the <90 pm fraction
were greater than the 105-2 10 pm fraction. The gross energy is a combination
of elastic and plastic (net compaction) energies. Therefore the next step was
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Figure 3.5 Effect of compression force on the gross energies of tablets made
from the <90 pm or 105-2 10 pm fractions of paracetainol, at a compression
speed of 10 mm s.
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Figure 3.6 Effect of compression speed on the gross energies of paracetamol
taMets made from the <90 pm or 105-210 pm fractions of paracetamol, at a
compression force of 15 kN.
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to distinguish the effect of particle sizes on these energies.
3.3.4.2 Influence of compression force or speed on the elastic energies
The effects of compression force or compression speed on the elastic energies
of tablets made from paracetamol are illustrated in figures 3.7 and 3.8,
respectively. Increase in the compaction force or compaction speed resulted
in an increase in the elastic energies made from two particle fractions.
Figures 3.7 and 3.8 also indicate that at different compaction forces or
speeds, the tablets made from the 105-2 10 pm fraction exhibited lower elastic
energies than the <90 pm fraction. However, Tukey's test showed that there
was no significant difference (P>0.05) between elastic energies for these two
fractions (<90 pm and 105-2 10 pm) at 30 kN compaction forces (figure 3.7),
and at 100 mm s compaction speed (figure 3.8). Elastic energy is not used
for formation of bonds. In fact, this energy is stored in tablets under stress
as deformation energy. The release of this stored energy at the end of the
compression cycle allows the distorted particles to return to their original
shape and so rupture weak particle-particle bonds (Yu et al, 1988). In the
present study, the results of elastic recovery were supported by the data of
the elastic energies. The elastic energies indicated that the tablets made from
smaller particles were relatively more elastic than tablets made from larger
particles, resulting in an increase in the elastic recovery of tablets made from
the <90 pm fractions (figure 3.4).
100
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Figure 3.7 Effect of compression force on the elastic energies of tablets made
from the <90 pm or 105-2 10 pm fractions of paracetamol, at a compression
speed of 10 mm s'.
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Figure 3.8 Effect of compression speed on the elastic energies of tablets made
from the <90 pm or 105-210 pm fractions of paracetamol, at a compression
force of 15 kN.
102
3.3.4.3 Influence of compression force or speed on the plastic (net
compaction) energies
Figures 3.9 and 3.10 show the plastic energies of paracetamol tablets at
different compaction forces or speeds, respectively. Increase in compression
force or compression speed resulted in an increase in the plastic energies for
tablets made from each particle fraction of paracetamol.
Plastic or net compaction energy is utilized for die wall friction, interparticle
friction, particle slippage and rearrangement, plastic deformation,
fragmentation and formation of bonds during compaction. Figures 3.9 and
3.10 indicate that the plastic energies of tablets made from the <90 pin
fraction were higher than for tablets made from the 105-2 10 pm fractions.
Tukey's test revealed that at 25 kN compaction force (figure 3.9) and at 250
nmi s (figure 3.10), there was no significant difference (P> .0.05) between the
plastic energies of tablets made from the <90 pin or 105-2 10 pm fractions.
Increased in plastic energies for smaller particles, may be attributed firstly,
to the increased frictional forces between the smaller particles. Secondly, as
described in section 3.3.2.1, the mean yield pressures of the smaller particles
were higher than those of the larger particles. Therefore, smaller fractions
need more energy for fragmentation and deformation.
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Figure 3.9 Effect of compression force on the plastic energies of tablets made
from the <90 pm or 105-2 10 pm fractions of paracetamol, at a compression
speed of 10 mm S'.
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Figure 3.10 Effect of compression speed on the plastic energies of tablets
made from the <90 pm or 105-210 pm fractions of paracetamol, at a
compression force of 15 kN.
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3.3.4.4 Influence of compression force or speed on the ratio of elastic
energy/plastic energy
Tables 3.4 and 3.5 show the ratios of elastic energy/plastic energy (EETPE) at
various compaction forces or speeds, respectively. The ratio of EEIPE
generally increased, with increase in compression force or speed. Tukey's test
showed that there were no significant differences (P>0.05) between the
EEIPE ratios obtained at 25 and 30 kN for both fractions, and also between
20 and 25 kN only for <90 p.m fraction (table 3.4). It was also found (using
Tukey's test) that there were no significant differences between the ratios of
EEIPE at 10 and 50 mm s for both particle sizes, and also at 100 and 250
Table 3.4 Effect of compression force on the ratio of EE/PE of paracetamol
tablets made from <90 pm or 105-210 p.m fractions, at a compaction speed of
10 mm s'.
Compression	 EE/PE ratio±SD
force (kN)	 105-210 pm	 <90 pm
10	 0.54±0.05	 0.74±0.06
15	 0.87±0.09	 0.92±0.04
20	 1.31±0.11	 1.36±0.14
25	 1.58±0.18	 1.73±0.11
30	 1.89±0.16	 1.78±0.17
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mm s ' only for the 105-210 pm fraction (table 3.5). These results indicated
that at higher compression speeds or compression forces the majority of
compaction energy was consumed as elastic energy, i.e. the tablets became
more elastic. Garr and Rubinstein (1991a) reported that the intensity of
capping of paracetamol compacts increased with increasing compaction speed.
They observed that the EEIPE ratio increased with compression speed and
suggested that the increase in capping tendencies with compaction speed was
related to increase in the EEIPE ratio.
Table 3.5 Effect of compression speed on the ratio of EEIPE of paracetamol
tablets made from the <90 pm or 105-210 pm fractions, at a compaction force
of 15 kN.
Compression	 EE/PE ratio±SD
speed (mm s)	 105-2 10 pm	 <90 pm
10	 0.87±0.09	 0.92±0.04
50	 0.75±0.06	 0.92±0.08
100	 1.08±0.08	 1.00±0.06
250	 1.14±0.12	 1.24±0.09
At constant compaction force or speed the ratios of EE/PE were apparently
higher for the smaller particles. Two way analysis of variance showed that
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there were no significant differences (P>0.05) between the EE/PE ratio of the
tablets made from the <90 pm or 105-210 pin fractions (table 3.5). However,
there were significant differences at different compaction forces (table 3.4).
Tukey's test revealed that there was significant differences between the ratio
of EE/PE only at 10 kN compaction force, and at other compaction forces the
differences between them were not significant.
Although the elastic energies of tablets made from smaller particles were
higher than larger particles (figures 3.7 and 3.8), the plastic energies were
also higher for the smaller particles (figures 3.9 and 3.10). Consequently
there was no large difference between the ratios of EE/PE for these two
particle fractions.
3.4 CONCLUSIONS
The results of Heckel analysis indicated that the main mechanism of
compression of untreated paracetamol was fragmentation. The larger particle
fraction of paracetamol underwent more fragmentation than the smaller
particles. Heckel analysis also indicated that for a given applied presxm,'th
larger particles of paracetamol produced denser compacts than the smaller
particles.
The results of elastic recovery, elastic energy and EE/PE ratio, at different
compaction force or speed, indicated that paracetainol particles underwent
high elastic deformation during compaction, resulting in weak and capped
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tablets.
It was found that larger particles exhibited less elastic recovery and elastic
energy as compared to smaller particles. This was attributed to increased
fragmentation of larger particles resulting in an increase in bonding between
particles due to the formation of more new, fresh and clean surfaces.
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CHAPTER 4. HABIT MODIFICATION OF PARACETAMOL
CRYSTALS
4.1 INTRODUCTION
Crystallization from solution is used widely for the purification of drugs
during their final stages of manufacture. The crystallization technique can
change the crystal properties such as habit, polymorphism and size. The
nature and extent of these changes depend on the crystallization conditions
such as presence of impurities, type of solvent and cooling rate as detailed in
section 1.2.
Crystallization of paracetamol from a wide range of solvents such as water,
alcohols, esters, ketons, dioxane or acetone produced essentially prismatic
polyhedral crystals (Fairbrother, 1974; Fachaux et al, 1992b; El-Said, 1995).
In fact the prismatic polyhedral habit is the dominant form in paracetamol
crystals. However, Fairbrother (1974) demonstrated that crystallization of
paracetamol from benzene, toluene and several chlorinated solvents such as
dichloroethane produced slender rhombohedral needles.
One common method of crystallization is by the addition of a second
substance which reduces the solubility of the solute in the solvent. This
method is known as salting-out. The added substance may be a liquid, solid
or gas, although liquids (known as diluents) are most frequently used. The
diluent must be miscible with the crystallization solvent and the solute
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should be relatively insoluble in it. This process is commonly used during
crystallization of organic substances from water-miscible organic solvents, by
controlled addition of water to the solution. The term "watering-out" is used
in this case. The advantages of salting-out method are described in section
1.2.6.2.
The aim of the work presented in this chapter is to modify paracetamol
crystals, using a watering-out crystallisation technique. The effect of factors
such as solvent type and crystallization temperature on the crystal habit are
studied. The solid state characteristics of the modified crystals are also
investigated.
4.2 MATERIALS AND METHODS
4.2.1 MATERIALS
Paracetamol and ethanol, as described in section 2.1, were used for this part
of the study.
4.2.2 METHODS
4.2.2.1 Crystaffization procedures
4.2.2.1.1 Crystallization of paracetamol using a watering-out method at 3°C
Samples of paracetamol (5g) were dissolved in 12 ml of ethanol at 75°C. The
111
temperature was then reduced to 65°C and the solutions were rapidly added
to 50 ml cold water at 3°C. The resultant solutions were mixed by means of
a glass rod and the temperature maintained at 3±1°C using an ice-water
bath. After 15 mm, with no agitation, the precipitated crystals were collected
by filtration using a sintered glass funnel No. 3 under vacuum. They were
spread on glass petri dishes and dried for 24 h at 55°C. The dried crystals
were stored in a desiccator at room temperature before use.
4.2.2.1.2 Alternative crystallization procedures
Crystallization of paracetamol by a watering-out method at 25°C was carried
out as explained in section 4.2.2.1.1 but the ethanolic solutions of
paracetamol were added to 50 nil water at 25°C and maintained in a water
bath at 25±1°C.
Paracetamol was crystallized from an ethanol/water mixture by dissolving 5g
paracetamol in a mixture of 12 ml ethanol and 50 ml water (the same
amount as used in section 4.2.2.1.1) at 65°C. The solutions were then cooled
to 3±1°C or 25±1°C, in an ice-water bath or in a water bath, respectively.
Paracetamol was crystallized directly from ethanol by dissolving 5 g
paracetamol in 15 ml ethanol at 65°C. The solutions were then cooled to
3±1°C or 25±1°C, in an ice-water bath or in a water bath, respectively.
Paracetamol was also crystallized directly from water by dissolving 1.5 g
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paracetamol in 60 ml water at 65°C. The solutions were then cooled in an ice-
water bath at 3±1°C or in a water bath at 25±1°C.
In all cases the precipitated crystals were collected after 15 nun by filtration
using a sintered glass funnel No. 3 under vacuum. They were spread on glass
petri dishes and dried for 24 h at 55°C. The dried crystals were stored in a
desiccator at room temperature before use.
4.2.2.2 Determination of paracetamol solubifity
In order to determine the solubility of paracetamol in water, ethanol or their
mixture, the following was carried out. First the UV calibration for solutions
containing different concentration of paracetamol (0.0 to 0.035 mg mt') in
ethanol or 19.35% v/v ethanol/water (the same ratio used during
crystallization) was determined at 250 or 246 nm, respectively (figures 4.la
and 4.lb). The best fit equations for Beer's law plot of UV absorbance versus
paracetamol concentration in ethanol or the ethanol/water mixture are given
by equations 4.1 and 4.2, respectively. The TJV calibration of paracetarnol in
water was as described in section 2.2.7.
Y = 0.020 + 87.4 C
	 (r=0.9995)	 Equation 4.1
Y = 0.006 + 68.6 C	 (r=0.9999)	 Equation 4.2
In these equations, Y is the absorbance of the paracetamol solution and C is
the concentration of paracetamol (mg nut1).
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Figure 4.1 Ultraviolet absorbance against concentration (mg mt') of
paracetamol in: (a) ethanol at 250 nm and (b) 19.35% v/v ethanol/water at
246 nm (each point is the mean ±SD of three determinations).
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Samples of paracetamol (1, 2 or 8g) were dispersed in 50 ml water, 19.35%
v/v ethanol/water or ethanol, in stoppered 100 ml conical flasks. The flasks
were shaken in a shaking water bath at 25±1°C or 3±1°C (ice-water) for 8
hours. Then, the paracetamol concentrations in the filtered solutions were
determined spectrophotometncally after appropriate dilution, using equations
2.5, 4.1 or 4.2.
4.2.2.3 Determination of the degree of supersaturation of the
crystallization systems
The degree of supersaturation, S, of crystallization systems was calculated by
equation 4.3, in which c is the concentration of paracetamol in solution and
c is the equilibrium saturation (solubility) of the paracetamol at
crystallization temperature (Mullin, 1993).
S=cic*	 Equation4.3
4.2.2.4 Scinning electron microscopy
Scanning electron micrographs of crystals and particle size measurements
were obtained using a scanning electron microscope as described in section
2.2.5.
4.2.2.5 Differential Scamiing Calorimetry (DSC), X-ray Powder
Diffraction (XPD) and Infrared spectroscopy (IR)
DSC, XPD and JR were carried out, as described in sections 2.2.4.1, 2.2.2 and
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2.2.3 respectively.
4.3 RESULTS AND DISCUSSION
4.3.1 MORPHOLOGY OF CRYSTALS
Figure 4.2 exhibits the scanning electron micrographs of paracetamol crystals
obtained by the watering-out method at 3°C. These crystals were very thin
and flaky. Figure 4.3 shows the scanning electron micrograph of paracetaniol
crystals obtained by the watering-out method at 25°C. These were prismatic
polyhedral crystals.
Crystallization of paracetamol from a mixture of ethanollwater at 3°C
produced thin plate-like crystals (figure 4.4a), while at 25°C it produced
polyhedral crystals (figure 4.4b).
Crystallization of paracetamol from water or ethanol at 3°C or 25°C, produced
prismatic polyhedral crystals (Figures 4.4c, d, e and f).
4.3.2 DEGREE OF SUPERSATURATION OF CRYSTALLIZATION
SYSTEMS
The degrees of supersaturation, 5, during crystallization of paracetamol in
water, ethanol or mixture of ethanollwater at 3°C or 25°C are given in table
4.1. The type of crystals obtained by these methods, including their average
length size, are also given in table 4.1.
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(a)	 (b)
Figure 4.2 Scanning electron micrographs of paracetamol particles
crystallized by watering-out method at 3°C (magnification of figures a and b
are xlOO and x200, respectively).
Figure 4.3 Scanning electron micrographs of paracetamol particles
crystallized by watering-out method at 25°C (magnification x200).
117
J,41
(a)	 (b)
(c)	 (d)
(e)	 (f)
Figure 4.4 Scanning electron micrographs of paracetamol crystallized: a) from
mixture of ethanollwater at 3°C and b) at 25°C, c) from ethanol at 3°C and
d) at 25°C, e) from water at 3°C and 0 at 25°C (all magnification x200).
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The polyhedral habit is the dominant form of paracetamol crystals and
crystallization of paracetamol from different solvents such as water, ethanol
or dioxane (Fachaux et al, 1992), isopropanol, clioxane or acetone and their
mixtures with water (El-Said, 1995), alcohols, esters, ketons or acetonitrile
(Fairbrother, 1974) produced prismatic polyhedral crystals. Table 4.1 clearly
indicates that a combination of ethanol and water as crystallization solvent
and a low crystallization temperature (3°C), i.e. rapid cooling, were required
to produce thin plate-like crystals of paracetamol. In the absence of one of
these two factors, polyhedral crystals were produced.
Table 4.1 also indicates that crystallization temperature had a great influence
on the degree of supersaturation of the ethanol/water system and produced
a high degree of supersaturation at 3°C. It has been reported that a change
in the degree of supersaturation may cause preferential growth of crystals in
one particular direction, leading to the formation of different crystal habits
(Mullin, 1993).
Figure 4.5 shows the cooling curves during crystallization of paracetamol by
watering-out method and during crystallization from mixture of ethanol/water
at 3°C or 25°C. It is obvious that crystallization temperature had a major
effect on cooling rate of crystallization system and crystallization at 3°C
caused a rapid cooling of the system.
Some workers have reported the effects of crystallization solvent or cooling
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Figure 4.5 Cooling curve of crystallization medium during watering-out
method at (E) 3°C and (U) 25°C, and during crystallization from a mixture of
ethanol/water at (A) 3°C and (a) 25°C.
121
rate on crystal habit. Marshall and York (1989) reported that nitrofurantoin
particles crystallized from formic acid were tabular while from a mixture of
formic acid/water were needle-like. Ibuprofen crystals obtained from hexane
were needle-like, whilst from methanol were grain-like (Gordon & Amin,
1984). Watanabe et al (1982) demonstrated that aspirin was crystallized from
water as plate-like crystals but from dioxane or n-heptane thin needle
crystals were yielded. Cooling rate has also a major influence on the crystal
habit. For instance, naphthalene was crystallized as thin plates from
methanol by rapid cooling but when it was slowly crystallized, it yielded
compact (grain-like) crystals (Wells, 1946). Garti and Tibika (1980)
demonstrated that by increasing the cooling rate during crystallization of
nitrofurantoin from a formic acid/ethanol mixture, more elongated crystals
were collected, i.e. the ratio of length to width increased with increase in
cooling rate.
Crystallization temperature or degree of supersaturation may also have a
major effect on crystal size. Rapid cooling of a hot and saturated solution
yields small crystals whereas a low crystallization rate produces larger
particles (Huttenrauch, 1983). Table 4.1 indicates that the paracetamol
crystals obtained from water or ethanol at 3°C were smaller than crystals
obtained at 25°C.
122
I0 50
40
lb
0
50
70
50
I60
S40
50
10
0
40
lb
10
40
U
S
'S
S
20
I
0
50-40 4010 10-150 10-10
Width (pm)
50
40
0
2O
C
10-40 4010 10-* 10-10100-250
Lgth (pm)
10-10 10-laO 10400100-210106-150
	
10-10 00-10 100-10 16450
	
6-10	 10-1	 126
Lcgth (pm)
	
Width (jim)	 Thickn.ii (ps)
(a)
(b)
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4.3.3 SOLID STATE CHARACTERISTICS OF POLYHEDRAL AND THIN
PLATE-LIKE CRYSTALS
Since the compaction properties of polyhedral crystals of paracetamol
obtained from water at 25°C and thin plate-like crystals obtained by
watering-out method at 3°C are studied in next chapter, therefore, it is now
useful to assess the solid state characteristics of these two forms of
paracetamol crystals.
4.3.3.1 Particle size distribution
Figure 4.6 shows the size distributions of polyhedral crystals and thin plate-
like crystals of paracetamol. There is a large difference between the size
dimensions of these two forms of crystals. This indicates a strong inhibition
of crystal growth at some crystal faces and inducement to more growth of
other faces for the thin plate-like crystals as compared to the polyhedral
crystals.
4.3.3.2 Differential Scinning Calorimetry (DSC)
The DSC scans of the thin plate-like crystals and polyhedral crystals of
paracetamol are illustrated in figure 4.7. The mean values of the onsets of the
melting point and the enthalpies of fusion for these two forms of crystals are
also presented in table 4.2. According to these results, no events such as
hydration, solvation or polymorphic modification, had occurred during the
crystallization in the particles.
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Table 4.2 The onsets of melting point (Tm) and enthalpies of fusion (LHf) for
thin plate-like and polyhedral crystals of paracetamol.
Crystal type	 Onset of Tm (±SD)
	
LHf (±SD)
(°C)	 (J/g)
Thin plate-like crystals 	 171.87±0.14	 179.35±10.47
Prismatic polyhedral crystals	 171.91±0.21	 176.75±4.82
4.3.3.3 X-ray powder diffraction (XPD)
The X-ray powder diffraction spectra for the thin plate-like and polyhedral
crystals of paracetamol, are presented in figure 4.8. Both samples exhibited
spectra with similar positions of peaks (29 values). Therefore polymorphism
can be ruled out. However, the relative intensities of their peaks were
modified. This is may be because the crystals exhibited preferred orientations
within the sample holder due to their markedly different crystal habits
(Marshall & York, 1989). Therefore the relative abundance of the planes
exposed to the X-ray source would have been altered producing the variations
in the relative intensities of the peaks (Marshall & York, 1989). El-Said
(1995) has also reported that paracetamol crystals obtained from different
solvents exhibited similar X-ray diffraction patterns, but different intensities.
This was attributed to difference in the crystal size.
125
37.5
a
25
0
-U.
I-
(a)	
12.5
0
Oat.: Hey Ii. 1995 08: 32cm
	
Ts.gsreture (C)
Scanning Rats: 10.0 C/sin
Seapis wt: 2.620 ap
50
37.5
C
25
(b)
12.5
0
Date: Hey 12. 1995 08: 57am	 Temperature (C)
Scanning Rate: 10.0 C/sin
Sample Wt: 2.080	 Peth:a:\
Figure 4.7 DSC scans of a) polyhedral and b) thin plate-like crystals of
paracetamol.
126
ei1a id.ntifictiofl: HADIPCWF	 2-feb-1996 p7: 13
40000
(countu
32400
25600
19500
14400.
(a)
10000
6400
3600
1600
ioojL
00 10
	 20	 30	 40	 do	 '	 do (2'T3
	
o
HAflTPCWF.
jd.nt j ficpt jpn .&oi p	 2-fab-1996 17: 08
40000.
(counts
32400.
25600.
19600
14400
(b)	 10000
8400.
10	 20	 30	 40	 do	 so (2T	 ,o
HAflIPPF
Figure 4.8 The X-ray powder diffraction spectra of a) polyhedral and b) thin
plate-like crystals of paracetamol.
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4.3.3.4 Infrared spectroscopy (IR)
The Infrared spectra of thin plate-like and polyhedral crystals ofparacetamol,
are presented in figure 4.9. It is obvious that the principal absorption bands
for the two samples are similar suggesting that there were no differences
between the internal structure and conformation of these samples.
4.4 CONCLUSIONS
Crystallization of paracetamol by a combination of "watering-out" from an
ethanolic solution and rapid cooling caused marked modffication to the crystal
habit and produced thin plate-like crystals which indicate strong inhibition
of crystal growth at different crystal faces.
It was found that crystallization solvent (ethanollwater) and crystallization
temperature (3°C), i.e. rapid cooling, are both critical in production of thin
plate-like crystals. The formation of thin plate-like crystals of paracetamol
was attributed to the interaction between paracetamol and binary solvent
system during crystallization at 3°C. Elimination of either of these factors
inhibited the production of thin plate-like crystals.
It was shown that this modified form of paracetamol crystals (thin plate-like)
is a habit modification and not due to polymorphism. It would be interesting
to see if the crystal habit has any effect on compaction behaviour of
paracetamol. Therefore, the compaction properties of thin plate-like crystals
of paracetamol are investigated in chapter 5.
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CHAPTER 5. INFLUENCE OF CRYSTAL HABIT ON THE
COMPACTION PROPERTIES OF PARACETAMOL
5.1 INTRODUCTION
The crystal habit of a drug is an important variable in pharmaceutical
manufacturing. Different crystal forms of a particular drug possess different
planes and thus differ not only in their specific surface, but also in their free
surface energy. Therefore, they may exhibit different physico-mechanical
properties (Huttenrauch, 1983). Properties such as dissolution rate, powder
flow and compressibility, which are of pharmaceutical interest, can differ for
different habits of the same drug (York, 1983; Marshall & York, 1991).
Attempts to change the morphology and the workability of drugs using
alternative crystallization procedures include modification of the crystal
habits of drugs such as ibuprofen (Gordon & Amin, 1984),
hexamethylmelaniine (Gonda et al, 1981 and nitrof'urantain <Martha?l &
York, 1989, 1991).
In this chapter the compaction properties of the two habits of paracetamol
crystals, produced by the different crystallization processes, described in the
previous chapter, are studied. The aims were firstly, to investigate whether
crystal habit had any significant effect on the compaction behaviour of
paracetamol and, secondly, whether the modified crystals showed improved
compaction properties.
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5.2 MATERIALS AND METHODS
5.2.1 MATERIALS
Prismatic polyhedral crystals of paracetamol obtained from water at 25°C
(figure 4.40 and thin plate-like crystals obtained by the watering-out method
at 3°C (figure 4.2), as described in chapter 4, were used. Several batches of
each crystal type were combined prior to study. For the purpose of
convenience, these two crystal forms are expressed as polyhedral and plate
crystals throughout this chapter.
5.2.2 METHODS
5.2.2.1 Particle size fractions
Sieved fractions of the polyhedral and plate crystals of paracetamol (105-210
jim) were obtained as detailed in section 2.2.13. The seived fractions were
dried in an oven at 55°C for 24 h and stored in tightly closed jars before use.
5.2.2.2. Compression
Compression was carried out using the compaction simulator (section 2.2.11).
Four tablets, 400 mg each, were made at compression speeds 10, 50, 100 or
250 mm s4 up to a maximum compaction force of 30 kN.
5.2.2.3 Analyses of compaction data
Analyses of the data according to the Heckel equation were carried out as
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detailed in section 2.2.12.2. Mean yield pressures (MYP), the relative
densities of powders at zero pressure (D0) and before appreciable load (Da),
and the extent of particle rearrangement (Db) were determined.
The plastic and elastic energies were measured using energy analysis on the
force-punch separation plots (section 2.2.12.1).
Tablets made from polyhedral or plate crystals of paracetamol were too weak
and capped after ejection, and it was impossible to monitor their thickness
outside the die. Therefore the percentage of elastic recovery in the die at
different compaction forces were determined, as detailed in section 2.2.12.3.
The results of analyses of compaction data of untreated paracetamol particles,
105-210 im (chapter 3), are included in this chapter for comparison.
5.3 RESULTS AND DISCUSSION
5.3.1 CRUSHING STRENGTH OF TABLETS
Compression of the plate and polyhedral crystals at all compression forces,
even at lowest compression speed, produced extremely weak tablets which
had no measurable strength and a high tendency to cap. The capping and
failure increased with increase in either compaction force or compaction
speed. These were similar results to untreated crystals (section 3.3.1).
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5.3.2 HECKEL ANALYSIS OF PARACETAMOL TABLETS
Figure 5.1 shows typical Heckel plots of the polyhedral and plate crystals of
paracetamol, obtained at a compaction speed of 10 mm s ' . This figure
indicates that the polyhedral crystals exhibited higher relative densities for
a given applied pressure than the plate crystals. Therefore, the degree of
densification that occured during compression was greater for the polyhedral
crystals. This can be attributed to increased frictional and cohesive forces
between the plate crystals, due to their large and flat surfaces (figure 4.2)
which would increase the contact points between them, restrict particle
sliding and thus reduce densification (York, 1978; Roberts & Rowe, 1986).
The slope of the plot for polyhedral crystals (figure 5.1) was greater than that
of the plate crystals. Table 5.1 indicates that the value of slope (K) was
greater for the polyhedral crystals and therefore the reciprocal of K, which
is the mean yield pressure, was lower.
The values of D0 and Da (table 5.1) indicate that densification due to die
filling and particle rearrangement for the polyhedral crystals was higher than
for plate crystals. A high difference between the values of D0 for these two
forms of crystals may be indicative of high frictional forces between the plate
crystals as compared to polyhedral crystals, which could restrict densification
due to die filling.
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Figure 5.1 Typical Heckel plots of polyhedral or plate crystals of paracetamol
obtained at a compaction speed of 10 mm s.
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Table 5.1 The values derived from the Heckel plots of figure 5.1 of polyhedral
and thin plate-like crystals of paracetamol compressed at a compaction speed
of 10 mm s'.
Polyhedral crystals Plate crystals
K	 0.0367	 0.0285
1/K=Mean yield pressure (MPa)
	
27.5	 35.3
Da	 0.71	 0.69
D0	 0.66	 0.53
	
0.965	 0.925
r**	 0.989	 0.997
r*=Correlation coefficient of initial portion of Heckel plot (0-20 MPa)
r**=Correlation coefficient of straight line portion of Heckel plot (20-65 MPa)
Table 5.1 indicates that the correlation coefficient of the initial part of Heckel
plot (0-20 MPa) was considerably lower for the plate crystals. This is
indicative of an extensive fragmentation of the plate crystals as compared to
the polyhedral crystals. As described in section 1.4.6, the correlation
coefficient of the initial part of Heckel plot can be a useful index in
estimating the degree of particle fragmentation. A linear segment (high value
of correlation coefficient) is obtained for non-fragmenting materials, while a
non-linear curve (low correlation coefficient) corresponds to materials which
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consolidate by fragmentation (Duberg & Nystrom, 1986; Humbert-Droz et al,
1983).
Therefore, the Heckel plot and the constants derived from it, were dependent
on the crystal habit of paracetamol. Marshall and York (1991) reported that
different crystal habits of nitrofurantoin, crystallized from different solvents,
similary exhibited different Heckel plots. They reported that the degree of
densification that occured during compression was greater for plate like
crystals as compared to needle-like crystals. Marshall and York (1991) also
demonstrated that the slope of Heckel plots, and thus the mean yield
pressures for the two crystal habits of nitrofurantoin were significantly
different. Needle like crystals of riitrofuranthin showed higher mean yield
pressure than plate like crystals. These observations were attributed to
markedly different crystal habits of these samples.
As mentioned in sections 1.4.5.2 and 3.3.2, the value of mean yield pressures
derived from the slope of the linear portions of the Heckel plots depend on
the elastic and plastic behaviour of the material under applied load.
Therefore, for elastic materials a false, low mean yield pressure is obtained
(Duberg & Nystrom, 1986; Fell & Newton, 1971). Using phase III of the
Heckel plot, it was found that a low mean yield pressure value obtained for
untreated paracetamol was due to its elastic behaviour and not plastic
deformation (section 3.3.2). Figure 5.2 shows the whole compression cycle
(compression and decompression phases) for the plate crystals ofparacetamol.
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Figure 5.2 Heckel plot, including compression and decompression phases, of
the plate crystals of paracetamol, obtained at a compression speed of 10
mm s•1.
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The large deviation from the horizontal during decompression (phase III) is
indicative of a high degree of elastic behaviour of these particles under
pressure.
5.3.2.1 Influence of compression speed on Heckel constants
The effect of compression speed on the constants derived from Heckel plots
(mean yield pressure, D0, Da and Db) of the two crystal habits (polyhedral and
plate crystals) of paracetamol were investigated and the results are presented
in this section.
Two way analysis of variance showed that there were significant differences
(P<0.05) between the mean yield pressures of polyhedral, plate and untreated
crystals (table 5.2). Tukey's test revealed that there were no significant
differences (P>0.05) between the mean yield pressures obtained at 250
mm s' for polyhedral and plate crystals. Tukey's test also revealed that there
were no significant differences between the mean yield pressures of untreated
and plate crystals at 10 or 50 mm s compaction speed.
As the compaction speed increased, the mean yield pressure for polyhedral
and plate crystals increased. However, Tukey's test revealed that there were
no significant differences (P>0.05) between the mean yield pressures obtained
at 10 and 50 mm s and also at 100 and 250 mm s for polyhedral crystals.
For plate crystals, the mean yield pressures were significantly different only
at 10 and 100 or 250 mm s.
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Table 5.2 The effect of compression speed on mean yield pressures (MYP) of
polyhedral, plate and untreated crystals of paracetamol.
Compression	 MYP±SD (MPa)
speed (mm
	 Polyhedral	 Plate	 Untreated
crystals	 crystals	 crystals*
10	 28.2±1.6	 35.1±1.8	 34.4±2.0
50	 30.5±1.4	 37.3±2.6	 35.5±1.2
100	 36.9±1.4	 41.9±1.3	 38.6±0.6
250	 38.9±0.8	 40.8±1.6	 42.3±1.6
* Taken from table 3.2
The changes of mean yield pressure with compaction speeds were calculated
as strain rate sensitivity (SRS), using equation 3.1 (section 3.3.2.1). The
values of SRS for polyhedral and plate crystals of paracetamol were 27 and
14%, respectively. The SRS value of untreated crystals was 18.7% (section
3.3.2.1). As mentioned in sections 1.4.6 and 3.3.2.1, due th the time dependent
nature of plastic flow, the mean yield pressures increase with increasing
punch velocity for plastic materials which consequently show higher values
of SRS (Roberts & Rowe, 1985; 1986). The results clearly indicate that
polyhedral and untreated crystals were more sensitive to compaction speed,
suggesting that they were more plastic than the plate crystals which were
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more brittle.
The values of D0, Da and Db (table 5.3) for both type of crystals tended to
decrease with increasing punch speeds. Tukey's test revealed that there were
no significant differences (P>0.05) between the values of D0 at all compression
speeds except at 10 and 250 mm s' for plate crystals. For polyhedral crystals,
the difference between the values of D0 at 10 and 50, and also at 50 and 100
mm s' compaction speeds were not significan. The values of D at 10 and 50
mm s 1 for the polyhedral crystals, and at 50 and 100 mm s' for plate crystals
were not significant (P>0.05). Tukey's test also revealed that there were no
significant differences (P>0.05) between the values of Db at 10 and 50 mm s'
for plate crystals. The values of Db for polyhedral crystals at 50 and 100, and
also at 100 and 250 were not significantly different.
Table 5.3 The values of Da, D0 and Db (xlO') (±SD) of polyhedral and plate
crystals of paracetamol at different punch speeds.
Compression	 Polyhedral_crystals	 Plate_crystals
speed (mm .1)
__________ D0	 Da	 Db	 D0	 Da	 Db
10	 6.50	 7.03	 0.50	 5.25	 6.93	 1.65
	
±0.05	 ±0.09	 ±0.05	 ±0.06	 ±0.05	 ±0.13
50	 6.50	 7.00	 0.50	 5.15	 6.65	 1.50
	
_____________ ±0.07
	 ±0.07	 ±0.07	 ±0.05	 ±0.05	 ±0.10
100	 6.40	 6.80	 0.40	 5.15	 6.57	 1.43
	
±0.04	 ±0.05	 ±0.04	 ±0.11	 ±0.04	 ±0.08
250	 6.20	 6.60	 0.37	 5.05	 5.98	 0.88
	
±0.05	 ±0.04	 ±0.04	 ±0.05	 ±0.10	 ±0.08
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The decrease of relative densities with increasing compaction speed may be
due to an increase in the frictional and cohesive forces between particles
and/or restriction of air escape from the powder bed (Roberts & Rowe, 1985).
At each compaction speed, the plate crystals of paracetamol showed lower
values of D0 and Da than the polyhedral crystals (table 5.3). However, Tukey's
test revealed that the values of Da obtained at 10 mm s for the two types of
crystals were not significanfly different (P>0.05). The degree of densification
that occurs during compression depends on the surface structure, size and
shape of particles (York, 1978; McKenna & McCafferty, 1982; Roberts &
Rowe 1985; 1986). As discussed earlier (section 5.3.2), the number of contact
points between plate crystals, because of their flat and large surfaces,
increased, resulting in higher interparticulate cohesive forces which tend to
oppose densification. This leads to a decrease in the relative densities of the
compacts.
The higher values of Db shown by the plate crystals (table 5.3) could be
attributed to a high degree of fragmentation of the particles at low pressure.
Humbert-Droz (1983) demonstrated that brittle materials are characterized
by a high value of Db because of the curvature of the initial part of Heckel
plot. Small particles, yielded from fragmentation of bigger crystals would fill
the void spaces between the particles, resulting in an increase in particle
rearrangement (Db).
141
5.3.3 INFLUENCE OF COMPACTION FORCE ON THE ELASTIC
RECOVERY OF PARACETAMOL TABLETS
The effect of compression force on the elastic recoveries in the die of tablets
made from different crystal habits of paracetamol are shown in figure 5.3.
The elastic recoveries of tablets made from untreated paracetamol, 105-2 10
pm, (section 3.3.3) are also exhibited in this figure.
The elastic recoveries of the tablets increased with increase in compression
force. The tablets made from plate crystal exhibited higher elastic recoveries
than those made from the polyhedral crystals. However, Tukey's test showed
that the differences between the elastic recoveries of tablets made from the
two crystal habits at 15 kN were not significant (P>0.05). Generally,
untreated crystals also exhibited lower elastic recoveries than plate crystals.
However, the differences between them was significant only at 20 and 25 kN.
It was shown that tablets made from larger particles of paracetamol exhibited
lower elastic recoveries than those made from a smaller fraction (section
3.3.3). This was attributed th a greater fragmentation of the larger particles
under pressure which would produce more fresh, clean surfaces and result in
an increase in interparticulate bonding. Although the plate crystals
underwent more fragmentation than the polyhedral crystals (section 5.3.2),
tablets made from the former exhibited higher elastic recoveries. Milosovich
(1963) reported that the poor compaction properties of a specific habit of a
drug can be attributed to the presence of crystal faces that give poor adhesion
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Figure 5.3 Effect of compression force on the elastic recovery in the die of
tablets made from polyhedral, plate or untreated crystals of paracetamol, at
a compression speed of 10 mm s'.
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to each other and the absence of faces that are required for optimal adhesion.
It is obvious that for plate and polyhedral crystals (figure 4.2 and 4.40 the
relative abundance of the different faces within the crystals were modified.
This can affect the interparticulate bonding between these crystals resulting
in different elastic recoveries for these two habits of paracetamol.
5.3.4 ENERGIES INVOLVED DURING THE COMPACTION PROCESSES
5.3.4.1 Influence of compression force or speed on the gross energies
The effects of compaction force or compaction speed on the gross energies of
tablets made from the polyhedral and plate crystals of paracetamol are
illustrated in figures 5.4 and 5.5, respectively. Increasing the compaction
force or compaction speed, resulted in an increase in gross energies for both
types of crystals.
Figures 5.4 and 5.5 also indicate that at all compaction forces or speeds the
tablets made from plate crystals consumed more energy during compaction
than tablets made from polyhedral or untreated crystals. The gross energies
of tablets made from polyhedral and plate crystals were significantly different
only at 15 and 20 kN. The increased gross energy for tablets made from plate
crystals could be attributed to an increase in plastic (net compaction) energy
and/or elastic energy of tablets, which will be studied in the next sections.
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Figure 5.4 Effect of compression force on the gross energies of tablets made
from the polyhedral, plate or untreated crystals of paracetainol, at a
compaction speed of 10 mm s.
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Figure 5.5 Effect of compression speed on the gross energies of paracetamol
tablets made from polyhedral, plate or untreated crystals of paracetamol, at
a compaction force of 15 kN.
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5.3.4.2 Influence of compaction force or speed on the elastic energies
The effect of compaction force or compaction speed on the elastic energies of
tablets made from polyhedral or plate crystals of paracetamol are illustrated
in figures 5.6 and 5.7. These figures indicate that with increasing the
compaction force or compaction speed the elastic energies of paracetamol
tablets increased.
Figures 5.6 and 5.7 also indicate that at different compaction forces or
speeds, generally the tablets made from polyhedral crystals exhibited lower
elastic energies than tablets made from plate crystals. However, Tukey's test
revealed that there were no significant differences between the elastic
energies of tablets made from polyhedral or plate crystals at 10, and at 15 kN
compaction forces (figure 5.6), and also at 50 mm s' compaction speed (figure
5.7). Tukey's test also revealed that at all compaction forces or speeds, except
at 100 mm s compaction speed, there were no significant differences
between the elastic energies of tablets made from untreated crystals with two
other samples (plate and polyhedral crystals). The results of elastic energies
(figure 5.6 and 5.7) supported the elastic recoveries (figure 5.3). These results
indicated that the plate crystals underwent more elastic deformation during
compaction than the polyhedral crystals.
Several studies have reported that crystal shape affects the compaction
properties of drugs. Hong-Guang and Ru-Hue (1995) investigated the
compaction properties of paracetamol of different crystalline shapes obtained
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Figure 5.6 Effect of compression force on the elastic energies of tablets made
from polyhedral, plate or untreated crystals of paracetamol, at a compression
speed of 10 mm s'.
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Figure 5.7 Effect of compression speed on the elastic energy of tablets made
from polyhedral, plate or untreated crystals of paracetamol, at a compaction
force of 15 kN.
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from different manufacturers. They reported that needle-like crystals of
paracetamol exhibited poorer compressibility and tablets made from them
showed a greater extent of capping and lamination compared to tablets made
from polyhedral crystals. This was attributed to greater elastic deformation
of the needle-like crystals. Marshall and York (1991) reported that needle-like
crystals of nitrofurantoin underwent more elastic deformation than plate-like
crystals. They showed that the elastic recoveries of tablets made from needle
like-crystals of nitrofurantoin were greater than those of plate-like crystals.
5.3.4.3 Influence of compression force or speed on the plastic (net
compaction) energies
Figures 5.8 and 5.9 show the effect of compression force or compression speed
on the plastic energies of tablets made from polyhedral or plate crystals of
paracetamol. According to these figures, increase in compression force or
speed resulted in an increase in the plastic energies.
The plastic energies of tablets made from plate crystals were higher than for
polyhedral and untreated crystals (figures 5.8 and 5.9). Tukey's test revealed
that at 15 kN compaction force (figure 5.8) and also at 10 and 250 mm
compression speeds (figure 5.9), there were no significant differences (P>0.05)
between the plastic energies of tablets made from two types of paracetamol
crystals. Increased plastic energies for plate crystals, may be attributed
firstly to the increased frictional forces and secondly more fragmentation for
plate crystals compared to polyhedral crystals during compaction.
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Figure 5.8 Effect of compression force on the plastic energies of tablets made
from polyhedral, plate or untreated crystals of paracetamol, at compression
speed of 10 mm s.
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Figure 5.9 Effect of compression speed on the plastic energies of tablets made
from polyhedral, plate or untreated crystals of paracetamol, at a compression
force of 15 kN.
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At all compaction forces or speeds the untreated particles exhibited lower
plastic energies than polyhedral or plate crystals of paracetamol. The two
crystal habits used in this study (polyhedral and plate crystals) were freshly
crystallized with smooth surfaces, sharp edges and with specific habit (figures
4.2 and 4.40. Untreated crystals, which had probably undergone mechanical
processing such as grinding, packaging and handing after crystallization, had
no smooth surfaces, sharp edges or specific habit and were grain-like (figure
3.1). Mechanical operations such as grinding have important effects in
cleaving different planes of the crystals. This affects the physico-mechanical
properties of crystals (Huttenrauch, 1983). The presence of cracks in the
crystal structure of untreated paracetamol could cause the ease fracture of
these particles during compression, resulting in lower energies required for
fragmentation of untreated crystals.
5.3.4.4 Influence of compression force or speed on the ratio of elastic
energy/plastic energy
Tables 5.4 and 5.5 show the elastic energy/plastic energy (EE/PE) ratio of
tablets made from polyhedral, plate or untreated crystals of paracetamol at
various compaction forces or speeds. The ratio of EE/PE generally increased
with increase in compression force or speed. Tukey's test showed that there
were no significant differences (P>O.05), for plate crystals, between the ratios
obtained at 15 and 20 kN (table 5.4). The ratios obtained at 100 and 250
mm s 1 for polyhedral crystals, and at 10 and 50 mm s' for plate crystals
(table 5.5) were not significantly different.
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Table 5.4 Effect of compression force on the ratio of EE/PE of paracetamol
tablets made from polyhedral, plate or untreated crystals, at a compaction
speed of 10 mm s'.
Compression	 EEIPE ratio±SD
force (1)
	 Polyhedral	 Plate	 Untreated
crystals	 crystals	 crystals*
10	 0.45±0.04	 0.39±0.04	 0.54±0.05
15	 0.64±0.01	 0.66±0.11	 0.87±0.09
20	 0.85±0.11	 0.78±0.08	 1.31±0.11
25	 1.10±0.08	 0.94±0.05	 1.58±0.18
30	 1.40±0.07	 1.37±0.19	 1.89±0.16
* Taken from table 3.4
These results indicate that at higher compaction forces or speeds the tablets
became more elastic, i.e. at higher forces or speeds, the majority of energy
involved during compaction, is utilized as elastic energy, resulting in
increased capping and failure (Garr & Rubinstein, 1991).
Although the elastic energies of tablets made from plate crystals were higher
than polyhedral crystals (figures 5.6 and 5.7), the plastic energies were also
higher for the plate crystals (figures 5.8 and 5.9). Therefore, there were no
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Table 5.5 Effect of compression speed on the ratio of EE/PE of paracetamol
tablets made from polyhedral, thin plate-like or untreated crystals, at a
compaction force of 15 kN.
Compression	 EE/PE ratio±SD
speed (mm s)	 Polyhedral	 Plate	 Untreated
crystals	 crystals	 crystals*
10	 0.64±0.01	 0.66±0.11	 0.87±0.09
50	 0.57±0.03	 0.55±0.05	 0.75±0.06
100	 0.75±0.09	 0.83±0.05	 1.08±0.08
250	 0.89±0.06	 0.96±0.08	 1.14±0.12
* Taken from table 3.5
significant differences (using two way analysis of variance) between the
EE/PE ratio of tablets made from these two types of crystals at different
compaction forces or speeds (tables 5.4 and 5.5).
At all compaction forces or speeds the ratio of EE/PE for untreated crystals
of paracetamol is more than that for polyhedral or plate crystals (tables 5.4
and 5.5). Increase in the EE/PE ratio for untreated particles can not be
related to poorer compaction properties of these particles as compared to
polyhedral or plate crystals. Although, the plastic energies of tablets made
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from polyhedral or plate crystals of paracetamol were significantly higher
than untreated crystals (figure 5.8 and 5.9), this increased energy was not
consumed for formation of bounds or plastic deformation of particles. Figures
5.3, 5.6 and 5.7 indicate that the elastic recoveries and elastic energies of
tablets made from untreated crystals of paracetamol were similar to those of
polyhedral or plate crystals, or even sometimes less than those for plate
crystals.
5.4 CONCLUSIONS
Crystal habit had a great influence on the compaction behaviour of
paracetamol. Heckel plots and their constants, strain rate sensitivities, elastic
recoveries, elastic energies and plastic energies were affected by the different
crystalline habits of paracetamol.
The results of Heckel ananlysis and strain rate sensitivity indicated that
polyhedral crystals underwent a greater plasticity during compression than
plate crystals which were more brittle in nature during compression.
The results of elastic recoveries and elastic energies indicated that the plate
crystals underwent more elastic deformation during compaction than the
polyhedral crystals.
The two crystal habits of paracetamol (plate and polyhedral crystals) did not
exhibit any major improvement in their compaction properties as compared
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to untreated paracetamol. Therefore, the next stage was to investigate a
crystallization procedure in which improvemed compaction behaviour was
produced.
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CHAPTER 6. STUDY OF INTERACTIONS BETWEEN
POLYVLNYLPYRROLIDONIE AND PARACETAMOL
6.1 INTRODUCTION
There are many examples in the literature in which interactions between
polyvinylpyrrolidone (PVP) and various pharmaceutical agents have been
investigated. It has been demonstrated that PVP is a strong crystal growth
inhibitor for some drugs such as sulphathiazole, salicylic acid and
paracetamol by adsorption on to their crystal surfaces (Simmonelli, 1970;
Ziller & Rupprecht, 1988 & 1990). A binding tendency between PVP and
various pharmaceutical compounds has been reported by several workers
(Higuchi & Kuramoto, 1954; Kahela & Austin, 1971b; Plaizier Vercammen &
Dc Neve, 1980; Horn & Ditter, 1982).
One group of additives used during crystallization processes is long chain
polymeric materials (Mullin, 1993). Those additives which influence the
crystallization processes are those that can be adsorbed on to the crystal
surfaces (Davey, 1982). The degree of adsorption between additives and the
crystal surfaces depends on their chemical and structural properties such as
the presence of anionic or cationic groups, or the possibility of the formation
of hydrogen bonds (Khamski, 1976; Davey, 1982). The aim of the work
presented in this chapter is firstly to investigate the possible interactions
between PVP and paracetamol, and secondly to predict whether PVP can be
used as an effective additive during crystallization of paracetamol.
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6.2 MATERIALS AND METHODS
6.2.1 MATERIALS
Paracetamol, different grades of PVP, ethanol and potassium bromide as
described in section 2.1 were used. Ethylenediamine tetra-acetic acid
disodium (EDTA) and sodium bicarbonate (each general purpose reagent,
BDH Chemicals Ltd, Poole, UK), and anhydrous theophylline (obtained from
BASF, Cheadle, Cheshire, UK) were also used for this part of study.
Theophylline is a white crystalline powder, soluble 1:80 in alcohol, 1:120 in
water, very slightly soluble in ether, freely soluble in dilute acids, ammonium
and alkali hydroxide solutions. Its maximum UV absorbances in aqueous acid
and aqueous alkali are at 270 and 275 nm, respectively (Moffat et al, 1986).
The chemical structure of theophylline is shown below:
C7H8N402
Mol. Wt=180.2
Figure 6.1 The chemical structure of theophylline.
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6.2.2 METHODS
6.2.2.1 Determination of paracetamol solubility in the presence of
Pyp
In order to determine the aqueous solubiity of paracetamol in the presence
of PVP the following was carried out. Samples of paracetamol (2.5 g) were
dispersed in 100 ml water or aqueous solutions containing 0.1% w/v PVP
10000 in stoppered 100 ml conical flasks. The flasks were shaken in a
shaking water bath at 37±1°C for 24 h. Then, using equation 2.5, the
paracetamol concentration was determined in the filtered solutions after
appropriate dilutions as described in section 2.2.7.1. Aqueous PYP solutions
had no absorbance above 240 nm. The presence of PVP in the paracetamol
solutions did not interfere with the UV absorbance of paracetamol at 244 nm.
6.2.2.2 Crystallization of paracetamol in the presence of different
grades of PVP
Solutions containing 21.75 mg ml paracetamol were prepared by dissolving
8.7 g paracetamol in 400 ml of distilled water at 55°C. PVP powders with
average molecular weights of 2000, 10000 or 50000 was added to the
solutions at 55°C to give concentrations of 5.75, 11.5, 23, 46 or 92 mgIlOO ml.
After complete dissolution of the PVP, the flasks were immersed into a water
bath at 30±1°C and the solutions were occasionally stirred. After 2 h, crystals
were observed in some flasks. The solutions with no visible crystals, were
then placed into a water bath at 25±1°C with no stirring. After 24 h, the
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crystals were observed in further flasks. Subsequently, the flasks containing
clear solutions (with no crystals) were stored in a refrigerator at 4±1°C. After
24 h these solutions were examined for crystal growth.
In the case of the high molecular weight PVP 1000000, an opaque (turbid)
solution was produced, after adding PVP to the paracetamol solutions, even
at lowest concentration of PVP (5.75 mg/lOU ml). The degree of turbidity of
these solutions increased with increase in the concentration of PVP.
Sekikawa et al (1972; 1978) reported that high molecular weight PVP (PVP
K90) could be coacervated by the addition of some electrolytes or aromatic
compounds such as benzoic acid, paracetamol or phenol. Therefore it was
decided not to examine the crystallization of paracetamol in the presence of
PVP 1000000.
6.2.2.3 Equilibrium dialysis
The interaction between paracetamol and PVP in aqueous solution was
investigated using dialysis. Visking tube No. 5-24/32 (Medicell International,
London, UK) with a molecular weight cut-off of 12000 daltons was used.
6.2.2.3.1 Preparation of dialysis tube
Dialysis tubing generally contains glycerin as plasticizer, traces of suiphurous
compounds and heavy metal ions (McPhie, 1971). Some of these contaminants
may have drastic effects during experiments and obviously must be removed
before use. A recommended and successful method for the preparation of
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dialysis tubes, is to simmer the dialysis tubing in solutions of sodium
bicarbonate, EDTA or distilled water, respectively (McPhie 1971).
Dialysis tubes (25 cm length) were boiled in solutions of 1% w/v sodium
bicarbonate, then in 1% w/v EDTA and finally in distilled water, 20 minutes
for each. A double knot was tied at one end of each tube and the sample
solutions were poured into it. A double knot was then tied at the top. The
distance between the two knots was about 11 cm in all experiments. Checks
were made to ensure that the tubes did not leak.
6.2.2.3.2 Experimental details
a) Equilibrium dialysis for paracetamol
Solutions containing PVP 50000 (4 or 8% wlv) were prepared by dissolving
PVP in distilled water containing 1x10 2 M paracetamol. Ten ml of these
solutions were poured into the dialysis tubes. These tubes were immersed
into the USP XXII dissolution flasks (described in section 2.2.8) containing
1000 ml distilled water at 37°C and the solutions were stirred at 50 rpm
using the USP XXII apparatus II. A diagram of set up is illustrated in figure
6.2 . The amounts of paracetamol in the solutions surrounding the dialysis
tubes were determined, spectrophotometrically at 244 nm, every hour for up
to 15 h. Sekikawa et al (1979) showed that the cellulose membrane did not
show any measurable binding or interaction with paracetamol. The
experiments were carried out in triplicate for each variable and the mean
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values were reported.
Figure 6.2 Diagram of a dialysis tube in a dissolution flask.
b) Equilibrium dialysis for theophylline
Solution containing 4% w/v PVP of molecular weight 50000 was prepared by
dissolving the PVP in distilled water containing 1x10 2 M anhydrous
theophylline. Ten ml of this solution was poured into each dialysis tube and
the amount of theophylline released in the dissolution medium determined
as explained for paracetamol, at 272 nm.
6.2.2.4 Preparation of a PVP-paracetamol co-precipitate
A co-precipitate of paracetamol/PVP (1:2), was prepared by dissolving
paracetamol (2 g) and PVP of molecular weight 50000 (4g) in 60 ml ethanol.
This solution was then heated in a water bath at 60±1°C for 24 h to
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evaporate the solvent. The produced crust was scraped off, ground and stored
in a desiccator before use.
6.2.2.5 Infrared spectroscopy
The infrared spectra of untreated paracetamol, the 1:2 paracetamoLPVP co-
precipitate (see section 6.2.2.4) and PVP 50000 were obtained as described in
section 2.2.3.
6.2.2.6 Differential scanning calorimetry (DSC)
The DSC studies were carried out for untreated paracetainol, PVP 50000, the
1:2 co-precipitate of paracetamollPVP and physical mixtures of paracetamol
and PYP 50000 containing 3, 5, 10, 20, 30 or 50% w/w PVP. The mixtures
were mixed by mortar and pestle. The mean values of onset temperatures of
melting and the enthalpies of fusion of these samples were measured as
explained in section 2.2.4.1.
6.2.2.7 Hot stage microscopy
Hot stage microscopy was carried out for untreated paracetamof, PVP 5CCCC,
the 1:2 co-precipitate of paracetamoliPVP and the physical mixtures of
paracetamol and PVP (see section 6.2.2.6), as explained in section 2.2.4.2. The
start and end points of melting and the behaviour of these mixtures during
heating were examined.
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6.3 RESULTS AND DISCUSSION
6.3.1 INFLUENCE OF PVP ON THE AQUEOUS SOLUBILITY OF
PARACETAMOL
There are a large number of papers in which the increase in absolute
solubility of active substances in solutions of PVP has been described. For
example, it has been reported that the aqueous solubility of trimethoprim
increased from 0.4 mg/mi in water to more than 4 mg/mi in the aqueous
solutions of 70% w/w PVP 40000 (Gupta et al, 1991). Cadwallader and Madan
(1981) reported that PVP significantly increased the solubilities of
testosterone, progesterone and diethylstilbestrol between 1.5-2 times in
solutions of 6% w/v of PVP K30. Collett and Kesteven (1974; 1978), reported
that the solubility of allopurinol in PVP solutions increased with increasing
concentrations of PVP. The solubility of naproxen increased by more than 6
fold in the presence of 10% w/v PVP 25000 (Bettinetti et al, 1988). In all
cases the increase in solubiity of active substances in the presence of PVP
has been attributed to their ability to form water soluble complexes with PVP
(Cadwallader & Madan, 1981).
In the present study, the aqueous solubility of paracetamol in the presence
of small amounts of PVP 10000 was investigated and the results are listed
in table 6.1. According to these results, PVP at the concentration used in this
study (0.1% w/v), did not affect the solubility of paracetamol. Lipman and
Summers (1980) reported that there is a 2.3 times increase in paracetamol
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solubility in the presence of 10% w/v PVP solution. Sekikawa et al (1979)
reported that the solubility of paracetamol increased about 1.15 times in the
presence of 1% w/v PVP K30. Table 6.1 shows that the concentration of PVP
in this study was below that which produces an increase in the solubiity of
paracetamol.
Table 6.1 Solubility of paracetamol in absence or presence of 0.1% w/v PVP
10000 in water at 37°C.
Solubility of paracetamol (g/lOOml±SD)
Water	 Water with 0.1% w/v
PVP 10000
2.02±0.04	 2.02±0.09
6.3.2 INFLUENCE OF DIFFERENT GRADES OF PVP ON
CRYSTALLIZATION OF PARACETAMOL FROM WATER
During crystallization of paracetamol from water, PVP had a strong
inhibitory effect on the precipitation of paracetamol crystals. The
precipitation of the solid phase (paracetamol crystals) in the presence of
different amounts of various molecular weights of PVP, is summarised in
table 6.2. These results clearly indicate that the inhibitory effect of PVP on
the crystallization of paracetamol was dependent on the molecular weight
and concentration of PVP. The lowest molecular weight of PVP (PVP 2000)
had a minor effect while the higher molecular weights of PVP (PSTP 10000 or
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Table 6.2 Effect of different amounts of various molecular weights of PVP on
the precipitation of paracetamol crystals.
Molecular Concentration	 2 h at	 2 h at 30°C 2 h at 30°C +
weight of
	 of PVP	 30°C	 + 24 h at	 24 h at 25°C
PVP	 (mg/lOOml) _________	 25 °C
	
+ 24 h at 4°C
0	 +	 *	 *
5.75	 +	 *	 *
11.5	 -	 +	 *
PVP2000	 23	 -	 +	 *
46	 -	 +	 *
92	 -	 -	 +
5.75	 -	 +	 *
11.5	 -	 -	 +
PVP 10000	 23	 -	 -	 +
46	 -	 -	 +
92	 -	 -	 +
5.75	 -	 -	 +
11.5	 -	 -	 +
PVP 50000	 23	 -	 -	 +
46	 -	 -	 +
92	 -	 -	 +
+ Crystal observed
- No crystal observed
* Test completed at previous stage
PVP 50000) had a marked inhibitory effect, even at very low concentrations.
Table 6.2 also indicates that by decreasing the crystallization temperature to
4°C, the paracetamol crystals had precipitated at all concentrations of PVP.
This is attributed to an increase in the supersaturation degree of the system,
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at low temperature, as shown in table 4.1.
In section 1.2.3, it was mentioned that the presence of impurities in a
crystallization system can suppress nucleation. This effect may be caused by
changing the equilibrium solubility of the solute in the solution or by
adsorption of impurity onto nuclei. Therefore, in the present study, two
hypothesis can be given for the inhibitory effect of PVP on the crystallization
of paracetamol:
1-By increasing the solubiity of paracetamol in the solution.
2- By adsorption onto the surfaces of nuclei (during crystal growth) and by
inhibition of the deposition of paracetamol molecules onto the crystal lattice.
Table 6.1 indicates that PVP 10000, at a concentration of lOOmg/lOOml, had
no effect on paracetamol solubility while it was shown that PVP 10000, even
at very low concentration (11.5 mg/100 ml), greatly inhibited the precipitation
of paracetamol crystals (table 6.2).
It has been long known that the presence of small amounts of high molecular
weight substances such as gelatin, sodium carboxymethylcellulose,
polyacrylamide or polyacrylic acid can suppress or inhibit the nucleation and
subsequently increase the induction time during crystallization of materials
from their aqueous solution (Mullin, 1993; Davey, 1982). The probable mode
of action of high molecular weight substances is that they render the nuclei
inactive by adsorbing onto their surfaces (Mullin, 1993). The inhibitory effect
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of PVP on the precipitation of paracetamol is probably via the adsorption of
PVP onto the surfaces of nuclei during crystal growth. This inhibits further
deposition of paracetamol molecules onto the nuclei and therefore increases
the induction time and inhibits the appearance of the solid phase.
A review of the literature, reveals that some workers have reported the
inhibition of crystal growth by PVP. Femi-Oyewo and Spring (1994) reported
that PVP K30 almost completely inhibited the crystallization of paracetamol
from water. Simonelli et al (1970) reported that PVP can completely inhibit
the growth of suiphathiazole crystals. This effect was attributed to adsorption
of PVP onto the surfaces of the sulphathiazole crystals. Ziller and Rupprecht
(1988) demonstrated that in a suspension of paracetamol, crystal growth can
occur with a decrease in temperature, but the crystal growth was
significantly impeded in the presence of a small amount of PVP 180000
(0.003% w/v). The inhibitory effect exhibited by PVP was molecular weight
dependent. Lower molecular weights of PVP had only a minor influence on
crystal growth. Ziller and Rupprecht (1990) also reported that PVP is a
strong crystal growth inhibitor for hydroxybenzoic acid derivatives, salicylic
acid and sulphathiazole. Ziller and Rupprecht (1990) demonstrated that PVP
had no effect on the crystal growth of compounds such as phenobarbitone,
xanthin derivatives (theophylline monohydrate and caffeine monohydrate),
phenacetin and acetanilide.
Simmoneli et al (1970) and Ziler and Rupprecht (1988) suggested that the
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inhibitory effect of PVP on the crystal growth of sulphathiazole or
paracetamol may be due to the formation of protective adsorption layers on
the crystal surfaces. These adsorbates produced a barrier which resisted the
diffusion of drug molecules from solutions to the crystal surface. Figure 6.3
shows a schematic diagram of the appearance of crystals at various stages of
growth in the absence or presence of PVP.
(a) Original crystal
(b) Gra	 (c) Polymer inlibitiou
Figure 6.3 Diagram of a crystal or a nuclei at various stages: (a) original
crystal; (b) after normal growth; (c) after the addition of PVP, showing
polymer inhibition.
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6.3.3 DIALYSIS STUDY OF THE BINDING TENDENCY BETWEEN PVP
AND PABACETAMOL
Dialysis membranes are thin films of highly polymerized substances such as
cellulose which in the presence of solvents, swell to form a molecular sieve,
where pores will retain polymer molecules with large molecular weights but
allow the diffusion of small molecules. Therefore, the drug molecules bound
to the polymer do not pass through the tube membrane and remain inside the
tube; only the unbound drug molecules pass through the membrane. This
method was used to determine the binding between paracetamol and PVP
(see section 6.2.2.3). The results of this study are presented in figure 6.4. It
is obvious that PVP had a retardant action on the diffusion of paracetamol.
This effect increased with increasing the concentration of PVP in the solution.
The slower release of paracetamol in presence of PVP may be attributed to
a binding propensity between PVP and paracetamol. Siguier et al (1948)
showed that PVP had a retarding action on the diffusion of morphine through
a dialysis membrane. This was attributed to the physicochemical
combinations of PVP with this drug.
As a control study, the dialysis test was carried out using theophylline in
place of paracetamol. It has been reported that there is no binding affinity
between xanthin derivatives such as theophylline or caffeine and PVP (Ziller
& Rupprecht, 1990; Higuchi & Kuramoto, 1954; Horn & Ditter, 1982). The
release of theophylline through the dialysis tube in absence or presence of 4%
w/v PITP 50000 is illustrated in figure 6.5.
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Figure 6.4 The passage of paracetamol through dialysis tube in the absence
(fl), or in the presence of (a) 4% or (+) 8% w/v of PVP 50000.
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Figure 6.5 The passage of theophylline through dialysis tube in the absence
(0) or in the presence of 4% w/v of PVP 50000 (•).
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It clearly shows that the presence of PVP had no effect on the release of
theophylline. Therefore, since there was no influence of PVP on the passage
of theophylline compared to paracetamol, the results indicate that there is a
potential for bonding between PVP and paracetamol.
The interaction of PVP in aqueous solution with various pharmaceutical
agents has been investigated extensively during the past years and it was
found that PVP has a great tendency to bind with some drugs and
preservatives. One of the most widely methods to examine this kind of
interaction is the equilibrium dialysis. In one earlier study, Higuchi and
Kuramoto (1954), investigated the complex formation between PVP K30 and
some drugs using equilibrium dialysis. They showed that PVP can bind to
suiphathiazole, sodium salicylate, mandelic acid and chioramphenicol. No
evidence of complex formation was detected with procaine hydrochloride,
bezylpenicilline, caffeine, theophylline and cortisone. Molyneux and Frank
(1961) and Plaizier Vercammen and De Neve (1980, 1981, 1983) showed that
there was an interaction between PVP with some aromatic compounds such
as benzoic acid and its derivatives, phenol and salicylic acid, in aqueous
solutions using equilibrium dialysis or ultrafiltration. Kahela and Austin
(1972), using the gel filtration, demonstrated that there was an interaction
between salicylic acid and PVP. All these workers reported that by increasing
the concentration of PVP in solution, the percentage of drug bound to PVP
increased.
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Horn and Ditter (1982) demonstrated that there is a binding affinity between
PVP 49000 and several drugs including paracetamol, using chromatographic
techniques and equilibrium dialysis. Sekikawa et al (1979) also showed a
binding tendency between PVP and paracetamol in their aqueous solution,
using dialysis. They showed that in the presence of 5% PVP 1(30, 12% of
paracetamol in a 1x10 2 M solution was bound to PVP. However, the results
of equilibrium dialysis in the present study (figure 6.4) indicated that after
a long period (12 hours) almost all of the paracetamol passed through the
dialysis tube. This clearly shows that there was no strong binding between
PVP and paracetamol.
Since dialysis is a diffusion-controlled process, in order to maintain an
outward free flow and complete removal of dialysable substances through a
membrane, it is essential to decrease the concentration of diffusible
substances outside the membrane. This can be achieved by using a large
volume of solvent outside the dialysis membrane (McPhie, 1971). Horn and
Ditter (1982) and Sekikawa et al (1979) used a very low volume of solvent
outside dialysis membrane (2 or 20 ml), which was also equal to the volume
inside of dialysis membrane. Possibly, under these conditions a complete
removal of the clialysable substance (paracetamol) through the membrane
would not be achieved.
The present study revealed that the nature of interaction between PVP and
paracetamol is physical and reversible. There is probably an equilibrium state
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between the amount of bound paracetamol and free paracetamol in the
presence of PVP inside the dialysis tube as shown by equation 6.1.
Paracetamol + PVP	 paracetamol-PVP	 Equation 6.1
By using a large volume of solvent outside the dialysis tube (100 times more
than inside), it allowed equation 6.1 to proceed towards the left hand side and
almost all of paracetamol was released through the membrane irrespective
of PVP concentration (figure 6.4).
6.3.4 MECHANISM OF INTERACTION BETWEEN PVP AND
PARACETAMOL
Several studies have been reported that the mechanism of interaction
between PVP and some drugs in their solution or co-precipitate is by the
formation of hydrogen bonds between the drug and PVP. Jurgensen Eide and
Speiser (1967) studied the interaction of some aromatic compounds with PVP
in their aqueous solution using equilibrium dialysis. They demonstrated that
aromatic compounds containing an -OH, -NH2 or -COOH group exhibited a
higher degree of interaction than compounds without such groups. This
indicated that hydrogen bonding plays an important role in such interactions.
Similar results were found by Horn and Ditter (1982) who studied the
interaction between P\TP and some drugs in their aqueous solution using
equilibrium dialysis or chromatographic techniques. Molyneux and Frank
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(1961) studied the JR spectra of dry PVP films containing varying
concentrations of aromatic compounds. For compounds which were capable
of hydrogen bonding, there were generally shifts in 0-H stretching bands to
lower wave numbers, indicating hydrogen bond formation. Matsumaru et al
(1977) demonstrated a weak hydrogen bond between the C(21)-hydroxyl group
of ajmaline and the carboxyl group of PVP, in their co-precipitate, using NMR
spectroscopy. Said et al (1974a,b) studied the interactions between PVP and
tolbutamide, succinyl suiphathiazole and chiorpropamide in their co-
precipitate using JR spectroscopy. The spectral data showed that a broad
peak for the co-precipitate formed due to 0-H stretching which confirmed
that the interaction between PVP and these drugs was via hydrogen bonding.
Doherty and York (1987) investigated the interactions between fursemide and
PVP in a solid dispersion system using JR spectroscopy. They showed the
existence of hydrogen bonding between the suiphonamide group in frusemide
and PVP. NMR data confirmed the JR results.
6.3.4.1 IR studies of paracetamolfPVP co-precipitate
The JR spectra for paracetamol, PVP, and for the 1:2 paracetamollPVP
co-precipitate are illustrated in figures 6.6a, 6.6b and 6.7a, respectively. The
JR spectrum of untreated paracetamol (figure 6.6a) shows a sharp band at
3325 cm' due to 0-H stretching but this sharp peak has changed to a broad
band in the co-precipitate (figure 6.7a). This may be attributed to the
hydrogen bonding between the hydroxyl group of paracetamol and the
carboxyl group of PVP.
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To enhance the resolution of the vibrations in the JR spectrum of the PVP-
paracetamol co-precipitate, the vibrations due to PVP were removed by
spectral subtraction using the FTIR computer and the resultant spectrum is
shown in figure 6.7b. This analysis shows that the 0-H vibrations in
paracetamol had been significantly shifted to lower frequencies.
This study demonstrated that paracetamol and PVP interact via hydrogen
bonding. This is expected as PVP contains a recurring carboxyl group which
allows it to hydrogen bond with the hydroxyl group of paracetamol as
illustrated in figure 6.8.
c)o ... . HO—"ñ---NHCOCH3
CH2 — CH — CH2"-
"PVP chain"	 "Paracetamol"
Figure 6.8 A diagram of a possible hydrogen bond formation between the
hydroxyl group of paracetamol and the carboxyl group of PVP
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6.3.5 THERMAL ANALYSIS OF THE 1:2 PARACETAMOLPVP CO-
PRECIPITATE AND THEIR PHYSICAL MiXTURES
6.3.5.1 DSC studies of paracetamol/PVP co-precipitate
Figure 6.9 shows the DSC scans of paracetamol, PVP 50000 and their co-
precipitate (1:2 drug to PVP). The scan of paracetamol shows a sharp melting
point with an onset of 17 1.6°C. The scan of PVP does not show any peaks.
Bettenetti et a1 (1988) showed that PVP has broad peak between 50-120°C
related to vaporization of adsorbed water. Degradation of PVP happens above
250°C. Figure 6.9 clearly shows that the fusion peak of paracetamol has
disappeared in the co-precipitate system of paracetamollPVP.
Disappearance of the fusion peak of naproxen in co-precipitates of
naproxenlPVP with less than 50% w/w of naproxen in the system has been
reported by Bettineti et al (1988). This was attributed to an interaction
between naproxen and PVP.
6.3.5.2 DSC studies of paracetamollPVP physical mixtures
The DSC scans for physical mixtures of paracetamol and PVP with different
ratios of paracetamol in the mixtures, are exhibited in figure 6.10. The onsets
of melting point and enthalpies of fusion of paracetamol in the mixtures are
given in table 6.3.
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Table 6.3 The onset of melting point (Tm) and enthalpy of fusion (M{f) for
physical mixtures of paracetamol and PVP of molecular weight 50000.
Concentration of PVP	 Onset of Tm (±SD)
	 AHf (±SD)
(%w/w)	 (°C)	 (Jig)
(Pure paracetamol)	 171.6±0.2	 176.1±2.2
3	 171.5±0.2	 150.0±2.4
5	 170.9±0.1	 134.6±4.5
7	 170.8±0.7	 126.1±3.2
10	 170.5±0.3	 104.7±3.6
20	 *	 62.4±3.1
30	 *	 30.8±0.6
50	 *	 0
(* Onset difficult to determine)
These data clearly indicate that the enthalpies of fusion of paracetamol
decreased as the proportion of PVP in the physical mixtures increased. In
figure 6.10, when the ratio of paracetamol was 50% w/w in the mixture, the
DSC scan with a flat baseline with no evidence for the fusion of paracetamol
or any eutectic temperature, was obtained. This behaviour is similar to that
of co-precipitate of paracetamollPVP (figure 6.9).
Ford and Rubinstein (1981) reported that when the DSC scan of a mixture
of a drug and excipient displays the elements characteristic of each
component, without alterations to the position of endotherms, a lack of
interaction is indicated. The absence of the characteristic melting points of
some drugs such as naproxen, ketoprofen and atenolol in their physical
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mixtures with PVP has been reported by Botha and Lotter (1989, 1990a, b).
In all cases, this behaviour was attributed to an interaction between drug
and PVP.
6.3.5.3 Hot stage microscopy of paracetamollPVP co-precipitate and
their physical mixtures
The behaviour of paracetamol, PVP or the 1:2 co-precipitate of
paracetamoliPVP with increasing temperature was observed using hot stage
microscopy. The paracetamol particles exhibited an initial melting at 171°C
which was complete at 174°C. The PVP particles did not show any events
such as melting with increasing temperature, except their colour became
yellowish above 250°C, possibly indicative of degradation. The
paracetamo]IPVP co-precipitate particles starteà to soiten anà me\t from
140°C and their melting was complete at about 165°C. The melted particles
were very viscous and they could not flow.
Observation of the physical mixtures of paracetamolfPVP with increasing
temperature showed that some particles started to melt at 140-143°C. when
the percentage of PVP in the mixtures was increased, the number of melted
particles at this temperature increased. The majority of particles started to
melt at 140°C, in the mixture containing 50% w/w PVP. The melting of these
mixtures was complete at 169-172°C, which indicates of presence of free
paracetamol.
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In paracetamolPVP co-precipitate, the paracetamol molecules are in intimate
contact with PVP, therefore all the particles exhibited the same behaviour
with increasing temperature. While, in physical mixtures the contacts
between paracetamol and PVP are at the edges and surfaces of particles,
therefore they exhibited behaviour corresponding to both paracetamoltPVP
and free paracetamol.
The paracetamol crystals under microscope were near shiny and grain-like,
while PVP particles Were dark with no specific shape, and therefore it was
easy to distinguish them from each other. It was observed that during the
melting of paracetamol, the PVP particles dissolved in the melted
paracetamol. For this reason, by increasing the percentage of PVP in the
mixtures, the viscosity of the melted liquid increased. When the content of
PVP in the mixtures was more than 50% w/w, all of the PVP particles were
unable to be dissolve in the melted paracetamol and they remained solid even
till 200°C. Apparently the melted paracetamol was saturated with PVP and
it was impossible to dissolve further PVP in the melt. These results can be
indicative of an interaction between PVP and paracetamol.
6.4 CONCLUSION
PVP had a significant inhibitory effect on the crystallization of paracetamol
from water. The inhibitory effect of PVP on the precipitation of paracetamol
crystals was dependent to its molecular weight. The higher molecular weights
of PVP were more effective crystal growth inhibitors. It was shown that this
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effect was not due to a change in solubility of the paracetamol. This effect of
PVP was attributed to the adsorption of PVP onto the paracetamol nuclei
(during crystal growth) which inhibited the deposition of paracetamol
molecules from solution onto the developing crystal lattices.
There is a potential of binding between PVP and paracetamol in their
aqueous solution. Infrared spectroscopy of paracetamollPVP co-precipitate
indicated that the mechanism of the interaction between PVP and
paracetamol is by hydrogen bonding. Thermal analysis studies also showed
that there was an interaction between PVP and paracetamol.
The results of this study showed potential application of PYP as an additive
during crystallization of paracetamol. Therefore, in next chapter the effect of
different grades of PVP as additives during crystallization of paracetamol,
will be studied.
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CHAPTER 7. CRYSTALLIZATION OF PARACETAMOL IN THE
PRESENCE OF DIFFERENT GRADES OF
POLYVINYLPYRROLIDONE
7.1 INTRODUCTION
One of the most common causes of habit modification is the presence of
impurities in the crystallizing solution. The presence of a low amount of an
effective additive in the crystallization medium can change the crystal size
and shape. The additives used in crystallization procedures may be classified
into several groups: surface active agents (surfactants), low molecular weight
of organic or inorganic substances, long chain polymeric materials and
proteinaceous substances (Mullin 1993).
There are several reports of attempts to change the crystal habit of a
particular substance in the presence of ac1iiti'es c1uiit cxJstai1izatiQn
process. For example, the crystal habit of adipic acid was modified in the
presence of anionic or cationic surfactants (Michael & Colville, 1960), or in
the presence of alkanols or alkanoic acids (Fairbrother & Grant, 1978, 1979).
Habit modification of paracetamol crystals in the presence of p-acetoxy-
acetanillide, or in the presence of agar or gelatin was reported by Chow et al
(1985) and Femi-Oyewo and Spring (1994), respectively. Mackaellar et al
(1994a,b) demonstrated that the use of poloxamer 188 (a surfactant) during
crystallization of ethyl p-hydroxybenzene, modified the size and habit of the
obtained crystals.
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In chapter 6, it was shown that polyvinylpyrrolidone (PVP) has potential as
an additive during crystallization of paracetamol. It was demonstrated that
in the presence of small amounts of PVP (<0.1% w/v), the crystal growth of
paracetamol from water at 25°C was inhibited. In section 4.3.2, it was shown
that crystallization of paracetamol by watering-out from its ethanolic solution
at low temperature (3°C), produced a high degree of supersaturation.
Therefore, this crystallization process is probably a suitable method for
crystallization of paracetamol in the presence of PVP.
The aim of the work presented in this chapter was to study the effects of
small amounts of different grades of PVP during crystallization of
paracetamol by the watering-out method. Furthermore, the properties and
solid state characteristics of the obtained crystals were investigated.
7.2 MATERIALS AND METHODS
7.2.1 MATERIALS
Paracetamol, different grades of PVP, ethanol, potassium iodide, iodine, citric
acid and potassium bromide as described in section 2.1, were used.
7.2.2 METHODS
7.2.2.1 Crystaffization procedures
The crystallization process used was similar to the method which was
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introduced in section 4.2.2.1.1 as the watering-out crystallization method.
Samples of paracetamol (5g) were dissolved in 12 ml of ethanol at 75°C. The
temperature of the solutions were allowed to fall to 65°C. Then the solutions
were added rapidly to 50 ml quantities of cold water at 3°C containing 0, 0.1,
0.3 or 0.5% w/v PVP of molecular weights of 2000, 10000 or 50000. The
resultant solutions were thoroughly mixed with a glass rod and maintained
at about 3±1°C in an ice-water bath with no agitation for five minutes. Then
the solutions were gently stirred by means of a glass rod. After 10 minutes,
the precipitated crystals were collected by filtration, using a sintered glass
funnel No.3 under vacuum. The crystals were spread on glass petri dishes
and dried for 24 h at 55°C. The dried crystals were stored in a desiccator,
over silica gel, at room temperature before use.
7.2.2.2 Quantitative determination of PVP in the particles
The amount of PVP adsorbed onto the paracetamol particles crystallized from
media containing PVP was determined by the photometric analysis of the
PVP-iodide complex as described in section 2.2.6.3. Each test was carried out
three times and the mean values are reported.
7.2.2.3 Scpnning electron microscopy
Scanning electron micrographs of crystals and particle size measurements
were obtained using a scanning electron microscope as described in section
2.2.5.
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7.2.2.4 Differential scanning calorimetry (DSC), X-ray powder
diffraction (XPD) and Infrared spectroscopy (IR)
DSC, XPD and IR studies were carried out, as described in sections 2.2.4.1,
2.2.2 and 2.2.3, respectively.
7.3 RESULTS AND DISCUSSION
7.3.1 INFLUENCE OF PVP ON INDUCTION TIME (TIME REQUIRED FOR
APPEARANCE OF CRYSTALS)
Following the addition of the ethanolic solution of paracetamol to cold water
containing different concentration of PVP, the time taken for appearance of
the first visible particles (induction time) depended on the molecular weight
and/or concentration of PVP in the solution (figure 7.1). With increasing
molecular weight and/or concentration of PVP, the induction time increased.
In the absence of PVP, crystals were observed within 15-20 s, whilst in the
presence of 0.5% w/v of PVP 50000 this time was 115 s.
7.3.2 INFLUENCE OF PVP ON CRYSTAL RECOVERY
The recovery of paracetamol during crystallization in the presence of PVP is
illustrated in figure 7.2. The recovery of paracetamol decreased as the
molecular weight and/or the concentration of PVP in the crystallization
medium increased. The recovery in the absence of PVP was 83.5% whilst in
the presence of 0.5% w/v of PVP 50000 was 67.5%.
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Figure 7.1 Induction time of crystallization as a function of concentration of:
(+) PVP 2000, (A) PVP 10000 or (N) PVP 50000.
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7.3.3 AMOUNT OF PVP IN THE PARTICLES
The amount of PVP taken up by paracetamol particles crystallized from
media containing different concentrations of various grades of PVP is
presented in table 7.1. According to these results, by increasing the molecular
weight and/or the concentration of PVP in the crystallization medium, the
amount of PVP adsorbed onto the particles increased.
Table 7.1 The percentage (%w/w) of PVP adsorbed onto paracetamol particles
crystallized in the presence of different concentrations of various grades of
PvP.
Concentration of PVP in crystallization medium (%w/v)
(0.1)	 (0.3)	 (0.5)
Molecular weight of PVP 	 pa)	 a)	 Ap
2000	 0.55±0.05	 2.13±0.09	 3.23±0.14
10000	 0.89±0.05	 3.21±0.07	 3.96±0.06
50000	 0.98±0.04	 3.48±0.07	 4.32±0.19
(a)Apflount of adsorbed PVP (%w/w)
7.3.4 INFLUENCE OF PVP ON THE MORPHOLOGY OF PARACETAMOL
PARTICLES
Figures 7.3, 7.4 and 7.5 illustrate paracetamol particles crystallized from
media containing different amounts of PVP 2000, PVP 10000 or PVP 50000,
respectively. These figures clearly indicate that the use of PVP in the
crystallization media, had a major effect on the morphology of paracetamol
crystals as compared to particles obtained in the absence of PVP (figure 4.2).
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Figure 7.2 Paracetamol recovery as a function of concentration of: (+) PVP
2000, (4) PVP 10000 or (•) PVP 50000.
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Paracetamol crystals obtained in absence of PVP were very thin and flaky,
whereas those obtained in the presence of ^0.3% w/v of PVP 10000 or PVP
50000 were near spherical in structure (figures 7.4b,c and 7.5b,c). With
higher magnification, the spherical particles obtained in the presence of 0.5%
w/v of PVP 10000 or PVP 50000 (figures 7.6b and c) seem to be agglomerates
(clusters) of numerous fine finger-like (rod-shape) microcrystals which had
stuck together. The particles obtained in the presence of PVP 2000 even at
highest concentration of PVP (0.5% w/v) consisted of a fewer microcrystals
which had stuck together (figure 7.6a).
7.3.5 ASSESSMENT OF PVP AS AN ADDITIVE DURING
CRYSTALLIZATION OF PARACETAMOL
As described in section 1.2.5.1.1, active additives influence the crystallization
process and produce crystals of a different shape to those formed from a pure
solution. Furthermore, the active additives increase the induction time and
also reduce the crystal growth and yield. These effects are attributed to the
adsorption of additives onto the crystal surfaces (Davey, 1982).
Chow and Hsia (1991), Gordon and Chow (1992) and Chow et al (1995)
reported that crystallization of phenytoin in the presence of three different
ester homologues of diphenylhydantoin changed the crystal habit and caused
a drastic reduction in crystal yield. These effects were attributed to the
adsorption of additive onto the crystal faces of phenytoin. It was also
suggested that the most active additive was the one which changed the crystal
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(a)	 (b)
(c)
Figure 7.3 Micrographs of paracetamol particles crystallized in the presence
of: a) 0.1, b) 0.3 ore) 0.5 %w/v of PVP 2000 (magnification x200).
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(a)	 (b)
(c)
Figure 7.4 Micrographs of paracetarnol particles crystallized in the presence
of: a) 0.1, b) 0.3 or c) 0.5% w/v of PVP 10000 (magnification x200).
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(a)	 (b)
(c)
Figure 7.5 Micrographs of paracetamol particles crystallized in the presence
of: a) 0.1, b) 0.3 or c) 0.5% w/v of PVP 50000 (magnification x200).
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Figure 7.6 Micrographs of paracetamol particles crystallized from media
containing 0.5% w/v of: a) PVP 2000, b) PVP 10000 or c) PVP 50000
(magnification xlSOO).
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habit at the lowest concentration and caused the most reduction in crystal
yield. It has been reported that crystallization of paracetamol from water in
the presence of agar or gelatin, changed the crystal habit of paracetamol and
caused a decrease in crystal yield (Femi-Oyewo & Spring, 1994).
In the present study the observed changes in crystal habit of paracetamol
(figures 7.3, 7.4 and 7.5), the delay in the appearance of crystals (figure 7.1),
reduction in crystal yield (figure 7.2) and sorption of PVP by paracetamol
particles (table 7.1), are indicative that PVP is an effective additive during
the crystallization of paracetamol. It appeared that the highest molecular
weight of PVP was the most effective additive. The relative effectiveness of
the three grades of PVP, as considered by the parameters mentioned above,
followed the order PVP 50000>PVP 10000>PVP 2000. In section 6.3.2, it was
shown that higher molecular weights of PVP were more effective crystal
growth inhibitor for paracetamol than lower molecular weights of PVP.
7.3.6 MECHANISM OF ACTION OF PVP DURING CRYSTALLIZATION OF
PARACETAMOL
Impurities can influence a crystallization process by adsorption onto the
surfaces of growing crystals and/or by changing the equilibrium solubility of
solute and therefore the degree of supersaturation of system (Mullin, 1993).
Increase in solution viscosity can also affect the crystallization process and
so reduce the crystal growth rate and therefore change the crystal properties
(El-Bary et a1, 1990; Mackellar et a!, 1994a).
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In section 6.3.1, it was shown that PVP 10000 of concentration of 0.1% w/v
had no significant effect on solubility of paracetamol. The viscosities of 0.1-
0.5% w/v solutions of PVP 2000, PVP 10000 or PVP 50000 do not show any
significant difference to pure water (Kollidon, Technical information, 1992).
Therefore, the observed effects of PVP during crystallization of paracetamol
may be attributed to the adsorption of PVP onto the surfaces of growing
crystals. Uptake of PVP by paracetamol particles (table 7.1) is also indicative
of adsorption of PVP onto the paracetamol particles. In section 6.3.2, it was
shown that PVP had a strong inhibitory effect on the precipitation of
paracetamol crystals. This effect was attributed to adsorption of PVP onto the
paracetamol nuclei.
Simonelli et al (1970) reported that PVP is a strong crystal growth inhibitor
for suiphathiazole. This inhibitory effect was attributed to adsorption of PVP
onto the surfaces of paracetamol crystals. Mackellar et al (1994a, b) reported
that crystallization of ethyl p-hydroxybenzene in the presence of small
amounts of a series of poloxamers, caused a decrease in the crystal size and
changed the crystal habit from plate to prismatic. It was found that
poloxainers exerted their effects through adsorption at crystal faces causing
a subsequent inhibition of crystal growth.
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7.3.7 SOLID STATE CHARACTERISTICS OF PARACETAMOL PARTICLES
CRYSTALLIZED IN THE PRESENCE OF 0.5% W/V DIFFERENT GRADES
OF PVP
7.3.7.1 Particle size distribution
The size distribution of diameter of agglomerated particles crystallized in the
presence of 0.5% w/v of different grades of PVP is illustrated in figure 7.7. In
general, the diameter of these particles was between 10-40 pm. Figures 7.Gb
and c indicate that each agglomerated particle crystallized in the presence of
0.5% w/v of PVP 10000 or 50000 consisted of hundreds of rod-shape
microcrystals which had stuck together. The thickness of these microcrystals
was about 1-2 pm.
7.3.7.2 X-ray powder diffraction
The X-ray powder diffraction spectra of untreated paracetamol and samples
crystallized from media containing 0.5% w/v of different grades of PVP (figure
7.8) exhibited essentially similar diffraction patterns (20 values), suggesting
that particles crystallized in the presence of PVP did not undergo structhraf
modifications. However, the differences in the relative intensities of their
peaks, may be attributed to differences in the crystal sizes and habits of the
samples (El-Said, 1995; Marshall & York, 1989).
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7.3.7.3 Infrared spectroscopy
The principal absorption bands of infrared spectra of untreated paracetamol
and particles obtained in the presence of 0.5% w/v different grades of PVP
(figure 7.9), were similar, suggesting that their structure and conformation
were similar.
7.3.7.4 Differential scRnning calorimetry
Differential scanning calorimetry of untreated paracetamol and samples
crystallized from media containing 0.5% w/v of different grades of PVP are
shown in figure 7.10. All samples showed a sharp melting point with flat
baseline which indicated that no events such as hydration, solvation or
polymorphic transition had occurred during crystallization of the particles.
However, the DSC scans (figures 7.lOc,d) show that particles crystallized in
the presence of PVP started to melt at lower temperature as compared to
untreated paracetamol (figure 7.lOa). The mean values of the onsets of
melting points and enthalpies of fusion for untreated paracetamol and
samples obtained from media containing different grades of PVP are
presented in table 7.2.
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Figure 7.8 The XPD spectra of: a) untreated paracetamol particles, and
paracetamol crystallized in the presence of 0.5% w/v of(b) PVP 2000, (c) PVP
10000 or (d) PVP 50000.
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Figure 7.9 The IR spectra of a) untreated paracetamol particles, and
paracetamol crystallized from medium containing 0.5% w/v of (b) PVP 2000,
(c) PVP 10000 and (d) PVP 50000.
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Table 7.2 The onset of melting point (Tm) and enthalpy of fusion (AHc) for
untreated paracetamol and particles crystallized in the presence of 0.5% w/v
of different grades of PVP.
Onset of Tm (±SD)
	
AHf (±SD)
____________________	 (°C)	 (J/g)
Untreated crystals
	
171.6±0.2	 176.1±2.2
Particles obtained in	 171.4±0.3	 155.1±3.3
presence_of PVP_2000 ________________ ________________
Particles obtained in 	 171.2±0.3	 148.5±5.7
presenceof PVP 10000 __________________ _________________
Particles obtained in 	 170.9±0.2	 138.3±4.3
presence of PVP 50000
Table 7.2 indicates that the onsets of melting point and enthalpies of fusion
of paracetamol crystallized in the presence of PVP decreased by 0.2-0.7°C and
2 1-38 J/g, as compared to the untreated samples. Decrease in enthalpy of
fusion and onset of melting point may be attributed to the presence of
amorphousness in the particles, or due to weakening and disruption of the
crystal lattice and order, or in this case, may be attributed to an interaction
between paracetamol and PVP in the particles. It was shown that particles
crystallized in the presence of PVP, contained small amounts of PVP (table
7.1).
In section 6.3.5.2, the DSC was carried out for physical mixtures of
paracetamol and PVP and their onsets of melting points and enthalpies of
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Figure 7.10 DSC scans of a) untreated paracetamol crystals and paracetamol
crystallized from media containing 0.5% w/v of: (b) PVP 2000, (c) PVP 10000
or (d) PVP 50000.
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fusion were given in table 6.3. These data (table 6.3) clearly indicated that
the enthalpies of fusion of paracetamol decreased as the proportion of PVP
in the physical mixtures increased. According to table 7.1 the crystals of
paracetamol formed in the presence of PVP 50000 contained 4.3% of PVP.
The values of enthalpy and onset of temperature of these particles (table 7.2)
are similar to those of the physical mixture containing 5% PVP 50000 (table
6.3). It is likely therefore that the low enthalpies of fusion for paracetamol
crystallized in the presence of PVP (table 7.2) are not due to amorphousness
or crystal disruption. Additionally data (JR and XPD) confirmed that no
structural modifications occurred in the samples crystallized in the presence
of PVP.
7.4 CONCLUSIONS
It was found that PVP is an effective additive during crystallization of
paracetamol and signif1cantl influenced the crystallization process and
changed the crystal habit. These effects were attributed to adsorption of PVP
onto the surfaces of growing crystals. It was found that the higher molecular
weights of PVP (PVP 10000 and PVP 50000) were more effective additives
than lower molecular weight PYP (PVP 2000).
Paracetamol particles obtained in the presence of 0.5% w/v of PVP 10000 or
PVP 50000 had near spherical agglomerated structure and consisted of
nwtierous rod-shape microcrystals which had stuck together. Particles
obtained in the presence of PVP 2000 consisted of fewer microcrystals.
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DSC, XPD and JR experiments showed that paracetamol particles crystallized
in the presence of PVP, did not undergo structural modifications compared
to untreated paracetamol crystals.
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CHAPTER 8. COMPACTION PROPERTIES OF PARACETAMOL
CRYSTALLIZED IN THE PRESENCE OF
POLYVINYLPYRROLIDONE
8.1 INTRODUCTION
There are several reports in the pharmaceutical literature of attempts to
change the morphology of drug crystals using alternative crystallization
procedures to improve their compaction properties. Examples include
spherical crystallization, which transforms crystalline drugs into
agglomerated forms (Morishima et al, 1994; Gordon & Chowhan 1990;
Guillaume & Guyot-Herman, 1993), crystallization from different solvents to
produce different crystal habit (Gordon & Aniin 1984) and incorporation of
additives by co-precipitation (Kaul et al 1992).
Attempts have been made to modify the paracetamol crystals using different
crystallization techniques, to improve its compaction properties (Fachaux et
al 1992, 1993; Di Martino et al 1994, 1995; Abdelilah et al 1995). In chapter
4 two modified forms of paracetamol crystals (thin plate-like and polyhedral
crystals) were prepared. These crystals did not exhibit any improvement in
their compaction properties compared to untreated paracetamol (see chapter
5). The aims of the work presented in this chapter were to investigate the
compaction properties of paracetarnol particles crystallized in the presence of
different grades of PVP, as described in chapter 7.
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8.2 MATERIALS AND METHODS
8.2.1 MATERIALS
Paracetamol particles crystallized in the presence of 0.1, 0.3 or 0.5% w/v of
PVP of molecular weight 2000, 10000 or 50000, as described in chapter 7,
were used. Several batches of each crystals were combined prior to study.
Untreated paracetamol, PVP of molecular weight 50000 and magnesium
stearate, as explained in chapter 2, were also used for this part of study.
8.2.2 METHODS
8.2.2.1 Particle size fractions
Sieved fractions of paracetamol particles crystallized in the presence of 0.5%
w/v of different grades of PVP (<90 pm), untreated paracetamol crystals (<90
pm), PVP 50000 (<45 pin) and magnesium stearate (<45 pm) were obtained
as detailed in section 2.2.13. Particles crystallized in the presence of 0.1 or
0.3% w/v of different grades of PVP were used unsieved as harvested from
crystallization medium. These particles had different ranges of size and
therefore it was impossible to obtain a specific sieved fraction for each of
them.
8.2.2.2 Preparation of physical mixtures
In order to investigate the effect of addition of PVP to paracetamol, on the
crushing strength of tablets, sieved fractions of paracetamol (<90 pm) with
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different contents of PVP 50000 (<45 pm) were mixed using a tumbler mixer
prior to compression.
A useful method to predict the mechanism of compaction of particles is to
determine the crushing strength of tablets with and without magnesium
stearate (Duberg & Nystrom, 1982). Sieved fractions of paracetamol (<90 pm)
with 0.5% w/w of magnesium stearate (<45 pm) were mixed using a tumbler
mixer for 1 h. This long mixing time was chosen to provide a layer or film of
magnesium stearate upon the surfaces of paracetamol particles (Bolhuis et
a!, 1975).
8.2.2.3 Compression
All the samples were dried in an oven at 55°C for 24 h and then stored in
tightly closed jars before compression. Compression was carried out using a
compaction simulator (section 2.2.11). Four tablets, 400 mg weight each, were
made at compression speeds of 10, 50, 100 or 250 mm s' up to a maximum
compaction force of 30 kN.
8.2.2.4 Crushing strength and capping tendency of tablets
The crushing strength of tablets were determined 24 h after compaction, as
described in section 2.2.14. Tablets were assessed visually for capping by
observation of the final tablets for horizontal striations. The tablets were
divided into four groups: no capping (-), low capping (+), high capping (++)
and very high capping (+-i-+).
216
8.2.2.5 Analyses of compaction data
Analyses of the data according to the Heckel equation were carried out as
detailed in section 2.2.12.2. Mean yield pressures (MYP), the relative
densities of powders at zero pressure (D0) and before appreciable load (Da),
and the extents of particle rearrangement (Db) were determined. The plastic
and elastic energies were measured using energy analyses on the force-punch
separation plots (section 2.2. 12.1). The percentages of elastic recovery in the
die at different compaction forces were determined, as detailed in section
2.2.12.3. The results of analysis of compaction data of untreated paracetamol
particles, <90 p.m (chapter 3), are included in this chapter for comparison.
8.3 RESULTS AND DISCUSSION
8.3.1 CRUSHING STRENGTHS OF PARACETAMOL TABLETS
8.3.1.1 Influence of compression force on the crushing strength of
tablets
The effects of compression force on the crushing strengths of tablets made
from paracetamol particles crystallized in the presence of different amounts
of PVP of molecular weight 2000, 10000 or 50000 are shown in figures 8.1,
8.2 and 8.3, respectively. The tendency of tablets made from these particles
to cap are presented in table 8.1. In chapter 3 it was shown that tablets made
from untreated paracetamol were very weak with no measurable hardness
and had a high tendency to cap. The data (figures 8.1, 8.2, 8.3 and table 8.1)
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Figure 8.1 Effect of compression force on the crushing strengths of tablets
prepared from paracetamol crystallized in the presence of: (+) 0.1, (') 0.3 or
() 0.5% w/v of PVP 2000, at a compression speed of 10 mm s'.
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Figure 8.2 Effect of compression force on the crushing strengths of tablets
prepared from paracetamol crystallized in the presence of: (+) 0.1, (a) 0.3 or
(U) 0.5% wfv of PVP 10000, at a compression speed of 10mm s'.
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Figure 8.3 Effect of compression force on the crushing strengths of tablets
prepared from paracetamol crystallized in the presence of: (+) 0.1, (i) 0.3 or
() 0.5% w/v of PVP 50000, at a compression speed of 10 mm s'.
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Figure 8.4 Effect of compression force on the crushing strengths of tablets
made from paracetamol crystallized in the presence of 0.5% w/v of: (•) PVP
2000, (*) PVP 10000 or () PVP 50000, at compression speed of 10 mm s1.
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Table 8.1 Effect of compression force on the capping tendency of tablets made
from paracetamol crystallized in the presence of 0.1, 0.3 or 0.5% w/v of
different grades of PVP, at a compression speed of 10 mm s'.
Particles crystallized in presence of:
Compression 
PVP 2000 (%w/v) PVP 10000 (%w/v) PVP 50000 (%w/v)
force(kN) ______ ______ ______ ______ ______ _____ ______ ______ _____
0.1	 0.3	 0.5	 0.1	 0.3	 0.5	 0.1	 0.3	 0.5
10	 +++ ++	 +	 ++	 -	 -	 +	 -	 -
15	 +++ ++	 +	 ++	 -	 -	 +	 -
20	 +++ 4+	 ++	 +4	 +	 -	 +	 -	 -
25	 +++ 4+-i- ++	 +++	 +	 -	 4+	 +	 -
30	 +++ +++ +++ +++ ++	 -	 +++	 +	 -
(-, +, ++ and +++) as defined in section 8.2.2.4
indicate improvement in the compaction properties of paracetamol particles
crystallized in the presence of PVP. These figures indicate that the crushing
strengths increased with increasing molecular weight and/or the
concentration of PVP in the crystallizing solution.
Figure 8.4 compares the crushing strengths of tablets made from particles
obtained in the presence of 0.5% w/v PVP. These results demonstrate that
particles crystallized in the presence of 0.5% w/v PVP 10000 or PVP 50000
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produced tablets with excellent hardness and lack of tendency to cap.
However, particles obtained in the presence of PVP 2000 showed little
improvement in their compaction properties. The high crushing strengths of
the tablets are indicative of stronger interparticulate bondlings between the
particles crystallized in presence of PVP compared to untreated paracetamol.
8.3.1.2 Influence of compression speed on the crushing strength of
tablets
The effects of compression speed on the crushing strengths and capping
tendencies of tablets made from paracetamol crystallized in the presence of
0.5% w/v PVP were investigated. The results are shown in figure 8.5 and
table 8.2. Tablets made from particles obtained in the presence of PVP 10000
or PVP 50000 exhibited good hardnesses with no tendency to cap, even at the
highest compaction speed (250 mm s O' ). However, for tablets made from
particles crystallized in the presence of PVP 2000, dramatic decreases in
crushing strength occurred with increasing compression speed. Tablets made
from particles crystallized in the presence of P'STP 10000 or PVP 50000 did
not show a major reduction in their crushing strength with increase in
compaction speed. Tukey's test revealed that the crushing strengths of tablets
were significantly different only at 10 and 250 mm s (P<0.05). The lack of
reduction in crushing strength with increasing compaction speed may be
attributed to fragmentation of the particles under the applied load.
The crushing strengths of tablets made from materials such as xylitol or
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Figure 8.5 Effect of compression speed on the crushing strengths of tablets
made from paracetamol crystallized in the presence of 0.5% w/v of: (+) PITP
2000, (A) PVP 10000 or (U) PVP 50000, at a compression force of 15 kN.
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Table 8.2 Effect of compaction speed on the capping tendency of tablets made
from paracetamol particles crystallized in the presence of 0.5% w/v of
different grades of PVP, at a compaction force of 15 kN.
Compression	 Particles crystallized in presence of:
speed (mm .1) PYP 2000 PVP 10000 PVP 50000
10	 +	 -	 -
50	 +	 -	 -
100	 ++	 -	 -
250	 ++	 -	 -
-, +, ++ and +++) as defined in section 8.2.2.4
dicalcium phosphate dihydrate (Emcompress®) which consolidate by a
dominant fragmentation mechanism were independent of compression speed
(Garr & Rubinstein, 1990; Garr 1992). Emcompress consists of aggregates of
smaller primary particles. These aggregates are extensively fragmented
during compression (Duberg & Nystrom, 1982). Paracetamol crystallized in
the presence of 0.5% w/v of PVP 10000 or PVP 50000 had an agglomerated
structure which consisted of numerous fine microcrystals which had stuck
together (figures 7.6b and c). It is reasonable to assume therefore that these
agglomerates undergo fragmentation during compaction.
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8.3.2 HECKEL ANALYSIS OF PABACETAMOL TABLETS
Figure 8.6 shows typical Heckel plots of paracetamol crystallized in the
presence of 0.5% w/v of different grades of PVP, obtained at a compaction
speed of 10 nim s'. This figure indicates that paracetamol crystallized in the
presence of PVP 2000 exhibited higher relative densities (greater
densification) for a given applied pressure than particles obtained in the
presence of PVP 10000 or PVP 50000. This can be attributed to increased
frictional and cohesive forces between the latter particles, due to their small
size, and rough and dented surfaces (figure 7.6b,c) which would restrict
particle sliding and thus reduce densification (McKenna & McCafferty, 1982;
Roberts & Rowe, 1986).
The slope for particles crystallized in the presence of PVP 2000 was greater
than that of PVP 10000 or PVP 50000 (figure 8.6). Table 8.3 indicates that
the slope (K) was highest for paracetamol crystallized in the presence of PVP
2000. Therefore the mean yield pressure (1/K) was lower. Table 8.3 also
indicates that the densification due to die filling (D0) is the same for all
particles, but the value of Da (densffication due to die filling and particle
rearrangement) was greater for particles crystallized in the presence of PVP
2000 than those obtained in the presence of PVP 10000 or 50000. This
indicates a higher degree of densification for the former particles.
Table 8.3 indicates that the correlation coefficient of the initial part of the
Heckel plot (0-20 MPa) was slightly lower for particles crystallized in the
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Figure 8.6 Typical Heckel plots of paracetainol particles crystallized in the
presence of 0.5% w/v of: (—) PVP 2000, (---) PVP 10000 or (....) PVP 50000,
at a compression speed of 10 mm s'.
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presence of PVP 2000. These results indicate that these particles possibly
underwent more fragmentation during the first stage of compaction (Duberg
& Nystrom, 1986; Humbert-Droz et al, 1983).
Table 8.3 The values derived from the Heckel plots of figure 8.6 of
paracetamol crystallized in the presence of 0.5% w/v of different grades of
PVP, compressed at a compaction speed of 10 mm s'.
Paracetamol crystallized in presence of:
PVP 2000	 PVP 10000 PVP 50000
K	 0.021	 0.018	 0.017
1/K=Mean yield pressure (MPa)
	
47.3	 56.0	 59.1
Da	 0.65	 0.64	 0.61
D0	 0.51	 0.51	 0.51
r*	 0.958	 0.967	 0.975
0.998	 0.997	 0.998
r*=Correlation coefficient of initial curve of Heckel plot (0-20 MPa)
r**=Correlation coefficient of straight line portion of Heckel plot (20-65 MPa)
Figure 8.7 shows the whole compression cycle (compression and
decompression phase) for particles crystallized in the presence of 0.5% w/v
PYP 10000 at a compaction speed of 10 mm s'. As mentioned in section
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Figure 8.7 Heckel plot, including compression and decompression phase, of
paracetamol crysta'lized in the presence of 0.5% w/v of PVP 10000, obtained
at a compaction speed of 10 mm s.
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1.4.5.2, phase III of a Heckel plot can be indicative of the behaviour of a
material under applied load (Duberg & Nystrom, 1986). A large deviation
from the horizontal in decompression phase for untreated paracetamol (figure
3.3) was attributed to a high degree of elastic behaviour (section 3.3.2). The
deviation from horizontal in phase III for particles crystallized in the
presence of PVP (figure 8.7) was less than that of untreated paracetamol
(figure 3.3). This indicates that the elastic behaviour of paracetamol
crystallized in the presence of PVP was lower than untreated paracetarnol.
83.3 INFLUENCE OF COMPRESSION SPEED ON HECKEL CONSTANTS
The effects of compression speed on the mean yield pressure, D0, Da and Db
of paracetamol crystallized in the presence of 0.5% w/v of different grades of
PVP were investigated (tables 8.4, 8.5).
Two way analysis of variance showed that there were no significant
differences (P>0.05) between the mean yield pressures of particles obtained
in the presence of PVP 10000 and PVP 50000. However, differences between
paracetamol obtained in the presence of PVP 2000 and those obtained in the
presence of PVP 10000 or 50000 were significant (table 8.4). As the
compression speed increased, the MYP for all samples generally increased.
One way analysis of variance showed that there were significant differences
(P<0.05) between the MYP with increasing compaction speed for all particles.
However, particles crystallized in the presence of the higher molecular weight
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Table 8.4 Effect of compression speed on the mean yield pressures (MYP) of
paracetamol crystallized in the presence of 0.5% w/v of different grades of
PvP.
MYP±SD (MPa)
Compression	 Particles obtained in presence of:
speed (mm s')
PVP 2000	 PVP 10000	 PVP 50000
10	 48.9±1.2	 56.8±1.7	 59.4±2.2
50	 53.7±2.7	 59.5±0.6	 61.5±2.3
100	 55.8±1.3	 61.5±1.4	 64.3±1.9
250	 57.5±1.1	 62.0±2.0	 63.1±1.3
of PVP (10000 or 50000) were less sensitive to changes in compaction speed.
The changes of MYP with different compaction speeds were quantified as
strain rate sensitivity (SRS), using equation 3.1 (section 3.3.2.1). The values
of SRS for particles crystallized in the presence of PVP 2000, PVP 10000 or
PVP 50000 were 5.9, 8.4 or 14.9%, respectively. As mentioned in section 1.4.6,
due to the time dependent nature of plastic flow, the mean yield pressures
increase with increasing punch velocity for plastic materials which
consequently show higher values of SRS (Roberts & Rowe, 1985, 1986). The
lower values of SRS for paracetamol crystallized in the presence of PVP
10000 or PVP 50000 indicate that these particles were less sensitive to
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compaction speed, suggesting that a high degree of fragmentation occurred
during compression. It has been reported that materials which consolidate by
fragmentation show no significant change in mean yield pressure with
increasing compaction speed and therefore exhibit a low SRS (Roberts &
Rowe, 1985; Garr, 1992).
The correlation coefficients of the initial parts of the Heckel plots (table 8.3)
indicated that during the first stage of compaction, particles obtained in the
presence of PVP 2000 probably underwent more fragmentation than
paracetamol obtained in the presence of PVP 10000 or 50000. This can be
attributed to the ease of fracture of the former particles at lower pressures
(0-20 MPa). However, at higher compaction pressures, more fragmentation
occurred for particles obtained in the presence of the higher molecular weight
PVP. Paracetamol crystallized in the presence of PVP 10000 or PVP 50000
consisted of numerous fine microcrystals which had stuck together (figure
7.6). Therefore, it may be expected that these particles underwent more
fragmentation during compaction.
The values of D0, Da and Db (table 8.5) for all paracetamol particles tended to
decrease with increasing punch speeds. One way analysis of variance
revealed that there were significant differences (P<0.05) between the values
of D0, Da or Db with increasing compaction speed for all samples. As
mentioned in section 3.3.2.1, at higher punch speeds the frictional and
adhesive forces between the particles increase (York, 1978), and the air
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escape from powder bed would be lower than at slower speeds. Therefore
these factors will reduce densiflcation of powder bed at higher punch speeds
(Roberts & Rowe 1985).
Table 8.5 also indicates that at each compaction speed, the value of D0 is
almost the same for all particles. Tukey's test revealed that at the majority
of compaction speeds the differences between the values of D0 were not
significant. However, the values of Da and Db show a slight decrease for
particles crystallized in the presence of higher molecular weight of PVP (PVP
10000 or PVP 50000) as compared to those obtained in the presence of PVP
Table 8.5 The effect of compression speed on the values of D0, Da and Db
(x10') (±SD) of paracetamol crystallized in the presence of 0.5% w/v of
different grades of PVP.
Compression	 Particles crystallized in presence of:
speed	
PVP 2000	 PVP 10000	 PVP 50000(mm s) ______ _______ _______ ______ _______ _______ ______ _______ ______
D0	 Db	 D0	 Da	 Db	 D0	 D8	 Db
10	 5.03	 6.53	 1.50	 5.15	 6.45	 1.30	 5.10	 6.35	 1.23
±0.20 ±0.10 ±0.08 ±0.05 ±0.05 ±0.00 ±0.08 ±0.05 ±0.05
50	 4.83	 6.33	 1.50	 4.87	 6.35	 1.48	 4.80	 6.07	 1.30
±0.08 ±0.05 ±0.08 ±0.05 ±0.10 ±0.09 ±0.08 ±0.20 ±0.09
100	 4.78	 6.18	 1.43	 4.87	 6.10	 1.23	 4.68	 5.90	 1.28
±0.10 ±0.05 ±0.10 ±0.05 ±0.00 ±0.04 ±0.09 ±0.20 ±0.09
250	 4.58	 5.75	 1.18	 4.80	 5.80	 1.00	 4.73	 5.58	 0.85
±0.10 ±0.05 ±0.15 ±0.00 ±0.08 ±0.08 ±0.05 ±0.09 ±0.10
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2000. Tukey's test showed that at most compaction speeds, the values of Da
or Db were significantly different. The degree of densification that occurred
during compression depends on the surface structure, size and shape of
particles (Heckel 1961; York 1978; York & Pilpel 1973; McKenna &
McCafferty, 1982; Roberts & Rowe, 1985, 1986). As discussed earlier (section
8.3.2), particles obtained in the presence of PVP 10000 or PVP 50000 were
very fine with rough and dented surfaces. Therefore it is expected that
frictional forces associated with these particles tend to restrict the particle
sliding and rearrangement and thus will reduce densification.
8.3.4 INFLUENCE OF COMPRESSION FORCE ON THE ELASTIC
RECOVERY OF PARACETAMOL TABLETS
The effect of compression force on the elastic recoveries in the die of tablets
made from paracetainol crystallized in the presence of 0.5% w/v of PVP is
shown in figure 8.8. The elastic recoveries of tablets made from untreated
paracetamol <90 pm, (chapter 3) are also shown. Tablets made from particles
crystallized in the presence of PVP exhibited lower elastic recoveries than
untreated paracetamol. Tablets made from particles obtaiied rn txe ptsrit
of PVP 10000 or PVP 50000 exhibited lower elastic recoveries than those
obtained in the presence of PVP 2000 following the removal of compression
pressure.
The crushing strengths and elastic recoveries indicated that the
interparticulate bondings between particles crystallized in the presence of
234
'-4
0
C)
C)
rl)
25
20
15
10
5
0
0	 5	 10	 15
	
20	 25	 30
	
35
Compression force (kN)
Figure 8.8 Effect of compression force on the elastic recovery in the die of
tablets made from: (0) untreated paracetamol, and paracetamol crystallized
in the presence of 0.5% w/v of(+) PVP 2000, () PVP 10000 or () PVP 50000,
at a compaction speed of 10 mm s.
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PVP should be much stronger than untreated paracetamol. Particles
crystallized in the presence of PVP were very fine (almost 20 jim) and each
particle consisted of numerous microcrystals which had stuck together (figure
7.6). Fragmentation of each particle under load will produce numerous fresh
and clean surfaces which can probably form bonds between each other.
8.3.5 ENERGIES INVOLVED DURING COMPACTION OF PARACETAMOL
8.3.5.1 Influence of compression force or speed on the gross energies
The effects of compaction force or compaction speed on the gross energies of
tablets made from paracetamol crystallized in the presence of 0.5% w/v of
different grades of PVP are illustrated in figures 8.9 and 8.10. Increasing the
compaction force or speed, resulted in an increase in gross energies for all
samples.
Figures 8.9 and 8.10 indicate that at all compaction forces or speeds, the
gross energies of tablets made from untreated paracetamol were less than
samples crystallized in the presence of PVP. These figures also indicate that
the gross energies of tablets made from paracetamol crystallized in the
presence of PVP followed the order PVP 50000>PVP 10000>PVP 2000.
However, Tukey's test revealed that there were no significant differences
(P>0.05) between the gross energies of samples obtained in the presence of
PVP 10000 or PVP 50000 at 20 kN compaction force, and also at compaction
speeds of 50, 100 and 250 mm s. The gross energies of paracetamol
236
-i
I-i
0
1-4
15
14
13
12
11
10
9
8
7
6
5
4
3
2
I
0
0	 5	 10	 15	 20	 25	 30
	
35
Compaction force (kN)
Figure 8.9 Effect of compression force on the gross energies of tablets made
from: (I) untreated paracetamol, and paracetamol crystallized in the presence
of 0.5% w/v of (•) PVP 2000, () PVP 10000 or (U PVP 50000, at a
compaction speed of 10 mm s.
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Figure 8.10 Effect of compression speed on the gross energies of tablets made
from: (0) untreated paracetamol, and paracetamol crystallized in the presence
of 0.5% w/v of () PVP 2000, (&) PYP 10000 or (U) PVP 50000, at a
compaction force of 15 kN.
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crystallized in the presence of PVP 2000 or PVP 10000 were significantly
different (P<0.05) only at a compaction speed of 50 mm s W ', and at compaction
forces of 10, 20 and 30 kN. The increased gross energies for tablets made
from particles obtained in the presence of PVP could be attributed to an
increase in plastic (net compaction) energies and/or elastic energies of tablets.
This will be further studied in the following sections.
8.3.5.2 Influence of compression force or speed on elastic energies
The effects of compression force or compression speed on the elastic energies
of tablets made from paracetamol crystallized in the presence of 0.5% w/v
pVp illustrated in figures 8.11 and 8.12. These figures indicate that, at
different compaction forces or speeds, the elastic energies of tablets made
from particles crystallized in the presence of PVP were less than that of the
untreated paracetamol. These figures also reveal that the elastic energies of
tablets made from particles crystallized in the presence of higher molecular
weight PVP were less than for particles obtained in presence of lower
molecular weight PVP. However, Tukey's test showed that there were no
significant differences (P>0.05) between the elastic energies of samples
obtained in the presence of PVP 10000 or PVP 50000 at all compaction forces,
and also at 10 or 50 mm s4 compaction speeds. The results of elastic
recoveries and elastic energies indicated that particles crystallized in the
presence of PVP showed less elastic behaviour than the untreated
paracetamol.
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Figure 8.11 Effect of compression force on the elastic energies of tablets made
from: (D) untreated paracetamol, and paracetamol crystallized in the presence
of 0.5% w/v of (+) PVP 2000, (A) PVP 10000 or (I) PVP 50000, at a
compaction speed of 10 mm s'.
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Figure 8.12 Effect of compression speed on the elastic energies of tablets
made from: (0) untreated paracetamol, and paracetamol crystallized in the
presence of 0.5% w/v of(+) PVP 2000, () PVP 10000 or (•) PVP 50000, at a
compaction force of 15 kN.
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8.3.5.3 Influence of compression force or speed on the plastic (net
compaction) energies
Figures 8.13 and 8.14 show the plastic energies of tablets made from particles
crystallized in the presence of PVP. These figures clearly indicate that the
plastic energies of tablets made from particles crystallized in the presence of
PVP were much higher than for untreated particles. This figures also indicate
that the plastic energies increased as the molecular weight of PVP increased.
Tukey's test revealed that the differences between the plastic energies of
paracetamol crystallized in the presence of PVP 10000 or PVP 50000 were not
significant at 20 kN compaction force, and also at 50, 100 and 250 mm s'
compaction speeds. The increases in plastic energy of tablets made from
particles crystallized in the presence of PVP may be attributed to the energy
required for fragmentation of these particles and most importantly to the
formation of bonds between the particles during compaction. The high
crushing strengths of the tablets made from particles obtained in the
presence of PVP indicated strong interparticulate bonding.
8.3.5.4 Influence of compaction force or speed on the ratio of elastic
energy/plastic energy
Tables 8.6 and 8.7 show the ratio of elastic energy/plastic energy (EE/PE) of
tablets made from paracetamol crystallized in the presence of PVP, at varying
compaction forces or speeds, respectively. The ratios of EE/PE for particles
crystallized in the presence of PVP were much lower than for untreated
crystals.
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Figure 8.13 Effect of compression force on the plastic energies of tablets made
from: (fl) untreated paracetamol, and paracetamol crystallized in the presence
of 0.5% w/v of (+) PVP 2000, (A) PVP 10000 or (•) PVP 50000, at a
compaction speed of 10 mm s'.
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Figure 8.14 Effect of compression speed on the plastic energies of tablets
made from: (fl) untreated paracetamol, and paracetamol crystallized in the
presence of 0.5% w/v of(+) PVP 2000, () PVP 10000 or () PVP 50000, at a
compaction force of 15 kN.
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Table 8.6 Effect of compression force on the ratio of EE/PE of tablets made
from paracetamol crystallized in the presence of 0.5% w/v different grades of
PVP, at a compaction speed of 10 mm s.
EE/PE ratio±SD
Compression Particles crystallized in the presence of: 	 Untreated
force (kN)
	
	 *
PVP 2000 PVP 10000 PVP 50000 paraceth.niol
10	 0.41±0.04	 0.23±0.02	 0.18±0.01	 0.74±0.06
15	 0.52±0.05	 0.34±0.05	 0.23±0.03	 0.91±0.04
20	 0.75±0.07	 0.47±0.05	 0.38±0.03	 1.36±0. 14
25	 1.00±0.07	 0.59±0.09	 0.44±0.06	 1.73±0.11
30	 1.10±0.15	 0.66±0.09	 0.52±0.07	 1.78±0.17
* Taken from table 3.4
These results indicate that for untreated particles the major portion of
compaction energy is utiised as elastic energy, while for particles obtained
in the presence of PVP a minor portion is used as elastic energy. These
results again confirmed that tablets made from particles crystallized in the
presence of PYP exhibited lower elastic behaviour than untreated
paracetamol. Tables 8.6 and 8.7 also indicate that paracetamol crystallized
in the presence of higher molecular weight of PVP (10000 or 50000) exhibited
lower EE/PE ratios than those obtained in the presence of PVP 2000.
However, Tukey's test revealed that there were no significant differences
(P>0.05) between the EE/PE ratios for particles crystallized in the presence
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of PVP 10000 or PVP 50000 at compaction speeds of 50 and 250 mm s', and
also at a compaction force of 30 kN.
Table 8.7 Effect of compression speed on the ratio of EE/PE of tablets made
from paracetamol crystallized in the presence of 0.5% w/v different grades of
PYP, at a compaction force of 15 kN.
EEIPE ratio±SD
Compression	 Particles crystallized in presence of:	 Untreated
speed (mm s.!)
PVP 2000 PVP 10000 PVP 50000 paracetamol*
10	 0.52±0.05	 0.34±0.05	 0.23±0.03	 0.91±0.04
50	 0.56±0.09	 0.32±0.05	 0.26±0.03	 0.92±0.08
100	 0.62±0.04	 0.47±0.05	 0.38±0.03	 1.00±0.06
250	 0.67±0.04	 0.44±0.06	 0.36±0.03	 1.24±0.10
* Taken from table 3.5
8.3.6 INFLUENCE OF ADDITION OF MAGNESIUM STEARATE ON THE
CRUSHING STRENGTH OF TABLETS
The crushing strengths and Heckel analyses at different compaction speeds
revealed that particles crystallized in the presence of PVP 10000 or PVP
50000 underwent fragmentation during compression. Another useful method
for estimating the degree of fragmentation of particles under load is to
determine the crushing strength of tablets with and without magnesium
stearate (Duberg & Nystrom, 1982).
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Materials which mainly deform by plastic deformation such as amylose V or
sodium chloride are sensitive to even small additions of lubricant and exhibit
a dramatic decrease in their crushing strength, but materials such as
Emcompress®
 which undergo complete fragmentation under pressure are
practically uninfluenced by mixing with magnesium stearate (Duberg &
Nystrom, 1982). These phenomena have been attributed to the formation of
a film by magnesium stearate over the surfaces of particles (Boihuis et al,
1975).
In the case of a plastic material which undergoes plastic deformation without
any fragmentation, addition of lubricant decreases the adhesion and bonding
properties between particles and therefore the crushing strength will be
dramatically decreased. The crushing strength of tablets made from amylose
V decreased from 19.5 kg to zero, and for sodium chloride from 7.5 to 0.5 kg,
without and with 0.5% magnesium stearate, respectively (De Boer, et al
1978). On the other hand, materials that fragment during compaction such
as Emcompress show little or no reduction in tablet strength, when lubricant
is added. This is due to the creation of new, fresh, clean and unlubricated
surfaces which are able to form bonds between particles (Deboer et al, 1978).
Paracetamol particles crystallized in the presence of PVP 10000 or PVP
50000 were mixed with 0.5% w/w of sieved fraction of magnesium stearate
(<45 pm) and were compressed at different compaction forces and the
percentage of reduction in crushing strength of tablets (compared to tablets
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Figure 8.15 Effect of compaction force on the reduction in crushing strengths
of tablets made from particles crystallized in presence of 0.5% w/v of (A) PVP
10000 or () PVP 50000, mixed with 0.5% w/w magnesium stearate.
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made from particles without magnesium stearate) were determined (figure
8.15). Particles crystallized in the presence of PVP 10000 or PVP 50000 did
not show a major reduction in their crushing strengths following the addition
of magnesium stearate. The maximal percentage reduction in their crushing
strength was less than 15%. This can be attributed to the fragmentation of
these particles under pressure, producing fresh and unlubricated surfaces for
particle bondings. The reduction in crushing strengths was lower for particles
crystallized in the presence of PVP 50000 than for particles obtained in the
presence of PVP 10000, indicating the greater tendency to fragment for the
former particles.
8.3.7 CRUSHING STRENGTHS OF TABLETS MADE FROM PHYSICAL
MIXTURES OF PARACETAMOL AND PVP 50000
In section 8.3.1, it was demonstrated that particles crystallized in the
presence of 0.5% w/v of PVP 50000 produced tablets with high crushing
strengths and no tendency to cap. In section 7.3.3 it was shown that these
particles contained 4.3% wfw of PVP. The question now is whether the
improved compaction properties of these particles was due to the presence of
PVP in the particles or is due to the morphology (i.e. agglomerated structure)
of these particles. There are some reports that the addition of some binders
such as Avicel, HPMC or PVP to paracetamol increased the crushing strength
of its tablets. However, among these binders, PVP was the least effective
(Krycer & Pope, 1983). Nystrom and Glazer (1985) and Nystrom et al (1982)
found that the tablet strength of physical mixtures of a poorly compressible
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substance such as paracetamol with binders such as PVP, increased with an
increase in the concentration of binder and also with a decrease in the
particle size of binder.
The physical mixtures of sieved fractions of PVP 50000 (<45 j.im) and
paracetamol were compressed at different compression forces and the
crushing strength of tablets are presented in table 8.8. These data clearly
indicate that the crushing strengths of tablets, even at the highest ratio of
PVP (50% w/w), were less than 5 kp, whereas, particles crystallized in the
presence of 0.5% w/v of PVP 50000, which contained about 4% w/w PVP
(table 7.1), produced tablets with crushing strengths of more than 15 kp
(figure 8.3). Although PVP is in intimate contact with particles crystallized
in the presence of PVP, i.e PVP has adsorbed onto the paracetamol particles
which is in different manner with physical mixture. The compaction
properties of particles crystallized in the presence of 0.5% w/v of different
grades of PVP followed the order: PVP 50000>PVP 10000>PVP 2000.
However, there were no major differences between the amount of PVP in
these particles (table 7.1). Figure 7.6 indicated that particles obtained in the
presence of PVP 10000 or PVP 50000 consisted of more microcrystals as
compared to those obtained in the presence of PYP 2000. Therefore, these
results indicate that an improvement in compaction properties ofparacetamol
crystallized in the presence of PVP was due to the morphology of particles i.e
agglomerated structure, not due to the presence of small amounts of PVP in
the particles.
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8.4 CONCLUSIONS
Particles crystallized in the presence of 0.5% w/v PVP 10000 or PVP 50000
produced tablets with excellent hardness with no tendency to cap even at
high compaction speeds. However, particles crystallized in the presence of
PVP 2000 exhibited little improvement in their compaction properties.
It was found that particles crystallized in the presence of PVP 10000 or PVP
50000 underwent a high degree of fragmentation during compaction resulting
in the formation of numerous fresh and clean surfaces for particle bondings.
The results of elastic recovery, elastic energy and elastic energy/plastic
energy ratio revealed that particles crystallized in the presence of PVP
exhibited much less elastic behaviour under pressure, as compared to
untreated paracetamol particles.
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CHAPTER 9. DISSOLUTION STUDY OF PARACETAMOL
CRYSTALLIZED IN ThE PRESENCE OF
POLYVINYLPYRROLIDONE
9.1 INTRODUCTION
Many methods have been used to enhance dissolution rates of poorly water-
soluble drugs. The methods include, for example, micronization, formation of
water soluble salts of compounds and solid dispersions (Chiou & Riegelman,
1971).
Chiou et al (1976) introduced a unique method to enhance the dissolution
rate of poorly water-soluble drugs. The basic method simply involved. the.
crystallization of the drug in an aqueous surfactant solution (polysorbate 80),
which caused a marked enhancement in the dissolution rates of obtained
drugs. There are several other reports of attempts to enhance the dissolution
rate of poorly water-soluble drugs based on crystallization in the presence of
surfactants or hydrophilic polymers such as poiyvinyipyrro)k3one,
polyethylene glycol or hydroxypropylmethylcellulose (Naggar et al, 1980; El-
Gindy & Shalaby 1982; Al-Meshal & York, 1984; El-Barry et al, 1990;
Shawky & Mesiha, 1988).
In chapter 8, it was shown that the crystallization of paraceta.rnol in the
presence of PVP improved its compaction properties. Since paracetamol is a
sparingly water-soluble drug, the aim of the work presented in this chapter
253
was to investigate the dissolution properties of paracetamol crystallized in
the presence of different grades of PVP to evaluate if its dissolution
properties were modified.
9.2 MATERIALS AND METHODS
9.2.1 MATERIALS
Untreated paracetaniol as described in sections 2.1.1; paracetamol particles
crystallized in the absence of PVP (thin plate-like crystals) or in the presence
of 0.1, 0.3 or 0.5% w/v of PVP 2000, 10000 or 50000, as described in section
7.2.2.1, were used.
9.2.2 METHODS
9.2.2.1 Particle size fractions
Sieved fractions of untreated paracetamol (<90 pIn) and samples crystallized
in the absence of PVP or in the presence of 0.5% w/v of different grades of
PVP (<90 pm), were obtained, as detailed in section 2.2.13. In the case of
particles crystallized in presence of 0.1 or 0.3% w/v of different grades of
PVP, they were used unsieved, as harvested from crystallization medium.
These particles had different ranges of size and therefore it was impossible
to obtain a specific seived fraction for each of them.
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9.2.2.2 Determination of solubility of paracetamol
In order to determine the aqueous solubility of modified paracetamol particles
crystallized in the presence of PVP, the following was carried out: Samples
(2.5 g) of paracetamol obtained in the presence of 0.5% w/v of PVP 10000 (as
a representative of a grade of PVP) were dispersed in 100 ml water in
stoppred conical flasks. The paracetamol concentration was determined in the
filtered solutions after 24 h, as described in section 2.2.7.1.
9.2.2.3 Determination of dissolution of paracetamol powders
The dissolution profiles of untreated paracetamol, and paraceta.mol particles
crystallized in the absence or presence of 0.1, 0.3 or 0.5% w/v of PVP 2000,
PVP 10000 or PVP 50000 were obtained as described in section 2.2.8. In all
tests, an appropriate amount of powder was taken which was equivalent to
35 mg of paracetamol.
When untreated paracetamol was directly added to the dissolution medium
by dusting onto the surface of water, the particles floated on the surface of
dissolution medium (water) and were not dispersed uniformly. Under these
conditions the dissolution results were not reproducible. To overcome this
problem and to give a uniform wetting of the drug powder, some workers
transferred the drug crystals into an empty tea bag which was then
suspended in the dissolution medium (El-Bary et al, 1990). In the present
study, as described in section 2.2.8, the paracetamol powders were placed into
small bags made from metal gauze with 25 pm mesh size. Then the bags
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were sunk into the water.
9.3 RESULTS AND DISCUSSION
9.3.1 AQUEOUS SOLUBILITY OF PARACETAMOL CRYSTALLIZED IN
THE PRESENCE OF PVP
The aqueous solubility of paracetamol crystallized in the presence of 0.5% w/v
of PVP 10000 is listed in table 9.1. There was no significant difference
between the solubility of untreated particles and samples crystallized in the
presence of PVP. According to table 7.1, the paracetamol particles crystallized
in the presence of 0.5% w/v PVP 10000 consisted of 3.96% w/w of PVP.
Therefore, the concentration of PVP in the medium was 0.12% w/v. As
described in section 6.3.1, this concentration is far below that which affected
the solubility of paracetamol.
Table 9.1 Aqueous solubility of untreated paracetamol and paracetamol
crystallized in the presence of 0.5% w/v PVP 10000.
Sample	 Solubility (g/100 ml)±SD
Untreated paracetamol	 2.02±0.04*
Paracetamol crystallized in the 	 2.11±0.09
presence of 0.5% w/v of PVP 10000
* Taken from table 6.1
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9.3.2 DISSOLUTION STUDIES OF PARACETAMOL CRYSTALLIZED IN
THE PRESENCE OF PVP
Figures 9.1, 9.2 and 9.3 show the dissolution profiles of paracetamol
crystallized in the presence of 0.1, 0.3 or 0.5% w/v of different grades of PVP,
respectively. The dissolution profiles of untreated paracetamol and samples
crystallized in the absence of PVP are also included in these figures. The
percentages of paracetamol dissolved within the first two minutes of study
are presented in figure 9.4. These figures indicate that there was a marked
enhancement in the dissolution characteristics of paracetamol crystallized in
the presence of PVP. This can be attributed to the followings.
1- Adsorption of PVP to paracetamol particles crystallized in the presence of
PVP (table 7.1) would undoubtly increase the wettability of these particles
and thereby increase the dissolution rate. The wetting of a powder is the first
step in the dissolution process. It is frequently difficult to disperse a poorly
water-soluble powder in a fluid owing to an adsorbed layer of air. Wetting is
the displacement of air from the surfaces of particles by a liquid (Hem et al,
1982). When the drug particles are encircled by the water-soluble polymers
or surfactant, the polymer can readily dissolve and cause the water to contact
and wet the particles (Chiou & Riegelman, 1971).
Chiou et al, (1976) reported that the crystallization of chioramphenicol,
suiphathiazole and prednisolone in the presence of polysorbate 80
significantly increased the dissolution rates of these drugs. This was
257
11)
0
ri
ri
0
Cd
'1)
Q
Cd
Cd
100
80
60
40
20
0
0246 8 10 12 14 16 18 20
Time (mm)
Figure 9.1 Percentage of paracetamol disolved against time (mm) for: (E)
untreated paracetamol, and paracetamol crystallized in (•) absence of PVP,
or in the presence of 0.1% w/v of (0) PVP 2000, (A) PVP 10000 or (A) PVP
50000.
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Figure 9.2 Percentage of paracetamol dissolved against time (mm) for: (0)
untreated paracetamol, and paracetamol crystallized in (U) absence of PVP,
or in the presence of 0.3% w/v of (0) PVP 2000, (A) PVP 10000 or () PVP
50000.
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Figure 9.3 Percentage of paracetamol dissolved against time (mm) for: (0)
untreated paracetamol, and paracetamol crystallized in (I) absence of PVP,
or in the presence of 0.5% w/v of () PVP 2000, (A) PVP 10000 or () PVP
50000.
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Figure 9.4 Percentage of paracetamol dissolved within the first two minutes
during dissolution studies of untreated paracetamol and samples crystallized
in the absence or presence of different amounts of various grades of PVP
(numbers in brackets are the percentage, %w/w, of PVP in the particles which
were taken from table 7.1).
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attributed to adsorption of small amounts of surfactant onto the drug
particles, which increased their wettability and therefore dissolution rate. El-
Bary et al, (1990) demonstrated that crystallization of chlorpropamide in the
presence of polysorbate 80, polyethylene glycol or PVP caused marked
enhancement in its dissolution rates. The authors claimed that washing the
crystals caused a marked decrease in the dissolution rate of chiorpropamide.
This was attributed to removing some of the adsorbed surfactant or polymer
during washing.
2- The faster dissolution rate of paracetamol crystals obtained in the presence
of PVP can be also attributed to reduction in the size o y.tetamo% rytX
following crystallization from PVP solutions. In section 7.3.4, it was shown
that paracetamol particles obtained in the presence of <0.3% w/v of PVP had
agglomerated structures which consisted of numerous fine rnicrocrystals
(figures 7.3-7.6). Decrease in particle size would increase the surface area of
paracetamol exposed to the dissolution media and subsequently increases the
dissolution rate. El-Bary et al (1990) and El-Samaligy et al (1994) similarly
reported that increase in dissolution rate of some drugs crystallized in the
presence of surfactants or soluble polymers was due to reduction in their
particle size.
Naggar et al (1980) reported that increase in dissolution rate of
phenylbutazone following crystallization in presence of polysorbate 80 may
be attributed to a slight increase in its solubiity. However, Chiou et al (1976)
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suggested that although the surfactants can increase the solubility of poorly
soluble compounds, the amounts of surfactant adsorbed onto the drug
particles crystallized in the presence of surfactants are probably too negligible
to affect the solubility of the drug in bulk solution. In the present study, the
results of solubility studies (section 9.3, table 9.1) indicated that the aqueous
solubility of paracetamol crystallized in presence of PVP was not significantly
different to untreated paracetamol.
Figures 9.1-9.4 indicate that with increasing the concentration andlor
molecular weight of PVP in the crystallization medium, the obtained
paracetamol exhibited faster dissolution rates. This may be attributed to
firstly, an increase in the amount of adsorbed PVP onto the particles (table
7.1) or secondly, with increasing the molecular weight and/or the
concentration of PVP in crystallization medium, the size of particles
decreased (figures 7.3-7.6). These factors lead to an increase in dissolution
rate of paracetamol. El-Barry et al (1990) & El-Samaligy et al (1994)
similarly demonstrated that by increasing the concentration and/or the
molecular weight of hydrophilic polymers such as PVP or polyethylene glycol
during the crystallization of salicyihydroxamic acid or chiorpropamide, the
dissolution rates of obtained crystals increased.
El-Gindy et al (1982) and Shawky and Mesiha (1988) reported that
crystallization of lorazepam or nalidixic acid in the presence of PVP caused
a faster dissolution rate than other polymers or surfactants (polysorbate 80
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or polyethylene glycol). The authors suggested that PVP is probably able to
form a water-soluble complex with these drugs on the surface of their
crystals. This may cause a faster dissolution rate. It was also shown that
when lorazepam crystallized in the presence of PVP produced crystals with
the smallest size and highest specific surface area than other polymers. This
may also increase the dissolution rate.
Chiou et al (1976) also suggested that presence of the surfactant during
crystallization process might also cause a defect in the crystal structure and
crystal would become thermodynamically unstable and, hence, dissolves
faster. The results of differential scanning calorimetry (table 7.2, section
7.3.7.4) exhibited that the paracetamol crystallized in the presence of PVP
had a lower enthalpy of fusion than untreated paracetamol, which was
attributed to the presence of PVP in the particles. This may make the
particles less stable, therefore they dissolve faster.
9.4 CONCLUSION
Crystallization of paracetamol in the presence of PVP caused a marked
enhancement in its dissolution rate. This enhancement was attributed to
adsorption of PVP onto the surfaces of paracetamol crystals which increased
their wettability. Decrease in crystal size of paracetamol obtained in presence
of PVP was another reason for the higher dissolution rate.
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CHAPTER 10. GENERAL DISCUSSION
10.1 INTRODUCTION
Paracetamol is a widely used analgesic which exhibits poor compressibility
during compaction, often resulting in weak and unacceptable tablets with a
high tendency to cap (Krycer et al, 1982). Some attempts have been made to
modify the properties of paracetamol crystals using different crystallization
techniques, in order to improve its compaction properties (Fachaux et a!,
1992, 1993; Di Martino et al, 1994, 1996; Abdelillah et al, 1995). However,
one of the disadvantages of the methods of these co-workers was the use of
toxic solvents, such as dioxane or tetrahydrofuran. The main aim of this
project was to study the consequences of altering the crystal properties of
paracetamol, using different crystallization procedures and toxicologically safe
solvents, on their compaction behaviour.
10.2 COMPACTION PROPERTIES OF PARACETAMOL
In general, the strength of a compact depends on the inherent ability of the
powder to reduce in volume during compression and the amount of
interparticulate attraction in the final compact (Milosovitch, 1963). The poor
compaction properties of paracetamol have been attributed to a low degree
of plastic flow and high elasticity (Duberg & Nystrom, 1986) and weak
bonding between particles (Obiorah & Shotton, 1976). In order to study the
fundamental compression characteristics of paracetamol, two different
particle size fractions (<90 pm and 105-2 10 pm), were compressed at different
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compression forces and speeds.
Compression of two particle sizes of paracetamol, at all compression forces
(10-30 kN), even at the lowest compression speed (10 mm s'), produced
extremely weak tablets which had no measurable strength and a high
tendency to cap. Heckel analysis indicated that the larger particles (105-210
pm) underwent more densification than smaller particles (<90 pm), during
compaction. This was attributed to increased frictional and cohesive forces
associated with the smaller particles which tended to restrict particle sliding
and thus reduced densification (York, 1978; Roberts & Rowe, 1986).
Furthermore, during compaction, the smaller particles yielded from
fragmentation of the larger angular shaped particles, probably tended to fill
the remaining interparticulate voids between the particles. This would lead
to a further increase in the relative density of the compacts made from larger
particles. In contrast, it would be expected that only a relatively small
amount of fragmentation would occur in the smaller particle size fractions
due to their spherical shape, as reported by McKenna and McCafferty (1982)
and Roberts and Rowe (1986).
The values of mean yield pressures (MYP) obtained for the <90 pm and 105-
210 pm particle sizes of paracetamol were 44.5 and 34.4 MPa, respectively.
A low MYP (less than 50 MPa), obtained for materials such as Avicel®,
indicates a high degree of plastic deformation under pressure (Roberts &
Rowe, 1987h; Garr & Rubinstein, 1991b). However, York (1978) and Duberg
266
and Nystrom (1986) reported that the value of MYP derived from the slope
of the linear portion of a Heckel plot depends on the elastic and plastic
deformation of the material under an applied load. Thus, for elastic materials
a false, low MYP is obtained (Fell & Newton, 1971). Therefore, it is difficult
to distinguish between plastic and elastic deformation evaluated from the
slope of the linear portion of Heckel plot. In an attempt to distinguish
between plastic and elastic deformation of materials, Duberg and Nystrom
(1986) divided the Heckel plot into three phases and showed that a
considerable deviation from the horizontal in phase III (decompression phase)
indicated elastic behaviour of material under pressure. A large deviation from
horizontal observed in the phase III of Heckel plot for paracetamol was
therefore indicative of a high degree of elastic propensity of these particles
under pressure. Therefore the low MYP found for paracetamol is attributed
to its elastic behaviour and not to plastic deformation.
The correlation coefficient of the initial part of Heckel plot (0-20 MPa) was
lower for larger particles, indicating a higher degree of fragmentation for the
larger particles than smaller fractions. It has been reported that a linear
segment (high value of correlation coefficient) for the initial part (phase I) of
a Heckel plot is obtained for non-fragmenting materials such as sodium
chloride. A non linear curve with a low value for the correlation coefficient,
corresponds to materials, such as Emcompress®, which consolidate by a
fragmentation mechanism (Duberg & Nystrom, 1982).
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The change of MYP with compaction speeds was calculated as strain rate
sensitivity (SRS). The calculated values of SRS for the <90 jim and 105-210
jim fractions of paracetamol were 13.6 and 18.7%, respectively. SRS is a
useful index which can show the plastic or brittle nature of a material. Due
to the time dependent nature of plastic deformation, the MYP increases with
increasing punch velocity for plastic materials such as Avicel and sodium
chloride, which consequently show high values of SRS (>40%) (Roberts &
Rowe, 1985; 1987a). However, for lactose, which deforms by a combination of
particle fracture and plastic deformation, the SRS was about 16% (Roberts
& Rowe, 1985). Therefore the rather low degree of SRS found for
paracetamol, is indicative that fragmentation is the dominant mechanism
during compaction. Similar results were obtained during the compaction of
paracetamol by Roberts and Rowe (1985).
At each compaction speed, as the particle size of paracetarnol decreased, the
MYP increased. It has been reported that for plastically deforniing materials
such as sodium chloride (Hersey et al, 1973; Humbert-Droz et al, 1983) and
microcrystalline cellulose (Roberts & Rowe, 1986) and starch (McKenna &
McCafferty, 1982), the measured MYPs were independent of particle size.
However, for materials that deform by particle fragmentation such as lactose
and calcium carbonate, the MYP increased with reduction in particle size
(Hersey et al, 1973; York, 1978; Roberts & Rowe, 1986). Therefore, the
findings in this study again indicated that paracetamol belongs to the group
of materials that deform by fragmentation.
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Tablets made from the larger particles of paracetamol (105-210 jim) exhibited
lower elastic recovery and elastic energy than smaller fractions (<90 jim).
This may be attributed to higher interparticulate bondings for the larger
fraction. Increased fragmentation of the larger size fractions of paracetamol
during compaction, probably caused an increase in interparticulate bonding
due to the formation of fresh and clean surfaces, as reported by McKenna and
MaCafferty (1982). The high values of the ratio of elastic energy/plastic
energy (EE/PE), indicated that the majority of the energy involved during
compaction was utilized as elastic energy. The ratio of EE/PE generally
increased with increasing compression force or speed. This indicated that at
higher compaction forces or speeds the tablets became more elastic. Similar
results were reported by Garr and Rubinstein (1991a). They observed that
the EE/PE ratio increased with compression speed and suggested that the
increases in capping tendencies with compression speed were related to an
increase in the EE/PE ratio.
The results of this study demonstrated that paracetamol is a poorly
compressible substance. The main mechanism of compression of paracetamol
was fragmentation. Paracetamol particles underwent a high elastic
deformation during compaction, resulting in weak and capped tablets.
10.3 HABIT MODIFICATION OF PARACETAMOL CRYSTALS AND
THEIR TABLETING CHARACTERISTICS
Crystallization of paracetamol from a wide range of solvents such as water,
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ethanol or dioxane (Fachaux et al, 1992), isopropanol, dioxane or acetone and
their mixtures with water (El-Said, 1995) or alcohols, esters, ketones and
acetonitrile (Fairbrother, 1974) produced essentially prismatic polyhedral
crystals. The polyhedral habit is the predominant form in paracetamol
crystals.
In an attempt to modify the crystal habit of paracetamol, concentrated
solutions of paracetamol in hot ethanol (5g/12m11) were rapidly added to 50 ml
of cold water at 3°C. After 15 mm, with no agitation, the precipitated crystals
were collected. This crystallization process, tenned the "watering-out"
method, caused marked modification to the crystal habit of paracetamol and
produced thin plate-like crystals. However, the crystallization of paracetamol
using the same method but at 25°C, produced prismatic polyhedral crystals.
Alternative crystallization procedures (from water, ethanol or water/ethanol
at 3°C or 25 °C) revealed that crystallization solvent (ethanol/water) and
crystallization temperature (3°C), i.e. rapid cooling, were both critical in the
production of thin plate-like crystals. Elimination of either of these factors
inhibited the production of thin plate-like crystals. Crystallization at 3°C
produced a high degree of supersaturation for the water/ethanol system. It
has been reported that a high degree of supersaturation may cause
preferential growth of crystals in one particular direction, leading to the
formation of different crystal habits (Mullin, 1993). Some workers have
shown that cooling rate has a major influence on the crystal habit. For
instance, naphthalene crystallized as thin plates from methanol by rapid
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cooling but when it was slowly crystallized, compact (grain-like) crystals were
formed (Wells, 1946). Garti and Tibika (1980) demonstrated that by
increasing the cooling rate during crystallization of nitrofurantoin from a
firmic acidlethanol mixture, more elongated crystals were collected.
DSC, JR and XPD studies revealed that the thin plate-like paracetamol
crystals obtained by the watering-out method at 3°C and the prismatic
polyhedral crystals obtained from water at 25°C, were habit modifications
and not polymorphic modifications.
Prismatic polyhedral crystals of paracetamol obtained from water at 25°C and
thin plate-like crystals obtained by the watering-out method at 3°C, were
compressed at different compaction forces or speeds to investigate whether
crystal habit had any significant effect on the compaction behaviour of
paracetamol and whether the modified crystals showed improved compaction
properties.
Compression of the thin plate-like and polyhedral crystals at all compression
forces (10-30 kN), even at the lowest compression speed (10 mm s 1 ), produced
very weak tablets with no measurable strength and a high capping tendency.
The Heckel plots and their associated constants were dependent on the
crystal habit. The degree of densification that occured during compression
was greater for the polyhedral crystals than for thin plate-like crystals. This
was attributed to increased frictional and cohesive forces between the plate-
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like crystals, due to their large and flat surfaces which would increase the
contact points between them, restrict particle sliding and thus reduce
densification.
The correlation coefficients of the initial part of Heckel plots (0-20 MPa) were
considerably lower for the plate-like crystals. This was indicative of greater
fragmentation of the plate-like crystals as compared to the polyhedral
crystals. Marshall and York (1991) reported that different crystal habits of
nitrofurantoin (needle and plate-like), crystallized from different solvents,
similarly exhibited different Heckel plots. They reported that the degree of
densification that occured during compression was greater for plate-like
crystals as compared to needle-like crystals. Needle-like crystals showed
higher mean yield pressure than plate-like crystals.
The values of SRS for polyhedral and thin plate-like crystals of paracetamol
were 27 and 14% respectively, which clearly indicate that plate-like crystals
were more brittle during compaction than polyhedral crystals.
The tablets made from plate-like crystals exhibited higher elastic recoveries
than those made from the polyhedral crystals. This may be attributed to the
interparticulate bondings between the former particles being weaker than
between the latter particles. Milosovich (1963) reported that the poor
compaction properties of a specific habit of a drug can be attributed to the
presence of crystal faces that give poor adhesion to each other and the
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absence of faces that are required for optimal adhesion. It is obvious that for
plate-like and polyhedral crystals the relative abundance of the different
faces within the crystals were modified. This can affect the interparticulate
bonding between these crystals resulting in different elastic recoveries for
these two habits of paracetamol.
The results of elastic energies supported the elastic recoveries. The plate-like
crystals underwent more elastic deformation during compaction than the
polyhedral crystals. Hong-Guang and Ru-Hue (1995) investigated the
compaction properties of paracetamol of different crystalline shapes. They
reported that needle-like crystals of paracetamol exhibited poorer
compressibility with a greater extent of capping and lamination compared to
tablets made from polyhedral crystals. This was attributed to greater elastic
deformation of the needle-like crystals.
The results of this study indicated that the crystal habit had a great
influence on the compaction behaviour of paracetamol. However, neither
polyhedral nor thin plate-like crystals exhibited any major improvement in
the compaction properties as compared to untreated paracetamol.
10.4 TABLETING CHARACTERISTICS OF PARACETAMOL
CRYSTALLIZED IN THE PRESENCE OF PYP
There are several reports on attempts to change the crystal habit of a
particular substance using additives during the crystallization process
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(Michael & Colville, 1960; Fairbrother & Grant, 1978, 1979; Chow et a!, 1985;
Femi-Oyew & Spring, 1994; Kaul et al, 1992). One group of additives used
during the crystallization processes is long chain polymeric materials (Mullin,
1993). There are several examples in the literature where PVP has been
demonstrated to be a strong crystal growth inhibitor for drugs such as
suiphathiazole, salicylic acid and paracetamol by adsorption on to their
crystal surfaces (Simmonelli, 1970; Ziller & Rupprecht, 1988 & 1990).
Paracetamol was crystallized in the presence of PVP using a watering-out
method, similar to that described in the previous section. Hot ethanolic
solutions of paracetarnol (5g/12m1) were rapidly added to 50 ml quantities of
cold water at 3°C containing 0, 0.1, 0.3 or 0.5% w/v PVP of molecular weight
2000, 10000 or 50000. The resultant solutions were maintained at about
3±1°C without agitation. After 15 mm the precipitated particles were
collected. The presence of PVP in the crystallization medium increased the
induction time required for appearance of crystals and decreased the crystal
recovery. The obtained paracetamol particles contained small amounts of
PVP. The use of PVP in the crystallization media had a major effect on the
morphology of the crystals. Paracetamol crystals obtained in the absence of
PVP were very thin and flaky, whereas those obtained in the presence of
^O.W/ w/v of PVP 10000 or P\TP 50000 were near spherical in shape. The
particles were agglomerates (clusters) of numerous fine rod-shape
microcrystals which had stuck together. The particles obtained in the
presence of PVP 2000, even at its highest concentration (0.5% w/v), consisted
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of a few microcrystals which had stuck together. Dàvey (1982) reported that
active additives influence the crystallization process and produce crystals of
different shape to those formed from a pure solution. Furthermore, the active
additives increase the induction time and also reduced the crystal growth and
yield. The observed changes in crystal habit of paracetamol, the delay in the
appearance of crystals, reduction in crystal yield and sorption of PVP by
paracetamol particles, were indicative that PVP is an effective additive
during the crystallization of paracetamol. It appeared that the highest
molecular weight of PVP was the most effective additive. The relative
effectiveness of the three grades of PVP, as considered by the parameters
mentioned above, followed the order PVP 50000>PVP 10000>PVP 2000. All
these observed effects of PVP during crystallization of paracetamol were
attributed to the adsorption of PVP onto the paracetamol particles during
crystal growth.
Particles crystallized in the presence of 0.5% w/v of PVP 2000, PVP 10000 or
PVP 50000 contained 3.23, 3.96 or 4.32% w/w of PVP, respectively. DSC, XPD
and JR experiments showed that paracetamol particles crystallized in the
presence of PVP, did not undergo internal structural modifications compared
to untreated paracetamol. However, DSC studies showed that the enthalpy
of fusion of paracetamol crystallized in the presence of PYP decreased. This
was attributed to the presence of PVP in the particles, and not crystal
disruption.
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The paracetamol particles crystallized in the presence of PVP were
compressed at different compaction forces and speeds. The tablets made from
these particles showed crushing strengths which increased with increasing
molecular weight and/or the concentration of PVP in the crystallizing
solution. The results of crushing strength demonstrated that particles
crystallized in the presence of 0.5% w/v PVP 10000 or PVP 50000 produced
tablets with excellent hardness and a lack of tendency to cap. These particles
did not show a major reduction in their crushing strength with increase in
compaction speed. This may be attributed to fragmentation of the particles
under applied load. It has been reported that the crushing strength of tablets
made from materials such as xylitol or Emcompress®, which consolidate by
fragmentation, were independent of compression speed (Garr & Rubinstein,
1990; Garr, 1992). Particles obtained in the presence of PVP 2000 showed
little improvement in their compaction properties.
The SRS values of particles crystallized in the presence of 0.5% w/v of PVP
2000, P\TP 10000 or PVP 50000 were 5.9, 8.4 or 14.9%, respectively. The
lower values of SRS for paracetamol crystallized in the presence of PVP
10000 or PVP 50000 indicate that these particles were less sensitive to
compaction speed, suggesting that a high degree of fragmentation occurred
during compression. Materials which consolidate by fragmentation show no
significant change in mean yield pressure with increasing compaction speed
and therefore exhibit a low SRS (Roberts & Rowe, 1985; Garr, 1992). Another
reason which indicates that particles crystallized in the presence of PVP
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underwent extensive fragmentation during compaction was the lack of major
reduction in the crushing strengths of the tablets following the addition of
magnesium stearate to the particles. It has been reported that materials
which mainly deform by plastic deformation such as sodium chloride are
sensitive to even small additions of lubricant and exhibit a dramatic decrease
in their crushing strength but materials, such as Emcompress®, which
undergo fragmentation, are practically uninfluenced by mixing with
magnesium stearate (Duberg & Nystrom, 1982).
A low deviation from the horizontal of the decompression phase (phase III)
of the Heckel plots of particles crystallized in the presence of P\TP and the
elastic recoveries indicated that tablets made from particles crystallized in
the presence of PVP exhibited lower elastic behaviour than untreated
paracetamol. Tablets made from particles obtained in the presence of PVP
10000 or PVP 50000 exhibited lower elastic recoveries than those obtained in
the presence of PVP 2000 following the removal of compression pressure.
Similarly, the elastic energies indicated that tablets made from particles
crystallized in the presence of PVP underwent less elastic deformation than
those composed of the untreated paracetamol. The tablets made from
particles crystallized in the presence of higher molecular weight PVP were
less elastic than for particles obtained in presence of lower molecular weight
PVP.
The energy analysis also revealed that plastic energies of tablets made from
277
particles crystallized in the presence of PVP were higher than for the
untreated particles. The increases in plastic energy of tablets made from
particles crystallized in the presence of PVP may be attributed to the energy
required for fragmentation of these particles and most importantly to the
formation of bonds between the particles during compaction. The high
crushing strengths of the tablets made from particles obtained in the
presence of PVP indicated strong interparticulate bonding.
The ratios of EETPE for particles crystallized in the presence of P\ TP were
much lower than for untreated crystals. These results indicate that for
untreated particles the major portion of compaction energy was utilised as
elastic energy, while for particles obtained in presence of PVP a minor portion
was used as elastic energy. These results again confirm that tablets made
from particles crystallized in the presence of PYP exhibited lower elastic
behaviour than untreated paracetamol. It was also shown that paracetamol
crystallized in the presence of higher molecular weights of PVP (PVP 10000
or PVP 50000) exhibited lower EE/PE ratios than those obtained in the
presence of PVP 2000.
The results of this study showed that particles crystallized in the presence
of O.5/ w/v of PVP 10000 or PVP 50000 produced tablets with excellent
hardness with no tendency to cap, even at highest compaction speed (250 mm
'). These particles exhibited considerably less elastic behaviour during
compaction, as compared to untreated paracetamol.
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CHAPTER 11. CONCLUSIONS AND RECOMMENDATIONS FOR
FUTURE WORK
11.1 CONCLUSIONS
Paracetamol as a model of a poorly compressible drug was subjected to
different crystallization procedures to produce different crystal morphologies.
The obtained particles were compressed at different compaction forces or
speeds to investigate whether crystal morphology had any significant effect
on the compaction behaviour of paracetamol and whether the modified
crystals showed any improvement in their compaction properties, as compared
to untreated paracetamol.
Untreated paracetamol exhibited poor compaction properties and produced
very weak tablets with a high tendency to cap. The results of Heckel analysis
indicated that the main mechanism of compaction of paracetamol was
fragmentation. The phase III of Heckel plot, elastic recovery, elastic energy
and elastic energy/plastic energy ratio indicated that paracetamol particles
underwent high elastic deformation during compaction, resulting in weak and
capped tablets.
Crystallization of paracetamol by a combination of "watering-out" from an
ethanolic solution and rapid cooling produced thin plate-like crystals. These
findings indicated a marked modification in the crystal habit compared to the
prismatic polyhedral crystals obtained from water. Compression of polyhedral
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and thin plate-like crystals revealed that crystal habit influenced the
compaction behaviour of paracetamol. Polyhedral crystals exhibited a greater
plasticity during compaction compared to the thin plate-like crystals, which
were more brittle. Thin plate-like crystals underwent more elastic
deformation during compaction than polyhedral crystals. These two crystal
habits of paracetamol did not exhibit major improvement in their compaction
properties compared to untreated particles.
Crystallization of paracetamol by a combination of "watering-out" from
ethanolic solutions at low temperature and in the presence of 0.5% w/v of
PVP molecular weight of 10000 or 50000 produced near spherical,
agglomerated particles of paracetamol. These agglomerates consisted of
numerous rod-shaped microcrystals which had stuck together. Particles
obtained in the presence of PVP 2000 consisted of fewer microcrystals. The
most important advantages of this crystallization method were using water
as the major portion of solvent and ethanol as the minor portion of solvent
(water and ethanol are the cheapest and safest solvents), and using a safe
and widely used excipient, PVP, as additive. Particles obtained in the
presence of P\TP 10000 or PVP 50000 produced tablets with excellent
hardness and with no tendency to cap even at high compaction speed.
Particles obtained in the presence of PVP 2000 exhibited little improvement
in their compaction properties. The results of elastic recovery, elastic energy
and elastic energy/plastic energy ratio revealed that particles crystallized in
the presence of PVP exhibited much less elastic behaviour under pressure, as
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compared to untreated paracetamol. Paracetamol crystallized in the presence
of PVP also exhibited a marked enhancement in dissolution rate. This was
attributed to adsorption of PVP onto the surfaces of paraetamol crystals
which increased their wettability and therefore dissolution rate.
11.2 RECOMMENDATIONS FOR FUTURE WORK
1- After crystallization of paracetamol in the presence of PVP, the residual
solvent contained PVP and paracetamol. Therefore, it is necessary to find an
appropriate method to separate and recover the PVP and paracetamol from
the residual solvent.
2- In this study, the paracetamol crystallized in the presence of PVP was
compressed without any excipients or adjuvants. Therefore, it would be useful
to find a suitable formulation in order to optimize the hardness, and
disintegration and therefore dissolution time of tablets made from
paracetamol crystallized in the presence of PVP.
3- In this study, the crystallization of paracetamol in the presence of PVP was
carried out using watering-out method. It would be interesting to see if
crystallization of paracetamol in the presence of PVP using the same solvents
(water/ethanol), but by evaporation of solvent in vacuum which will be a rapid
crystallization, can produce such compressible particles as obtained by the
watering-out methods.
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4- Crystallization of paracetamol by watering-out technique from its ethanolic
solution in the presence of PVP improved its compressibility. It would be
interesting to see if this technique would also prove useful in improving the
compression properties of other poorly compressible drugs.
5- Crystallization of paracetamol was carried out in presence of only PVP.
However, there are some reports that other polymers such as HPMC which
can inhibit the crystallization of drugs. Therefore, the potential of using other
polymers during the crystallization of paracetamol should be investigated.
282
APPENDIX 1
1- Composition of 0.006 N iodine solution for photometric measurement of
PVP in aqueous solution:
0.81 g of sublimed iodine and 1.44 g of potassium iodide dissolved in 1000 ml
of water.
2- Composition of blank solution for photometric measurement of PVP in
aqueous solution:
50 ml of water + 25 ml of 0.2 M citric acid solution + 10 ml 0.006 N iodine
solution.
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ABBREVIATIONS
Hf
pm
BDH
BP
C
Cs
CT
D
DSC
EDTA
EE
ER
g
h
JR
J
kg
kN
kp
kV
Ln
LVDT
mPa s
M
mg
mm
ml
mm
Mol. Wt.
MPa
MYP
N
Enthalpy of Fusion
Micrometer
British Drug Houses
British Pharmacopoeia
Concentration
Crushing Strength
Capping Tendency
Relative Density
Differential Scanning Calorimetry
Ethylendiamine Tetra-Acetic Acid
Elastic Energy
Elastic Recovery
Gram
Hour
Infrared
Joule
Kilo gram
Kilo Newton
Kilo Pound
Kilo Volt
Natural Logarithm
Linear Variable Differential Transformer
Milli Pascal Seconds
Molar
Milligram
Minute
Milliitre
Millimetre
Molecular Weight
Mega Pascal
Mean Yield Pressure
Normal
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nm
PE
PF
PH
psi
PvP
r
S
SD
SEM
SRS
TA
Tm
TPL
USP
Uv
v/v
w/v
w/w
XPD
Nanometre
Plastic Energy
Pyrogen Free
Polyhedral
Pounds per square inch
Polyvinylpyrrolidone
Correlation Coefficient
Second
Standard Deviation
Scanning Electron Microscopy
Strain Rate Sensitivity
Thermal Analysis
Melting point
Thin Plate-like
United State Pharmacopoeia
Ultraviolet
Volume in Volume
Weight in Volume
Weight in Weight
X-ray Powder Diffraction
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